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Gene targeting is a method for introducing mutations into specific genes of an organism. To date most work in the field has
focused on the creation of insertion or deletion events to generate a null allele in the gene of interest in murine embryonic
stem (ES) cells, with the objective of introducing this mutation into the mouse germline. This has facilitated the study of the
in vivo role of many genes at the level of the organism and provided a ready source of cell lines carrying the desired mutation
for further analysis. The generation of more subtle mutations, where function of the gene is modified rather than ablated, is
also desirable. This thesis is concerned with "Hit and Run" gene targeting in ES cells, a method designed with the objective
of introducing small mutations into the genome. The procedure relies on the integration of a vector carrying the desired
mutation, and positive and negative selectable markers. After isolation of an event which has introduced the vector into the
target locus by positive selection and genomic screening, a second selection performed upon the negative selectable marker is
carried out. This should select for clones which have undergone an intra-chromosomal recombination event which removes
the vector sequences and restores the locus. Some of the reverted clones obtained will have retained the mutation.
The hit and run targeting technique relies on a high degree of fidelity in the homologous recombination process, to avoid the
introduction of mutations other than the desired mutation into the target locus. However, relatively little is known about the
fidelity of gene targeting homologous recombination events. Part of this thesis examines this question in a model gene, the
hprtb'm3 null mutant locus. This allele is useful for studying gene targeting reactions because selections either for or against
gene activity may be simply achieved by in vitro chemical selection. The hprtb'm3 gene was targeted with an insertion-type
vector designed to restore hprt gene function which also incorporated the positive selectable marker neo. The neo gene was
initially used to select stably-transfected clones. The clones were then studied genotypically and phenotypically to seek events
where apparently correct homologous recombination events at the hprt locus failed to restore gene function and thus
suggested errors in the targeting process. The data indicate that the rate of error in recombination must be low.
Mutations in the kirsten-ras proto-oncogene are recognised to be of great significance in neoplasia, but relatively little is
known about its function in normal mammalian development. Several features of the gene make it suitable for study by
means of hit and run gene targeting: it has an untranslated 5' exon of undefined function, may be activated by point
mutations, and contains alternative C-terminal exons. Hit and run experiments designed to modify these features of the gene
have been carried out. A hit and run vector designed to delete a 2.5kb region surrounding the promoter/exon 0 region
targeted the locus at a low but observable frequency. However, closer examination of the targeted locus revealed a more
complicated structure than that predicted, and reversion events under back-selection were found to produce either a variant of
the structure predicted for an insertion event or a wild-type structure. It is suggested that a combination of concatenation and
extra-chromosomal recombination events resulted in a complex insertion structure which was capable of undergoing multiple
excision events.
Hit and run vectors were also used with the objective of introducing point mutations into exons 1 and 4B of the K-ras gene.
After an unmeasurably low targeting frequency was observed for the first of these vectors, a "Fast-Track" protocol was
attempted with both of these vectors which was designed to expand the effective number of potentially targeted clones
backselected. This method was shown to enrich slightly for events at the target locus in the case of the construct used to
delete exon 0, but was unsuccessful in generating the designed target locus in these experiments. RT-PCR of the modified
gene was found to be a good method of screening targeted clones for subtle modifications not detectable by Southern analysis.
As a complement to the targeting studies of splicing variants in the K-ras gene, splicing variant usage in the tissues of the
developing mouse was also analysed by RT-PCR using primers specific for both variants and comparing quantities of each
message. Consistent with other work in the field, this analysis demonstrates that K-ras1 is ubiquitously expressed in the
developing mouse. However, previous work has failed to differentiate between splice variants of Y-ras mRNA. Here it is
shown that whilst K-rcwB has a ubiquitous pattern of expression, the pattern of Y-rasA expression appears to be more
limited, and K-raxA is usually expressed at a lower level than K-rcwB. Little or no temporal variation of relative splice
variant usage within tissue types was observed, suggesting that the definition of Y-ras expression patterns is an early event in
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Much of eucaryotic genetic analysis has been carried out in organisms such as yeast,
Drosophila melanogaster and Caenorhabditis elegans (see, for example, Alberts et
al., 1994). These species are of small size and typically have short generation times
which permit the relatively simple creation and analysis of a wide variety of
mutations. As a model system for the genetic analysis of mammals however, such
species are somewhat limited. The size and generation times of mammals, together
with the large genome size (approximately 3xl09 bp/haploid genome), makes such
studies more difficult. In the mouse over 1300 loci are known with naturally-
occurring mutations, many of which are for genes which have not as yet been cloned
(Green, 1989). This compares poorly with an estimated complement of 104-105 genes
in the mammalian genome (Alberts et al., 1994). Thus many mammalian genes,
notably some involved in immune system function or implicated in the development
ofmalignancy, have no known naturally-occurring mutants.
Several thousand genetic diseases are known in humans (McKusick, 1978), most of
which have no direct parallel in an experimental animal which may be used as a model
in the study of the disease and as a test-bed for potential therapies.
1.1.1 Transgenic Mammals
Transgenic mammals, most usually mouse, but also other species both laboratory and
domestic, have been created by the micro-injection of DNA into oocytes or retroviral
insertion (reviewed in Palmiter & Brinster, 1986; Jaenisch, 1988) and have proved
very helpful in the study of many genes. This technique however is limited by the fact
that genetic material may only be added to the genome, not subtracted, at genetic loci
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and in copy numbers which may not be predicted. Phenotypes obtained by such
procedures may be affected by both the position and the number of copies of the
injected sequence which integrate into the genome (reviewed by Palmiter & Brinster,
1986). Local position effects at the site of integration or the lack of introns or
enhancer elements within the transgene can cause attenuation of expression to below
physiological levels (Jaenisch, 1988). Conversely, integration of multiple tandemly-
arrayed copies (a common event) or the presence of cryptic promoter sequences in
the transgene can cause unexpectedly high expression in a tissue (e.g. Al-Shawi et al.,
1991). Should the transgene integrate into an endogenous gene the results of the
experiment may be complicated by additional effects due to loss of activity of the
integration locus.
It is often beneficial to generate a null allele for a gene of interest. However, the use
of transgenic expression of antisense sequences with the objective of effectively
deleting a gene, although successful in some cases where a complete ablation of
function is unnecessary to generate a phenotype (Katsuki et al., 1988), is of variable
and unpredictable efficiency (Katsuki et al., 1988; Munir et al., 1990).
Reverse genetics of mammals, most notably in the mouse, has been revolutionised in
the past decade by the combination of two systems. These are the
Embryonal/Embryonic Stem Cell (ES Cell) system, and the Gene Targeting system.
1.2 Embryonal Stem Cells
1.2.1 Early Murine Development (Hogan et al, 1986)
After fertilisation, the egg divides during its journey down the oviduct to produce a
morula (ball of cells) within the zona pellucida. As it reaches the 8- to 16-cell stage
the cells (a.k.a. blastomeres) flatten and become polarised (compaction). Further
division produces a blastocyst, which consists of a layer of cells (the trophoectoderm)
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derived from the apical domains of the polarised cells surrounding a fluid-filled cavity
(the blastocoel) and the cells of the inner cell mass (ICM), which are derived from the
basal domains of the polarised cells. The blastocyst expands and by the 64-cell stage,
when the ICM consists of approximately 20 cells, it hatches from the zona pellucida
and implants into the uterine epithelium, 4-4.5 days post-coitum (p.c.).
Just before implantation the primitive endoderm, a layer of epithelial cells,
differentiates from and surrounds the ICM. These cells go on to form the yolk sac of
the embryo. The core of the ICM forms a layer of cells called the epiblast and this
forms the ectoderm, endoderm and mesoderm. The ICM therefore gives rise to the
entire foetus.
1.2.2 The Germline
The primordial germ cells (PGCs) originate from extra-embryonic tissue (Ginsburg et
al. 1990) and migrate from the extraembryonic mesoderm to the gonads by day 12.5-
13.5 p.c. (Ginsburg et al., 1990; Fox et al., 1981; Stinnakre et al., 1981). They
generate the germ cells in the adult embryo. However, they may only be cultured in
vitro for a limited period before reaching mitotic arrest (Matsui et al., 1991) and
appear to be incapable of contributing to tissues in a chimaera following direct
explantation from an embryo (Stewart et al., 1994). Embryonic Germline (EG) cells
are derived from PGCs by inducing them to divide in culture for long periods in the
presence of multiple growth factors (Matsui et al., 1992; Resnick et al., 1992), and
have recently been shown to be capable of contributing to the somatic tissues and
germline of chimaeras (Stewart et al., 1994; Matsui et al., 1992).
1.2.3 Teratomas: Tumours of the Germline
Teratomas and teratocarcinomas are tumours which occur most commonly in the
gonads, but they are also observed at other sites. They are defined by a confused
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appearance due to the presence of multiple differentiated cell types usually derived
from all three germ layers, which differentiate from a malignant developmentally
pluripotent cell population: the embryonal carcinoma (EC) cells (Solter & Damjanov,
1979; Martin, 1980; Mintz & Fleischman, 1981; Silver et ai, 1983; Gardner, 1983).
If all the EC cells differentiate the result is a benign teratoma; any malignancy is due
entirely to the remaining EC cells. In mouse strain 129 spontaneous testicular
teratomas are observed frequently (Stevens, 1983) and they can also be induced in a
histocompatible recipient by grafting of the male genital ridges from a 129-strain
embryo. Such transplanted tumours are therefore derived from PGCs (see previous
section). Grafts from early stage embryos of many mouse strains can also produce
teratomas in the recipient, but these are derived from the epiblast. This has been
interpreted as meaning that EC cells behave malignantly by virtue of their local
environment (at least initially), rather than being triggered to do so by an oncogenic
stimulus at the genetic level. The fact that EC cells may originate either from the
epiblast or the PGCs (reviewed in Hooper, 1992) suggests a close relationship
between all of these cell types.
Chimaeras may be made with EC cells by either injecting a blastocyst with EC cells
or aggregating EC cells with morulae (Bradley, 1987). They have a variety of
possible fates: (1) failure to integrate; (2) colonisation of the extra-embryonic tissues;
(3) proliferation resulting in the death of the host embryo; (4) integration into the
embryo to produce tumours; (5) integration into the embryo and contributing to the
somatic tissues or (6) integration and contribution to the functional germline cells of
the embryo. Depending on the EC cell line used to make the chimaera, the relative
frequency of each of the above possibilities can vary (reviewed in Papaioannou &
Rossant, 1983). Importantly however, possibility (6), that is colonisation of the
germline by EC cells in chimaeras, is very rare (Papaioannou & Rossant, 1983;
Stewart & Mintz, 1981, 1982). This is likely to be due to the fact that selection either
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in the primary tumour or as the cell undergoes adaptation to culture conditions
results in a specific, germline-incompetent, subpopulation outgrowing the truly
pluripotent EC cells. Despite their relatively homogenous appearance, different EC
lines vary in their required culture conditions and the extent to which they will
differentiate. Few have a normal diploid karyotype. (Table 1, Appendix of Silver et
al., 1983).
1.2.4 Embryonal Stem Cells
The apparent similarity between pluripotent EC cells and the cells of the epiblast and
PGCs suggested that cell lines derived directly from the ICM might also be expected
to be pluripotent. Embryonal (or embryonic) stem cells (ES cells) were first isolated
from blastocysts by isolation and disruption of the ICM followed by subculture of the
cells on feeder cell layers (Evans and Kaufman, 1981) or in EC cell-conditioned
medium (Martin, 1981) to prevent differentiation. ES cells are pluripotent, and like
EC cells may be induced to differentiate into a variety of different lineages in vitro
(reviewed by Hooper, 1992). Injection of ES cells into blastocysts creates chimaeric
progeny which may include ES cell-derived tissues in all three germ layers including
the germline and the extraembryonic membranes (Bradley et al. 1984; Beddington &
Robertson, 1989). Levels of chimaerism can be extremely high with ES cell-derived
chimaeras. Because ES cells also contribute to the germline of a chimaera, it is
possible to generate mice derived from ES cells which have undergone manipulation
in vitro (Gossler et al., 1986; Robertson et al., 1986).
Most ES cell lines described have a 40, XY karyotype (Robertson et al., 1983) and
are therefore male as opposed to the majority of EC cell lines which are XO. This is
of benefit because male animals have a higher reproductive potential than females and
so ES cell-derived germ cells present at a low frequency will be easier to detect.
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Pluripotency is obviously a defining characteristic of ES cells, and it is important that
it be preserved while the cells are manipulated in vitro. Differentiation was originally
prevented in ES (and EC) cells by co-culturing the ES/EC cells on layers of
mitotically inactivated mouse embryo fibroblasts (Martin & Evans, 1975). ES cells
may also be cultured on permanent fibroblast lines such as STO fibroblasts.
Subsequently medium conditioned by the Buffalo Rat Liver (BRL) epithelial cell line
(Smith & Hooper, 1987) or human bladder carcinoma 5637 cells (Williams et al.,
1988) was shown to include an efficient inhibitor of differentiation which permitted
the continuous culture of ES cells in the absence of feeders. Isolation of the anti-
differentiating activity showed that it is identical to the leukaemia inhibitory factor,
LIF (Williams et al., 1988; Smith et al., 1988; Moreau et al., 1988), so-called
because in vitro it inhibits the M1 myeloid leukaemia cell line. More recently, ciliary
neurotrophic factor (CNTF) has also been shown to maintain the pluripotency of ES
cells in vitro (Ip et al., 1992; Wolf et al., 1994), as has human oncostatin M (OSM)
(Gearing & Bruce, 1992).
The ability of the ES cells to contribute to the germline of the developing mouse thus
provides a means of creating a mouse strain carrying a desired modification if such a
change can be introduced into the ES cell.
1.3 Homologous Recombination in Mammalian Cells
Homologous recombination (HR) is recombination between DNA molecules
dependent on homology between the recombining sequences and not on the specific
sequence per se. In addition to procaryotic organisms, it also occurs in eucaryotic
organisms during meiosis, mitosis and DNA repair (reviewed in Bollag et al., 1989;
Hooper, 1992). Evolutionarily HR functions to generate genetic variation and to
rescue genetic information which may be lost in DNA damaging events by repairing a
DNA molecule using information from the sister DNA molecule. Mammalian cells
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may also undergo other types of recombination such as nonhomologous
recombination and specific recombination types such as occurs in developing
lymphocytes during immunoglobulin gene rearrangement.
HR occurs in mammalian cells between introduced free DNA molecules (Extra-
Chromosomal Recombination, ECR), between homologous sequences in the
chromosomes (Intra-Chromosomal Recombination [ICR] between homologous
regions on a chromosome, and inter-chromosomal recombination, between
homologous sequences on sister chromatids) and between an introduced sequence
and a chromosomal sequence (gene targeting, considered in more depth in the next
section) (reviewed in Bollag et al., 1989; Hooper, 1992).
Whilst there are variations which attempt to account for certain specific observations,
the models of recombination all invoke a free end of a single-strand of DNA which
invades into a homologous double-stranded DNA molecule to produce a
heteroduplex structure (so called because it involves a single strand from two
different DNA molecules and thus mismatches in base-pairing are possible). The
pairing of the strands releases a single strand of uncut sequence from the recipient
molecule in a structure called a D-loop in response to repair synthesis at the end of
the invading strand forcing it from the recipient duplex. The D-loop may then
hybridise with the remaining strand of the donor molecule. This forms a strand
exchange structure called a Holliday Junction (Holliday, 1964). The two major
models suggest either a single-stranded nick (Meselson & Radding, 1975) or a
double-stranded break (Orr-Weaver et al., 1981) in the initiating strand. Depending
on how the Holliday junctions are resolved (see figures 1-1 and 1-2), crossover, gene
conversion or a combination of possibilities may be the result. Schematic diagrams of
the Meselson-Radding and double-strand break-repair models of recombination are
shown in figures 1-1 and 1-2.
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Figure 1-1: Meselson-Radding Model of Homologous Recombination
Each line represents a single strand of DNA with the 3' end marked by an arrow.
Newly-synthesised sequence is drawn as a fine line. Recombination is initiated by a
single-stranded nick in one of the recombining molecules. The 3' end of the nick acts
as a primer for repair synthesis and the newly-synthesised strand displaces a single-
stranded D-loop from the other homologue as it invades (1). The D-loop is degraded,
and by a combination of this degradation of the recipient and synthesis on the donor
an asymmetric heteroduplex (a heteroduplex on only one of the homologues) forms
(2). Ligation produces a Holliday Junction which may move along the paired
molecules by branch migration (3). As shown the Holliday Junction has two crossed
and two uncrossed strands. If the crossed strands are cut (4), the structure resolves
to give two double stranded molecules, each consisting of a strand which is identical
to the parent and one of which has undergone a gene conversion event without a
crossover. The size of the region having undergone gene conversion differs between
the molecules (it is smaller in the "lower/grey" case) because the newly-synthesised
sequence was copied from the donor homologue. The Holliday Junction may
alternatively isomerise, so that the crossed strands become uncrossed, and vice-versa
(5). When this structure resolves, it produces crossover products with a segment that
has undergone gene conversion (6).




























Figure 1-2: Double-Strand Break-Repair Model of Homologous
Recombination
Recombination is initiated by a double-stranded break in one of the homologues,
which is followed by exonuclease digestion to leave a gap flanked on either side by 3'
overhanging ends. A 3' end can invade the other duplex, displacing a D-loop (1). As
repair synthesis enlarges the D-loop, this free strand may anneal to the free 3' end at
the other end of the gap (2). This strand then acts as a template for repair synthesis,
thus repairing the gap (3). Ligation results in the formation of two Holliday
Junctions, both of which may branch migrate. Depending on whether neither (4), the
left (5), the right (6), or both (7) Holliday Junctions undergo isomerisation prior to
resolution, there are several possibilities for the final structure. Resolutions 5 and 6
lead to a crossover event, whereas 4 and 7 do not.




The outcome (reviewed in Bollag et al., 1989; Hooper, 1992) of a recombination
event may be either a reciprocal exchange between the DNA molecules (crossover), a
non-reciprocal exchange (gene conversion), a gene conversion with an associated
crossover or a non-conservative recombination event. These possibilities are shown
in figure 1-3.
1.3.1 Extrachromosomal Recombination
ECR has been extensively studied and has provided much information on the
mechanism and requirements for recombination in mammalian cells. It should be
noted however, that there are important differences between ECR and recombination
involving the chromosomes (see below).
ECR studies (reviewed in Bollag et al., 1989) have typically involved the
introduction of a defective selectable system into the cultured cells, followed by
selection as an assay for recombination. Such systems are typically either defective
viral genomes, which produce a functional virus upon recombination and are
monitored by the appearance of a plaque of lysed cells, or a selectable marker such as
defective neo genes which confer resistance to the aminoglycoside G418 upon
recombination to produce a functional gene. ECR may be assayed either by direct
selection for the recombined marker, which relies on subsequent integration of the
plasmid into the genome, or by harvesting of the low molecular weight DNA and
transformation of recombination-incompetent bacteria followed by selection for
recombination-dependent and recombination-independent markers. ECR frequencies
of 1-20% have been measured in the former systems, and 10~2-10"4 in the latter. Both
intra- and inter-molecular recombination events have been observed. It has been
suggested that almost every transfected DNA molecule may undergo at least one
ECR event (Folger et al., 1985). The mechanism of ECR may employ part of the
molecular machinery required for integration of the molecule into the genome, which
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Figure 1-3: The Possible Results of a Recombination Event
A and a, B and b, C and c represent different alleles at a genetic locus undergoing
recombination. Each line represents a double stranded DNA molecule. Crossover
results in the translocation of information, whereas gene conversion may result in the
loss of genetic information. Non-conservative recombination results in the
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is why those assays for ECR reliant on subsequent stable transformation of the
recombined plasmid give higher HR frequencies. In Rat-20 cells which had
undergone an ECR event which reconstructed the aprt gene 50% of the cells went on
to stably integrate the gene into the genome, in contrast to only 5% of cells
transfected with wild-type aprt (measured in a transient expression assay) (Wong and
Capecchi 1986).
Recombination is modulated temporally: DNA molecules must be introduced into the
cell within an hour of each other for recombination to occur (Folger et al., 1985),
suggesting that within a relatively short time they become refractory to
recombination, perhaps by assembly into chromatin. ECR in the aprt system was
shown to occur preferentially (15-fold higher) during early to mid-S phase than in
early Gi phase of the cell cycle (Wong & Capecchi, 1987). Transcription stimulates
recombination six-fold in mammalian cells (Nickoloff & Reynolds, 1990), also
suggesting a role for the "activity" of DNA in recombination.
The homology requirements for HR are an important consideration. They differ
between different types of recombination. For ECR the recombination frequency
shows a biphasic relationship increasing with the length of homology, interpreted as
there being two systems in mammalian cells capable of accomplishing ECR, with one
operating on shorter lengths of homology than the other (Rubnitz & Subramani,
1984; Ayares et al., 1986). This biphasic relationship was not however observed with
replicating substrates (Ayares et al., 1986). The transition occurs in the range of
about 150-400 base pairs, with recombination still measurable with lengths of
homology as short as 14 bp (Rubnitz & Subramani, 1984). 19% nucleotide
mismatches reduce the frequency of ECR 3- to 15-fold compared to perfectly
homologous sequences, which is a much smaller attenuation than the reduction in
ICR under such conditions of over 1000-fold (Waldman & Liskay, 1987).
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As expected from the yeast paradigm (Orr-Weaver et al., 1981), double-stranded
breaks within or near the region of homology increase the frequency of ECR some
10-fold (reviewed in Bollag et al, 1989). A break some distance from the homology
has a smaller effect, but small heterologies do not significantly affect the
recombination frequency. (Wake et al., 1985).
1.3.2 Intrachromosomal Recombination
Intrachromosomal Recombination (ICR) occurs at lower frequencies (typically 10~6-
10~5 events/cell/generation) than ECR in mammalian cells (reviewed in Bollag et al,
1989) and requires longer lengths of homology than ECR: a minimum of between
134 and 232 bp (Waldman & Liskay, 1988). The recombination frequency increases
in a linear fashion as the length of homology increases from 292-2000 bp (Liskay et
al., 1987). Regions of heterology reduce the frequency of ICR, but an adjacent
region of perfect homology ameliorates this effect suggesting that initiation rather
than propagation of the event is mainly affected and that the recombination efficiency
is determined by the maximum length of perfect homology (Waldman & Liskay,
1988). ICR shows very high fidelity of recombination (Stachelek & Liskay, 1988). As
is the case with ECR, the rate of ICR is enhanced by transcriptional activity of the
recombining loci (Nickoloff, 1992).
1.3.3 Gene Targeting
The observations considered above have encouraged the use of homologous
recombination as a strategy for modifying the mammalian genome. HR between
introduced plasmid DNA sequences and homologous chromosomal sequences is
called gene targeting.
Initial experiments, as with ECR and ICR, relied on the reconstruction of a crippled
selectable marker as a method of selection for HR events and targeting frequencies of
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10" to 10" with ratios of homologous to non-homologous events of 10 " to 10 were
observed (reviewed in Bollag et al., 1989; Hooper, 1992).
Based on the finding that linearisation of the targeting vector within the region of
homology increases the targeting frequency by up to 1000-fold in fungi (reviewed in
Orr-Weaver & Szostak, 1985) and also stimulates ECR in mammalian cells (see
section 1.1.6.1), mammalian gene targeting vectors are also linearised. Targeting
constructs carrying a double-stranded break or gap in the homology undergo HR
between 33 and 140 times as efficiently as uncut (supercoiled) plasmids (Valencius &
Smithies, 1991a; Jasin & Berg, 1988) and the presence of a gap instead of a break
does not significantly reduce the targeting frequency because the gap is repaired by
gap repair, using information from the target gene (see figure 1-2). Heterologies
close to the gap are often lost, suggesting that the gap may be enlarged during repair
and/or that the free ends of DNA may not always directly participate in HR events;
therefore perhaps the improvement is due to the greater steric freedom of linear DNA
molecules than supercoiled ones (Shulman et al., 1990; Valencius & Smithies, 1991a;
Hasty et al., 1992; Kumar & Simons, 1993; Deng et al., 1993).
Copy number of either target sequence or vector is irrelevant to targeting frequency
(Thomas et al., 1986; Zheng & Wilson, 1990) and this has generally been taken to
imply that the step of homologous sequence location by the targeting vector is not
rate-limiting in a gene targeting reaction.
The first endogenous gene to be modified by gene targeting in mammalian cells was
the (3-globin gene, in human cells (Smithies et al., 1985). Currently most gene
targeting is carried out on murine ES cells with the objective of creating mice
carrying specific mutations.
1.3.3.1 Gene Targeting Strategies
Two major systems are available when considering the strategy of a gene targeting
experiment, which utilise different recombination possibilities observed in initial
targeting experiments. Insertion (O-type) vectors are linearised within the region of
homology and integrate in their entirety into the genome by means of a single
crossover event at the site of linearisation. They thus result in a duplication of the
homology region within the genome, separated by the vector sequences and
selectable marker. Replacement (Q-type) vectors are linearised outwith the region of
homology and result in the replacement of a length of the genomic sequence with
vector sequence comprising the homology which is divided into two lengths by
intervening sequence, usually a selectable marker . This is usually assumed to occur
by means of two separate crossovers although the observations that both types of
vector can have similar efficiencies (Thomas & Capecchi, 1987) and that the length
of homology on the small arm of the vector does not effect its targeting frequency
provided it is above a minimum of less than 470 bp (Hasty et al., 1991a) suggested
that in fact only one crossover is necessary. Branch migration of the crossover
through the vector to resolve at the other region of homology may be the mechanism
(Ellis & Bernstein, 1989). These two strategies are shown in figure 1-4 parts (a) and
(b).
There is some debate about the relative advantages of these two strategies both in
terms of their targeting efficiencies and the nature of the structure they are likely to
produce upon integration. Initial reports suggested that replacement and insertion
vectors targeted the locus at the same frequency (Thomas & Capecchi, 1987, Deng
& Capecchi, 1992), but some workers have found targeting an order of magnitude
(Hasty et al., 1991b) or greater (Dickinson et al., 1993; Rudolph et al., 1993a) more
efficient with insertion vectors. Furthermore, it has been argued that replacement
Figure 1-4: Gene Targeting Strategies
(a) Gene Targeting by Insertion
The bars represent genomic sequence, and lines represent vector (bacterial plasmid)
sequence. A region of homology (light grey) to the genomic locus of interest
(stippled grey) is linearised internally, so that recombination results in a locus
containing a duplication of the region of homology interrupted by the vector
sequence. Selection for a positive integration event using the neo gene, which confers
resistance to G418 (orientation indicated by an arrow) and Southern analysis are used
to identify the correctly-targeted clone.
(b) Gene Targeting by Replacement
The homology (light grey) to the target locus (stippled grey) is interrupted with the
selectable marker (neo; orientation indicated by an arrow) to create a mutation. The
vector is linearised outside the region of homology. A double-crossover event results








vectors can frequently recombine in an unexpected fashion (Hasty et al., 1991b;
Zhang et al., 1994), but this may be related to the lengths of homology on each arm
of the vector, and provided each arm is over 1 kb in size the replacement vector will
recombine as predicted (Thomas et al., 1992).
1.3.3.2 Homology Requirements for Gene Targeting
The length of homology required for efficient gene targeting events has been studied
to a limited extent, mostly in selectable genes such as hprt which provide a simple
means of isolating and characterising homologous recombinants (See section 1.1.8).
In common with other types of HR event in mammalian cells (see above), the
targeting frequency of the hprt gene shows a dependence on the length of homology
but there is some doubt about the exact relationship, since differences have been
observed between experiments even in the same system. At the murine hprt locus in
ES cells, an approximately linear relationship between targeting frequency and length
of homology was observed over the homology range 1.3-6.8kb (Hasty et al., 1991a),
but an exponential relationship was observed by other workers (Thomas & Capecchi,
1987; Deng & Capecchi, 1992). There was also an exponential increase in targeting
frequency at the aprt locus in Chinese hamster ovary (CHO) cells between 896 bp
and 3275 bp (Scheerer & Adair, 1994). A greater than linear relationship between
length of homology and targeting frequency was observed at the p. immunoglobulin
locus in hybridomas, where an increase in targeting frequency of 4-fold was observed
with an increase in homology from 4.3-9.5kb (Shulman et al., 1990). Concordant
with these observations, an increase in targeting frequency of 1.7-fold was seen at the
unselectable cftr locus in murine ES cells when the homology was increased in size
from 3.5kb to 4.3kb (Dickinson et al., 1993).
Sizeable interruptions in homology are largely irrelevant to the targeting frequency
(Mombaerts et al., 1991; Zhang et al., 1994), permitting the creation of relatively
large insertion or deletion mutations.
The maximum size of homology resulting in an increase in targeting efficiency is an
important factor, balancing ease of construction of the targeting vector with high
targeting frequency (see above). Based on the initial finding that a relatively small (2-
fold) increase in homology produced a large improvement (20-fold) in targeting
efficiency (Thomas & Capecchi, 1987), it was suggested that the use of very large
pieces of homology (greater than 30kb) would be of benefit (Bollag et al., 1989). In
experiments studying the relationship between length of homology and targeting
frequency (see above) saturation of the mammalian HR apparatus appeared to occur
in the region of 14 kb (Deng & Capecchi, 1992). With an isogenic construct
incorporating 17kb of homologous sequence, 78% of integration events were by
homologous recombination (Te Riele et al., 1992), which suggests that under
optimised conditions, HR rather than random integration can be the major event in
mammalian cells, as it is in yeast (Rothstein, 1991). Several workers have reported
much higher targeting frequencies than were first observed in gene targeting
experiments when using vectors with upwards of about lOkb of homology (Rudolph
et al., 1993a; Deng & Capecchi, 1992).
A related issue to the length of homology in a targeting vector is the extent to which
small mismatches in the homology can reduce the efficiency by reducing the size of
the maximum length of uninterrupted homology (see section 1.1.6.2). Several studies
have shown improvements in targeting frequency of between 4- or 5- and 25-fold by
the use of isogenic constructs (Te Riele et al., 1992; Van Deursen & Wieringa, 1992;
Deng & Capecchi, 1992) over the use of non-isogenic DNA which had small
heterologies of approximately 0.7-2% (Te Riele et al., 1992; Van Deursen &
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Wieringa, 1992). A Ren-ID targeting vector which was also greater than 95%
homologous to the Ren-2 gene was observed to target only Ren-ID (Miller et al.,
1992). However, individual mismatches separated from the site of linearisation by
2.4kb and 3.2kb of isogenic sequence did not adversely affect targeting frequency,
suggesting that the minimum length of perfect homology required for efficient
targeting is smaller than this (Dickinson et al., 1993).
1.3.3.3 Fidelity of Gene Targeting
When introducing subtle mutations into the genome, the fidelity of gene targeting by
HR is an important consideration because the effect of the intended change may be
complicated by the presence of subsidiary mutations introduced by the HR process.
Unfortunately this is an area where relatively little information exists. Some early
results suggested that targeted HR may introduce mutations at the target locus
(Thomas & Capecchi, 1986; Doetschman et al., 1988; Thompson et al., 1989;
Brinster et al., 1989), in contrast to ICR which is known to be very accurate
(Stachelek & Liskay, 1988). Thomas & Capecchi observed that in targeting
experiments designed to correct a deficient neo gene by HR, 50% of the recovered
clones had a second mutation rather than a correction at the site of the first mutation.
Since not all introduced mutations are likely to result in restored neo function the
actual mutation rate was probably much higher. Doetschman et al. and Thompson et
al. reported that deletions were observed in the hprt gene after targeting. Brinster et
al., using pronuclear injection as their method of introducing DNA, found 15 new
mutations introduced into a 1.5kb length of sequence. However, to date only one
systematic high-resolution study of the fidelity of gene targeting reactions has been
carried out (Zheng et al., 1991). In this study though, chemical cleavage of sequence
mismatches surrounding the site of integration of the targeting vector showed only
two point mutations in 80kb of sequence from 44 studied clones, and thus it was
concluded that gene targeting can be extremely accurate.
1.3.3.4 Enriching and Screening for Targeting Events
In the majority of gene targeting experiments, integration of the targeting construct
occurs rarely compared to the number of electroporated cells (typically around 10~5)
and of these integration events the proportion of legitimate HR events may vary
widely (over 3 orders of magnitude) between genes (reviewed in Camerini-Otero &
Kucherlapati, 1990). The reasons for such wide variability are unknown, and
conclusions are difficult to draw because of the complication of the picture by the
very different strategies, characteristics of homology used etc, in different targeting
experiments. The organisation into chromatin of genes, or their location in "hot-
spots" for recombination, or regions where it is suppressed, may be a significant
factor. Whilst transcription of genes may improve targeting efficiencies (Mansour et
al., 1988), it is not essential for a gene to be "targetable" by HR (Smithies et al.,
1985; Johnson et al., 1989; Jeanotte et al., 1991).
Therefore selective methods and/or rapid screening techniques are required in order
to isolate the desired clones. Some initial targeting experiments in ES cells were
carried out on the hprt locus, permitting direct selection of targeted recombinants
(Thomas & Capecchi, 1987; Doetschman et al., 1987, 1988; Thompson et al., 1989),
but clearly methods applicable to unselectable genes are required.
Expression of a positive selectable marker is used to isolate those clones derived
from cells which have stably integrated the targeting plasmid into the genome.
Usually this is neo, which confers resistance in vitro to the synthetic aminoglycoside
G418 (Southern & Berg, 1982), but others such as hyg, conferring resistance to
hygromycin B, and hprt minigenes (Selfridge et al., 1992; Detlott et al., 1994) are
also available. Multiple selections to enrich for HR events at the expense of non¬
homologous events have been applied and this has increased the efficiency of
selection to such an extent that isolation of targeted clones is often a relatively simple
matter.
The first of these is the positive-negative selection (PNS), used with replacement
vectors (Mansour et al., 1988), and this has become the standard method for the
production of gene knock-outs in mice over the past few years. The strategy is shown
in figure 1-5. Initially PNS was reported as giving enrichments of 2000-fold for HR
events over illegitimate events (Mansour et al., 1988), but this appears to be the
exception rather than the rule and more normally enrichments of about 2-20-fold are
observed (Zijlstra et al., 1989; Mombaerts et al., 1991; Rudolph et al., 1993a;
Hanson & Sedivy, 1995). This is likely to be due in part to exonuclease degradation
of the negative selectable marker prior to integration of the plasmid into the genome.
Such reductions in enrichment may be ameliorated by the presence of additional
sequence or hairpin-shaped oligonucleotide linkers on the free ends of the construct
to protect the negative selectable gene (Bernetgrandaud et al., 1992; Horie et al,
1994; Horie & Shimada, 1994). The diphtheria toxin A chain has also been used as
the negative selectable marker in the PNS procedure, where a 9- to 29-fold
enrichment for HR events was observed (McCarrick et al., 1993).
An alternative strategy for enrichment of homologous recombination events is to use
a selectable marker gene in the construct lacking either a functional promoter or
polyadenylation sequence or requiring the trapping of an enhancer (Doetschman et
al., 1988; Dorin et al., 1989; Jasin & Berg, 1988; Sedivy & Sharp, 1989;
Schwartzeberg et al., 1989; Joyner et al., 1989; Jeanotte et al., 1991). Such an
approach enriches for correctly-targeted events by preventing expression of the
positive selectable marker when an illegitimate recombination event occurs: it is
Figure 1-5: Positive-Negative Selection
The strategy is a refinement of targeting by replacement (figure 1-4). Another
selectable marker (HSVtk) is situated outside the region of homology. This selectable
marker permits negative selection with ganciclovir (GANC). A faithful homologous
recombination event results in the loss of this marker, so that a correctly-targeted
clone is G418r, because of the neo insertion, and GANCr, because the HSVr& gene is
not incorporated (upper structure). A random insertion of the vector into the genome
is most likely to occur via the free ends of the structure however, so that the HSVY/:
gene is also likely to become integrated (lower structure). These events may be














relatively improbable that the construct will integrate adjacent to a sequence capable
of activating expression of the neo gene, so that it remains silent and the cell dies.
Different selections vary in efficacy, for example hyg produces 200-fold fewer
colonies than wild-type neo\ a weaker mutant neo was used to improve the targeting
efficiency of the c-myc gene, which is expressed at a relatively low level (Hanson &
Sedivy, 1995). Selectable markers should therefore be selected according to their
biological properties and those of the gene to be modified. Wild-type neo is such a
strong selection that it may be used without a promoter to target genes with
extremely low levels of expression (Jeanotte et al., 1991; DeGregori et al., 1994).
Screening of the resultant clones by Southern analysis or PCR is then used to identify
those clones which have undergone an HR event at the desired locus. PCR across the
junction of the insertion of the vector (Kim & Smithies, 1988) provides one of the
most sensitive methods of detection of targeted clones, permitting the use of pools of
clones to screen very large numbers, but is prone to error (Frohman & Martin, 1990;
Kim et al., 1991) and should therefore be used in conjunction with a confirmatory
screen carried out by Southern analysis. A similar method of screening large cell
numbers in groups is to enrich for the desired cells by sib-selection (Cavalli-Sforza &
Lederberg, 1956) coupled to PCR.
More recently the detection of homologous recombinants has been achieved by
assaying for secretion of a protein which will only occur in recombinants (Itzhaki &
Porter, 1991; Smith & Kalagerakis, 1991), either using an inducible promoter or
modifying an allelic variant of the targeted secreted protein.
1.3.3.5 Strategies for Site-Directed Mutagenesis in the Mouse
The discussion above pertains to gene targeting in general. Most targeting
experiments described to date have had the objective of introducing a large mutation
into a gene in ES cells to create a null allele, with the aim of generating a "knockout"
mouse as an aid to study of the gene's function in vivo and as a source of cell lines
carrying defined mutations. Phenotypes obtained with knockout mice have varied
from having no observable effect on health and viability to being lethal in early
embryonic life, and different targeted mutations in the same gene have produced
different phenotypes. In the case of the cystic fibrosis transmembrane receptor cftr a
complete knockout (Snouwaert et al., 1992; Colledge et al., 1992; O'Neal et al.,
1993) has a perinatal lethal phenotype, but a mutation achieved by insertion can be
spliced out in a minority of transcripts and the reduced level of expression provides a
model of human cystic fibrosis (Dorin et al., 1992). Similarly, mutations in the Hox
2.6 gene have subtly different phenotypes depending on the site of interruption of the
gene (Ramirez-Solis et al., 1993), and a knockout of the N-myc proto-oncogene is
lethal at day 10.5 of embryogenesis (Stanton et al., 1992; Charron et al., 1992; Sawai
et al, 1993) whereas a "leaky" mutation permits survival to birth (Moens et al.,
1992). Some mutations have proved to be disappointing in that they produce a
phenotype which gives little clue as to the function of the gene, or do not model the
human disease for which they were designed.
The introduction of more subtle mutations such as missense mutations to modify
specific functions of a protein is therefore desirable and likely to become more
important. Such small modifications to the genome present problems in terms of their
creation without other changes being co-introduced, and in terms of their detection.
A point mutation may introduce a selectable phenotype as is sometimes the case with
conventional gene inactivation; for example introduction of a point mutation into
RNA polymerase II conferred resistance to a-amanitin (Steeg et al., 1990), but this is
likely to be the exception rather than the rule. There are several strategies now
available for such experiments, including microinjection of a targeting construct with
no selectable marker (Zimmer & Gruss, 1989) or coelectroporation of the selectable
marker (Shulman et al., 1990; Davis et al.. 1992), replacement where the selectable
marker is located in a nominally "neutral" part of the homology (Rubinstein et al.,
1993), "plug & socket" targeting (Detlott et al., 1994; figure 1-6), "tag and
exchange"/double replacement targeting (Askew et al., 1993; Stacey et al., 1994; Wu
et al., 1994; figure 1-7), site-specific recombinase systems (Gu et al., 1993; Fiering et
al., 1993; Jung et al., 1993) and "hit and run"/"in-out" targeting (Hasty et al., 1991c;
Valencius & Smithies, 1991b; figure 1-8). They have slightly different characteristics,
so that selection of the technique can be chosen according to the objectives of the
experiment. The technique of Rubinstein et al is essentially a standard
replacement/PNS-type strategy. However, instead of incorporating a deletion or
insertional mutation caused by the neo gene interrupting exonic sequence into the
homology, they inserted a point mutation into the proopiomelanocortin (POMC)
gene, and located the neo cassette downstream of the polyadenylation site. Although
they showed that the POMC gene was not activated in reverse by the PGK promoter,
as may have been expected (Johnson & Friedman, 1990), this system obviously relies
on the fact that a suitably innocuous region of the genome will be available.
Especially for large genes, and occasions where a mutation is to be introduced into an
exon which is some distance from sequences outwith the gene, an intronic site would
have to be selected. This may be problematic due to the interruption of enhancer-type
sequences or the introduction of cryptic splice-acceptor sites within the selectable
marker. For example, an insertional disruption of the mouse major adult (3-globin
gene created a much more severe phenotype than a deletion at the locus, and it was
suggested that this was due to the presence of the additional promoter driving the
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Figure 1-6: "Plug and Socket" Gene Targeting
The targeting is carried out in hprt cells, to permit selection for hprt in the second
step. The regions of homology (medium grey and white) are interrupted by a neo
gene, to permit positive selection for a correctly-targeted clone, and a defective hprt
gene. Vector 1 is targeted into the locus by replacement using neo selection, to create
the "socket". This clone, which is G418r, HATS, is then targeted with vector 2 (the
"plug"), carrying a subtle mutation (light grey), and another defective hprt gene.
Since there are different deletions in the hprt genes in both vectors 1 and 2 (hatched
regions), the only HATr clones resulting are those which have correctly recombined
to give a functional hprt gene at the target locus, and in the process introduced a
subtle mutation into the target gene. Screening of HATr clones is then carried out to

















Figure 1-7: Double Replacement Gene Targeting
This strategy also uses two vectors, like plug and socket targeting. In the figure an
hprt minigene is used for both positive and negative selection, but neo for positive
selection and HSVtk for negative selection have also been successfully employed (see
text). In the first step, PNS targeting is used to generate a HATr knockout clone.
Here a selection based on hypoxanthine and azaserine (which does not inhibit
thymidylate synthetase) would be used to avoid the thymidine present in HAT
medium rescuing the HSVtk selection. The targeted clone is then re-targeted with a
second vector carrying homology identical to the endogenous locus except for the
desired mutation (light grey square). The double-targeted clone is once again HATS,















Figure 1-8: Hit and Run Gene Targeting
An insertion vector carrying both positive and negative selectable markers (neo and
HSWtk respectively) and a subtle mutation in the region of homology is used to target
the locus of interest, generating a structure consisting of a linear duplication of the
region of homology interrupted by the vector sequence, which is neo . Depending on
the result of any branch migration event, the mutation may be in either the left
duplication, the right duplication, both duplications or neither duplication of
homology. The clone is then subjected to backselection (negative selection; in this
case GANC) and intra-chromosomal recombination events between the duplications
of homology either regenerate the wild-type structure or insert the mutation,

















Targeted Mutant: G418s GANCr
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neo cassette introduced into the region interacting with the Locus Control Region at
the expense of endogenous promoters driving globin gene transcription (Shehee et
al, 1993).
The plug and socket system developed at North Carolina also leaves the selectable
marker in the genome and so the same caveat must apply here as well. However, this
system is useful where many mutations are to be produced, since the same "socket"
can be used to generate many different mutants by the use of different "plug"
constructs. The positive selection at the second step is also more effective than
negative selection strategies, such as are used in hit and run or tag and exchange.
Recombinase enzyme systems rely on the use of either the Cre/lox-P (derived from
bacteriophage PI) or FLP recombinase (derived from yeast) systems to remove the
selectable marker sequence. Recombinase-mediated systems require the placement of
the necessary ds-acting sequences either side of the sequence to be deleted, and leave
a single copy of this sequence in the genome (about 50 bp) after excision by the
specific enzyme, but are very efficient.
Targeted recombination events are rare, of the order of 10~5 to 10~6 per transfected
cell (see above), but as only 1 in 10 cells integrates the transfected DNA it is possible
to enrich for targeted clones by selecting for transfected cells with a selectable
marker. Thus the coelectroporation strategy also introduces a selectable marker into
the genome, but relies on the fact that the mouse genome is sufficiently large (2000
centimorgan) that the chance of the introduced mutation and the neo selectable
marker becoming closely linked is only about 0.05%. Separation of the selectable
marker from the introduced point mutation can therefore be achieved by meiosis.
However, with this strategy a laborious PCR screen is required and a mouse must be
generated before the allele of interest can be studied in the absence of the selectable
marker.
The only methods therefore which definitively effect the precise modification of the
genome and introduce no other changes which might complicate analysis of the
phenotype are microinjection of sequences, tag and exchange and hit and run. The
former however has only been achieved on one occasion, as yet without germline
transmission of the produced allele, and therefore its generality as a strategy must
remain in doubt.
The hit and run strategy was the first of the latter two to be shown to be practicable
(Hasty et al., 1991c; Valencius & Smithies, 1991b), and has been employed on
several occasions since (Rudolph et al., 1993a, 1993b; Serwe & Sablitzky, 1993;
Bautista & Shulman, 1993; Ernst et al., 1994; Gorry et al., 1994). This system
requires the construction of only one vector, making it preferable in situations where
only one mutation is to be introduced at the locus. As shown in the diagram,
reversion may be either to wild-type or the desired mutant. Reversion occurs at
widely different frequencies depending on the gene studied (Hasty et al., 1991c), as is
seen for initial targeting events (Camerini-Otero & Kucherlapati, 1990). "Hit and
run" has also been used to generate conventional insertion-mutant type structures
where replacement vectors have proved ineffective (Rudolph et al., 1993a).
Tag and exchange, or double replacement, relies on a second targeting event with
another construct to introduce the planned mutation (figure 1-7). This method is
likely to be useful where multiple independent modifications of the locus are required,
since the same "tagged" gene may be used for any number of exchanges.
Furthermore, the tag itself may have utility as a knockout allele against which to
compare subsequent, more subtle, mutations. In such cases however, it should be
noted that the use of the HSWtk gene as the negative selectable marker is
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inappropriate because testicular expression from a cryptic promoter is incompatible
with germline transmission of the mutant allele (Al-Shawi et ai, 1991). Loss of the
second selectable marker can occur in ways other than by HR, and a high background
of non-targeted cells has been observed after electroporation of the second vector
(Bradley, 1993), but this should be less of a problem when using hprt selection rather
than, for example, HSVtk selection (Stacey et al., 1994) because positive selection
for gene function may be maintained until introduction of the second construct.
1.4 The Hprt System (Reviewed by Stout & Caskey, 1985)
The hypoxanthine-guanine phosphoribosyltransferase {hprt) gene has proved to be a
useful system in studies aimed at developing gene targeting strategies or studying the
mechanism of HR in mammalian cells. Two features make hprt suitable for such
experiments. Hprt is X-linked, and therefore a single copy of the gene may still be
observed at the level of the phenotype, because the gene is hemizygous in males and
in females only one copy of the gene will be expressed because of X-chromosome
inactivation. As remarked in section 1.1.5, most ES cells are male and therefore can
be expected to behave identically with respect to /i/?/t-dependent selection. Hprt
function may be selected either for or against in cultured cells by chemical selection,
and thus a simple phenotypic change can be used to follow the genotype of the gene.
Hprt is a housekeeping gene, expressed at a low level in most tissues. It is a part of
the purine metabolism pathway (figure 1-9; see, for example, Voet & Voet, 1990),
serving to salvage hypoxanthine and guanine by transfer of a phosphoribosyl group
from 5'-phosphoribosyl-1-pyrophosphate (PRPP) to produce inosine monophosphate
(IMP) or guanosine monophosphate (GMP), respectively. Cells can also synthesise
these mononucleotides de novo, but this pathway is blocked by the drug aminopterin
and the cell can thus be made dependent upon its salvage pathway and will die unless
functional hprt can provide purines. This is the basis of the HAT (hypoxanthine-
Figure 1-9: Purine Metabolism
The figure shows a schematic outline of the purine salvage pathways in mammals.
Abbreviations: ADA, adenosine deaminase; AMP, adenosine monophosphate;
AMPRT, amidophosphoribosyltransferase; ATP, adenosine triphosphate; GMP,
guanosine monophosphate; HPRT, hypoxanthine-guanine phosphoribosyltransferase;
IMP, inosine monophosphate; N, nucleotidase; Pi, inorganic phosphate; PNP, purine
nucleoside phosphorylase; PPit pyrophosphate; PRPP, 5'-phosphoribosyl-l-
pyrophosphate; R-l-P, ribose-1-phosphate; UO, urate oxidase (this step does not




aminopterin-thymidine) selection (Szybalski & Szybalska, 1962): hypoxanthine is
provided as a substrate for /zprr-catalysed purine conversion because aminopterin
blocks the de novo pathway; thymidine is also included in the selection as
aminopterin, being an antifolate drug, also inhibits the thymidylate synthase reaction.
Hprt is also capable of phosphoribosylating the toxic guanine analogue 2-hydroxy-6-
mercaptopurine (6-thioguanine, 6-TG) and this is fatal for the cell (Stutts &
Brockman, 1963). It is thus possible to select either for function or for lack of
function in hprt very simply.
The structure of the murine hprt gene is shown in figure 2-1, together with the
structure of the mutant hpri*m-3 allele in the ES cell line E14TG2a (Hooper et al.,
1987), which carries a deletion encompassing the promoter sequences and exons 1
and 2 (Thompson et al., 1989).
1.5 The Kirsten-/?as Proto-Oncogene.
1.5.1 General Introduction: The Ras Genes
The ras genes comprise a gene family and are ubiquitous amongst eucaryotic
organisms, having been identified in mammals, birds, insects, molluscs, nematodes,
fungi and plants (reviewed by Barbacid, 1987; Valencia et al., 1991). They are part
of a greater superfamily of genes which all encode small guanine nucleotide-binding
proteins of 20-25kd in size, which as well as ras also include the families of the rac,
rap, rab, ral and rho genes.
Mammals encode 3 ras genes, designated K-ras-2, H-ras-1 and N-ras, in the mouse
present on chromosomes 6, 7 and 3, respectively (O' Brien, 1984). They encode
highly-related proteins generically known as p21 (Shih et al., 1979). In humans and
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rats, pseudogenes of H-ras (H-ras-2) and K-ras (K-ras-1) have also been
characterised.
The Kirsten-ras proto-oncogene (hereafter, K-ras) was one of the first genes
discovered to have an association with malignancy, being described in the context of
the Kirsten rat sarcoma vims as the transforming element of the vims (Kirsten &
Mayer, 1967). K-ras was subsequently shown to be a mutant homologue of a cellular
gene transduced by the retrovirus (Ellis et al., 1981). H-ras was identified similarly
(Harvey, 1964; DeFeo et al., 1981). N-ras was identified as a transforming gene
present in a neuroblastoma cell line homologous to H-ras and K-ras (Shimizu et al.,
1983a).
The biology of ras has provoked intense study in the last 15 years because of the
association of the ras genes with human malignancies (reviewed by Bos, 1989);
approximately 30% of cancers, including almost 100% of pancreatic carcinomas,
50% of colon and thyroid cancers and 30% of lung malignancies and myeloid
leukaemias, have mutant ras alleles.
The effects of ras may be observed in bioassays, where ras genes or proteins are
added to a system to elicit a r<zs-dependent response. This may be cell-proliferation
dependent, such as focal transformation of established rodent fibroblasts, DNA
synthesis, tumour formation or transformation of a primary cell line in cooperation
with another oncogene such as myc, or morphological such as the induction of
differentiation in an appropriate cell type (reviewed by Lowy and Willumsen, 1993).
The wide variety of bioassays available for ras is a reflection of its involvement in
diverse effects such as proliferation and differentiation in a multitude of biological
systems.
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1.5.2 Structure of the Ras Genes
In this and the following sections, it should be noted that many characteristics of K-
ras also apply to other ras genes as well, and therefore where appropriate ras or
p2lras will be used to denote general findings.
The three mammalian ras genes have a similar structure, consisting of a 5' noncoding
exon (exon 0) and four coding exons. The introns however are very heterogeneous,
so that the genes vary in size: N-ras and H-ras span approximately 7kb and 3 kb
respectively, whereas K-ras is much larger, covering 35-40kb. K-ras also differs from
the other ras genes in that it codes for alternative fourth coding exons designated 4A
and 4B (McGrath et al., 1983; Shimizu et ai, 1983b; Capon et al., 1983), making a
total of 6 exons in all coding for two isomorphic proteins which differ in their C-
terminal regions. A diagram of the K-ras gene and its transcription and translation
products is shown in figure 1-10. N-ras, H-ras and K-rasA all encode proteins of 189
amino acids; exon 4B has one less codon and therefore K-ras is 188 amino acids
long. Between ras genes the splicing junctions of the exons correspond exactly,
suggesting that the proteins are derived from a common ancestral protein. They are
highly conserved both between species and between each other (Barbacid, 1987;
A B
Lowy & Willumsen, 1993). K-ras and K-ras proteins are identical from the N-
terminus to residue 164 (i.e. to approximately 1/3 way through exon 4) except for
differences at residues 151 and 153, but are then extremely heterogeneous in the
remaining 24/25 amino acids leading to the C-terminus. However, between species
exons 4A and 4B are highly conserved, suggesting that the heterogeneous regions of
the proteins are associated with specificity of function. This structure of a highly-
conserved N-terminal region and a divergent C-terminal region is usual in ras genes
(Barbacid, 1987; Valencia et al., 1991; Lowy & Willumsen, 1993), but within the
heterogeneous region some conservation is observed. A cysteine residue is always
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Figure 1-10: The Kirsten-ras Gene
K-ras is a gene comprising 6 exons, including a 5' untranslated exon (exon 0) and five
translated exons, designated 1, 2, 3, 4A and 4B, spanning approximately 40kb of
genomic sequence (not to scale). Alternative splicing possibilities may generate two
mRNA species, depending on whether exon 4A is included or not. Because there is a
nonsense codon at the end of exon 4A, the two protein isoforms generated either
have the amino acid sequence corresponding to exons 1-2-3-4A or 1-2-3-4B,
differing just at their C-termini.
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Figure 1-10
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present at codon 186 (185 in K-ras8) and is followed by two aliphatic amino acids
and a residue which is usually either serine or methionine. The C-terminal four
residues are therefore collectively referred to as the CAAX motif, and their strong
conservation between genes and species reflects their importance for ras function
(see section 1.2.3.2).
The promoter of K-ras, like that of the other two ras genes, is located in the region
of the untranslated exon 0 (Jordano & Perucho, 1986; Hoffman et al., 1987;
Yamamoto & Perucho, 1988). It lacks a TATA and CAAT box, but contains multiple
copies of the GC box sequences GGGCGG/CCGCCC both 5', 3' and internal to exon
0. Transcriptional activity appears to be bi-directional from these sites (Hoffman et
al., 1987). Such sequences are recognised by the Spl transcription factor (reviewed
by Kadonaga et al., 1986) and are characteristic of "housekeeping" genes. Sequences
at the 5' end of the promoter region have also been shown to have enhancer-like
activity (Jordano & Perucho, 1988) and to bind nuclear factors other than Spl
(Jordano & Perucho, 1988; Hoffman et al., 1990).
1.5.3 Biological Activities of Ras: Proliferation, Differentiation and
Neoplasia
The ras genes and proteins have been implicated in a diverse collection of cellular
phenomena, with observations depending on the system under study. Ras mutations
are observed in many cancers (Bos, 1989), and the ras status of the cell affects the
way it behaves in vitro and in vivo.
Microinjection of oncogenic p2\rai protein induces proliferation of resting cells
(Feramisco et al., 1984; Stacey & Kung, 1984), and the introduction of an activating
point mutation into the endogenous H-ras gene of immortal untransformed
fibroblasts predisposed them to transformation (Finney & Bishop, 1993). Transgenic
mice carrying activated ras alleles are predisposed to tumours of the tissues in which
the promoter driving expression of the transgene are active (Quaife et al., 1987; Sinn
et al., 1987). Transformation may also be induced by overexpression of the c-one
form of ras, suggesting that the transformation of cells by ras is an inappropriate
manifestation of a normal cellular process (Chang et al., 1982). Conversely,
disruption of activated K-ras by HR in colon carcinoma cell lines resulted in a less
malignant phenotype as defined by morphology, the ability to grow in soft agar, and
growth rates both in vitro and as tumours in nude mice (Shirasawa et al., 1993).
Activation of ras is observed in response to external mitogenic signals such as
epidermal growth factor (Kamata & Feramisco, 1984), and the action of the ras
proto-oncogene-mediated signalling pathway(s) is essential for the proliferation of
NIH3T3 cells in response to serum-stimulation (Mulcahy et al., 1985; Cai et al.,
1990). Ras proteins also induce processes such as membrane ruffling and pinocytosis
in addition to proliferation in resting cells (Bar-Sagi & Feramisco, 1986). In yeast, a
deficiency of both the RAS genes was observed to be incompatible with viability
(Tatchell et al., 1984). Thus the ras signalling pathway plays a vital role in the
cellular activation, proliferation and function of normal cells.
In addition to its role in cellular proliferation, which upon deregulation may create a
transformed phenotype, ras has also been shown to play a role both in promoting and
inhibiting differentiation. Pheochromocytoma line PC 12 cells differentiate in response
to nerve growth factor, observed morphologically by the generation of neurites, but
microinjection of inactivating antibodies to p21rai prevents this response (Hagag et
al., 1986), as does the transfection of a dominant-negative H-ras mutant (Szerberenyi
et al., 1990). By contrast, myogenic differentiation is inhibited by the expression of
activated ras proteins in immortal myoblasts (Olson et al., 1987; Gossett et al., 1988)
but not in EC cells (Rudnicki et al., 1989). This difference in the differentiation
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response of cells to p2\rai indicates that factors other than ras status, such as
interactions with other oncogenes and the exact lineage of the cell, are also important
in its decision to commit to a certain pathway of differentiation.
Ras is now known to be directly involved in several specific eucaryotic
developmental processes, including vulval induction in C. elegans (Han & Sternberg,
1990; Beitel et al., 1990), eye development of Drosophila (Simon et al., 1991), and
the progression of preimplantation-stage embryos in the mouse (Ahmad & Naz,
1993; Yamouchi et al., 1994)
1.5.4 Biochemistry of Ras
1.5.4.1 The GTP-GDP Cycle
The ras genes encode small monomelic molecules which migrate as a 21kd protein.
p2\ras is a guanine-nucleotide binding protein, specifically GTP and GDP, (Scolnick
et al., 1979; Shih et al., 1980; Tamanoi et al., 1984; Temeles et al., 1985) and
incorporates a GTPase activity (Gibbs et al., 1984; McGrath et al., 1984; Sweet et
al., 1984; Manne et al., 1985; Temeles et al., 1985). This GTPase activity effectively
limits the half-life of the GTP-bound form of the molecule, and is attenuated in
12
oncogenic mutants of ras such as the val mutant. The GTP*p21 form of the protein
has been shown to be the physiologically "active" form of the protein. In vitro GTP*
p21 but not GDP*p21 causes activation of Saccharomyces cerevisiae adenylyl
cyclase (Field et al., 1987; 1988). Microinjection into various cell types of p2\ras
complexed to non-hydrolysable analogues of GTP but not GDP was found to induce
effects similar to those observed in bioassays of activated oncogenic ras proteins
(Trahey & McCormick, 1987; Satoh et al., 1987).
The p2lras proteins bind guanine nucleotides with very high affinity (Kd~10 11 M)
(Feuerstein et al., 1987a; 1987b) and thus the spontaneous rate of dissociation of the
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nucleotide-p21 complex is very low, =10° moles s"1 mof1 complex (John et al.,
1990). This binding is much tighter than is required to saturate the p21rai with
nucleotide with the concentrations of GTP (>10~4 M) and GDP (>105 M) found in
the cytoplasm, so that p2\ras effectively cycles slowly between its GTP- and GDP-
bound forms. Because the cellular concentration of GTP is higher than that of GDP
dissociation of the bound nucleotide results in its rapid replacement from the cytosol
by GTP, and thus dissociation of the nucleotide*p21 complex "activates" the
molecule (see above). Certain point mutations change the exchange rate and are
activating because they are associated with an unusually high level of GTP*p21
(reviewed in Lowy & Willumsen, 1993). The intrinsic GTPase activity of p21ra'5 is
also very low, &cat.GiP of the order of 0.02 min'1 (Neal et al., 1988). Therefore in the
cell the p2\ras molecule effectively binds GTP, where it is in the active form, and
subsequently hydrolyses the GTP to GDP and P, with a half-life of 1-5 hours, in the
process inactivating itself. Activated mutant ras molecules have a GTP*p21 half-life
of 3-9 times longer (Sweet et al., 1984; Gibbs et al., 1984; Lacal et al., 1986; John et
al., 1988). The GTP*p21 form of the complex is thought to have several
conformations, one of which is an efficient catalyst for hydrolysis of GTP (reviewed
in Bourne et al., 1991). This explains its intrinsically slow rate of hydrolysis, although
other possibilities such as participation of GAP residues directly in the hydrolysis
mechanism have been proposed (Bollag & McCormick, 1991).
Such low intrinsic activities both for the rate of exchange (activation) of ras and the
rate of hydrolysis (inactivation), but with the rate of hydrolysis exceeding that of
exchange, mean that in most cells, ras is predominantly in the GDP*p21 state (Gibbs
et al., 1990; Satoh et al., 1990a; Downward et al., 1990). Activation of the cell, for
example activation ofmouse fibroblasts by epidermal growth factor (EGF) or platelet
derived growth factor (PDGF) elevates GTP*p21 levels some 2-4-fold (Gibbs et al.,
1990; Satoh et al., 1990a, 1990b), or in human T-cells GTP*p21 increases from 5%
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total complex to 80% total complex upon stimulation (Downward et al., 1990). To
activate the cell by increasing the fraction of ras in the GTP*p21 state requires a 100-
fold drop in the ratio of exchange rate:GTPase rate. Regulation of this ratio, and
hence of the biological activity of pl\ras, is believed to be achieved through effector
proteins which either accelerate the rate of GTP hydrolysis (GTPase activating
proteins, GAPs) or nucleotide exchange (guanine nucleotide exchange factors,
GEFs), thus moving the equilibrium of GTP*p21: GDP*p21 (reviewed by Bollag &
McCormick, 1991; Boguski & McCormick, 1993; Feig, 1994). In mammals the
GAPs include pl20GAP (Trahey & McCormick, 1987) and neurofibromin (the
product of the NF1 neurofibromatosis tumour suppressor gene: Xu et al, 1990); the
GEFs include mSosl, mSos2 and hSosl, (murine and human homologues of the
Drosophila Son of Sevenless gene: Bowtell et al., 1992; Chardin et al., 1993), Ras-
GRF/cdc25Mm (a homologue of the yeast cdc25 gene: Martegani et al., 1992; Shou et
al., 1992; Wei et al., 1992) and Vav (Gulbins et al., 1993). The exchange factor
SmgGDS (Small GTP-binding protein Guanine nucleotide Dissociation Stimulator:
Yamamoto et al., 1990) appears to be specific for K-ras amongst the ras proteins,
although it does interact with related proteins such as Racl, RhoA and Rap 1A. These
results taken together have lead to the proposal of a model for p2lras action as is
shown in figure 1-11.
1.5.4.2 Subcellular Localisation: C-Terminal Modification
Ras proteins are synthesised on ribosomes in the cytosol (Shih et al., 1982; Ulsh et
al., 1984; Fujiyama & Tamanoi, 1986) but are localised at the inner surface of the
plasma membrane (Willingham et al., 1980; Willumsen et al., 1984a; Fujiyama &
Tamanoi, 1986). This localisation is essential for the normal activity of ras proteins
and mutants which remain in the cytoplasm are incapable of transforming cells, even
if they carry oncogenic mutations as well (Willumsen et al., 1984a, 1984b), or of
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Figure 1-11: The ras GTP-GDP Cycle
Regulation of p2lras by guanine nucleotide exchange factors (GEFs), which activate
p2lras by catalysing exchange of bound GDP for cytosolic GTP, and GTPase
activating proteins (GAPs), which inactivate p2\ras by accelerating hydrolysis of
bound GTP to GDP. Unbound p2\ras is not shown because the binding constant of
the molecule for guanine nucleotide is so high that these species are very short-lived






activating the MAP kinase cascade in fibroblasts (see below; Leevers & Marshall,
1992). Membrane localisation is mediated by several post-translational modifications
of the protein which increase the hydrophobic nature of the molecule rather than the
presence of hydrophobic sequences within the primary structure (reviewed by
Newman & Magee, 1993; Glomset & Famsworth, 1994). Attachment to the
membrane requires the prenylation of p21r<"; a farnesyl (CI5) moiety is added to the
sulphydryl group of cys186/185 (the C of the CAAX motif) by a thioester link
(Hancock et al., 1989, 1991). In the case of H-ras, N-ras and K-rasA the cysteine
186 B
residues slightly N-terminal to cys are also palmitoylated, but K-ras , which lacks
the necessary cysteine residues, has a polylysine motif present in the heterogeneous
C-terminal region of the protein which is involved in membrane targeting (Hancock
et al., 1990; Jackson et al., 1994). The basic residues of the polylysine region may
enhance the membrane targeting of the molecule by permitting charged interactions
with negatively charged head groups of acidic membrane phosphoglycerides
(Glomset & Farnsworth., 1994), and this domain has recently been shown to be
required by K-ras in malignant transformation ( Jackson et al., 1994). Following the
isoprenylation reaction, the terminal three amino acids of the CAAX motif are
removed by proteolysis and the C-terminal carboxyl group is methylesterified, and
these steps are required for fully efficient membrane localisation (Hancock et al.,
1991).
1.5.4.3 How p21ras Activates the Cell
Results obtained in the last two years have now produced a very clear picture of the
way in which ras is able to activate the cell (figure 1-12; for reviews see McCormick,
1993; Feig, 1993; Moodie & Wolfman, 1994; Hall, 1994; Avruch et al, 1994). Sos
has recently been shown to be an activator of p21ras in response to cellular activation,
for example by EGF activating the EGF receptor tyrosine kinase. Interestingly, Sos
Figure 1-12: Ras Activation of the Cell
A mitogen, such as EGF, binds to its receptor tyrosine kinase (RTK), which is
activated and autophosphorylates. The phosphorylated cytoplasmic domain of the
RTK may then bind with the SH2 domain of an adapter protein such as Grb2. The
SH3 domains of Grb2 interact with Sos, recruiting it to the cell membrane. There is
therefore a high effective local concentration of Sos at the plasma membrane. Sos is a
GEF for p21r<", and thus ras is activated by exchange of GDP for GTP. ras then
recruits raf to the membrane, interacting through its CR1 region. Once raf is
membrane-localised, it may interact with other proteins (?) and activate the MAP

































requires prenylation of ras to efficiently promote guanine nucleotide exchange
(Porfiri et al., 1994). Guanine nucleotide exchange is promoted through adapter
proteins such as Grb2 (the mammalian homologue of Sem-5 of C. elegans and drk of
Drosophila), so called because it has both SH2 and SH3 "Src homology domains".
The SH2 and SH3 domains provide a link between the activated
(autophosphorylated) receptor and Sos, respectively. Once converted to the GTP*
p21 state by Sos in response to the extracellular mitogenic signal, ras may initiate a
kinase cascade. Ras recruits another member of the GTPase superfamily to the
complex, namely raf. The localisation of raf at the plasma membrane allows
activation by raf of the MAPK (mitogen activated protein kinase) cascade. This
cascade has pleiotropic affects on the cell, influencing cytoplasmic organisation,
cytoplasmic phospholipase A2, other serine/threonine kinases such as Rsk and
MAPKAP-K2 and transcription factors such as c-fos, c-myc, c-jun, ATF-2 and Elk-1.
1.5.5 Expression ofRas
Several workers have investigated the expression of ras genes in both normal and
dysplastic tissue, at the RNA and protein levels. In tumours the expression of ras
genes is elevated with respect to control tissues in about 50% of cases when RNA
transcripts are assayed, and similar results have been obtained with immunoblot assay
of p21 ras proteins (reviewed by Barbacid, 1987). Mutant alleles of K-ras have been
observed to be preferentially expressed over normal alleles in about two thirds of
colorectal carcinomas examined (Kotsinas et al., 1993), and this may provide a
selective growth advantage to the tumour.
In normal proliferating liver, ras was observed to be upregulated several-fold
(Goyette et al., 1983). Systematic studies of ras expression in the normal tissues of
several mammalian species have also been undertaken, to clarify the role of the genes
in development and in normal cell function. The ras genes appear to be expressed
ubiquitously, but with variations in levels between different genes and cell types. In
the mouse, the H-ras gene is expressed ubiquitously at approximately constant levels
in both the embryo and extra-embryonic tissues, with higher levels observed in bone,
kidney, brain and skin post-natally (Muller et al., 1982; Slamon & Cline, 1984; Leon
et al., 1987). K-ras is also expressed ubiquitously at approximately constant levels
until about day 16 of development, when levels decrease to about 25-50% relative to
those observed in midgestation embryos (Muller et al., 1983). In the adult K-ras is
most prevalently expressed in the gut, lung and thymus, and was less represented in
tissues such as skin, liver, skeletal muscle, ovary and spleen (Leon et al., 1987). K-
ras transcript and protein levels are modulated in some tissues with age (Tanaka et
al., 1986; Leon et al., 1987). It is of note that H-ras appeared to be most highly
represented in the skin because H-ras, and not K-ras or N-ras, is a target for
oncogenic mutations in the skin of mice with chemically induced tumours (Balmain et
al., 1984).
N-ras was expressed at highest levels in thymus and testis, and lowest in liver and
kidney, but again appears to be represented to some extent in all tissues (Leon et al.,
1987).
Consistent with the observation that ras genes are ubiquitously expressed, they have
also been observed in very early-stage embryos and in cells of the germline. In male
germ cells the 3 ras genes show distinct levels of expression: K-ras mRNA being
elevated in pachytene cells and N-r&y in early round spermatids. In contrast, H-ras
expression is constant during spermatogenesis (Sorrentino et al., 1988). In
preimplantation-stage mouse embryos all three ras genes are expressed (Pal et al.,
1993). Modulation of expression of H-ray and K-ras was not observed during
differentiation of F9 EC cells (Lockett & Sleigh, 1987).
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During rat development, analysis with a polyspecific anti-p21 ras antibody showed
very wide protein expression of p21 ras, but in earlier stages of development staining
was weaker in some extraembryonic tissues (Brewer & Brown, 1992). Despite the
association of ras with proliferation of tissues, examination of tissues with anti-p21ras
monoclonal antibodies has frequently revealed the highest levels of expression in
terminally differentiated tissues, such as adult (and embryonic) brain and epithelial
cells of the endocrine glands, or non-dividing tissue such as heart muscle (Spandidos
& Dimitrov, 1985; Tanaka et al., 1986; Furth et al., 1987; Chesa et al., 1987).
CHAPTER 2-
THE FIDELITY OF GENE
TARGETING
The Fidelity of Gene Targeting
2.1 Introduction
Much of this thesis (chapters 4 and 5) concerns itself with hit and run gene targeting.
Because this technique was designed for the purpose of introducing small mutations
into the genome, a high degree of precision is required to produce the desired results,
arguably not the case for knockout-type experiments. As described in the
introduction, section 1.3.3.3, relatively little is known about the fidelity of gene
targeting events. Some early results suggested that the recombination process may be
prone to errors (Thomas & Capecchi, 1986; Doetschman et al., 1988; Thompson et
al., 1989; Brinster et al., 1989). Although intra-chromosomal recombination is
known to be very accurate (Stachelek & Liskay, 1988), it is not possible to
extrapolate this assumption to gene targeting because some of the enzymatic systems
which accomplish this HR event are likely to be different, perhaps including some of
those involved in the extra-chromosomal recombination mechanism. Because intra-
chromosomal recombination seems to proceed with fidelity, it is likely that undesired
mutations co-introduced in a hit and run experiment would be introduced with the
initial insertion event ("hit" stage).
The only precise study of the fidelity of gene targeting, by chemical mismatch
analysis, suggested that gene targeting is in fact quite accurate (Zheng et al., 1991).
Zheng and co-workers used a knockout of the hprt locus in mouse and human cells
as their test system, and then analysed independent G418- and 6-TG-resistant clones
for the presence of mutations suggesting errors in the targeting process. Then-
analysis relied on the mutation being relatively close to the site of integration (within
approximately 700bp of the insertion site), and was designed primarily to detect small
mutations within this region.
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The experiments described in this chapter were intended to further the understanding
of the fidelity of insertion events in the context of a hit and run experiment.
2.2 Experimental Design
The hprtb'"u mutation (Thompson et al 1989), present in the E14TG2a ES cell line
(Elooper et al.. 1987), was chosen as a convenient system in which to study errors in
recombination for reasons already outlined in section 1.4. To this end, a targeting
event was designed, such that accurate recombination would restore function in the
hprtb'm3 gene. Many errors in recombination would therefore be observable at the
level of the phenotype. The structure of the hprtb ,rLi locus is shown in figure 2-1,
where it may be seen that the mutation rendering the E14TG2a line resistant to 6-TG
is a deletion encompassing the promoter region and exons 1 and 2. There is thus no
significant possibility of background reversion to wild-type, as there might be with a
point mutation. The experimental design is shown in figure 2-2. A vector
incorporating sufficient upstream control sequences to drive the repaired hprt gene
(Melton et al., 1986) plus a fragment spanning exons 1 and 2 is therefore capable of
repairing the hprtb',ru gene (Doetschman et al., 1987; Thompson et al., 1989). A neo
gene was also included in the construct, and was used to initially select the clones on
the basis of their resistance to G418 rather than to HAT medium. Clones were then
studied both by Southern analysis and HAT selection. This allowed the comparison
of genotype with phenotype; a lack of correlation between the results of the Southern
analysis and the ability of the cell to survive or otherwise in HAT medium might
signify a clone which has failed to recombine correctly. The level of hprt enzyme
activity was also assessed in HAT-resistant (HATr) clones, in case small mutations
introduced during the insertion event had deleterious effects on the protein but did
not completely ablate gene function, resulting in an hprt allele with reduced activity
compared to wild-type.
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Figure 2-1: The Murine hprt Locus
The structures of the wild-type (HATr/6-TGs) hprt locus and the mutant (HATs/6-
TGr) hprtb m3 locus, present in the E14TG2a murine ES cell line. Exons are marked
as grey blocks, with transcribed but untranslated regions hatched. Intronic sequence
is shown as a black line. The sizes of different restriction fragments observable with
exon-specific probes are shown in kb. Selected restriction enzyme sites marked: B,
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Figure 2-2: A Strategy for Examining the Fidelity of Gene Targeting
The hprtb m3 locus is targeted with a correction vector designed to convert phenotype
from HATs/6-TG" to HATr/6-TG\ Clones are isolated by virtue of their resistance to
G418, rather than HAT, and therefore selection is not dependent upon restoration of
function. The correction vector is based upon pDWMlOl (Thompson et al., 1989)
and is shown in figure 2-3. Vector pDWMlOl contains 9kb of the murine hprt gene,
between 2.3kb and 4.2kb of which is homologous to the mutant hprtb-m3 allele
(depending upon the exact but unknown location of the 3' endpoint of the deletion
encompassing exons 1 and 2 in E14TG2a). The vector has the same organisation as
the wild-type gene except that intron 1 is reduced from 10.8kb to 4.1kb. The
homologous sequence is derived from a mouse myeloma library (Melton et al., 1984)
and as such is considered not isogenic with the 129/ola sequence of the target locus.
In experiment HPRT/I, a single plate of electroporated cells was selected in HAT
medium, to generate targeted clones selected at the level of the phenotype as positive
controls for those generated by selection in G418; These clones were designated
HI/Hx.
After isolation, clones are then screened in duplicate, at the level of the genotype by
Southern analysis and at the level of phenotype by HAT selection. Clones which
appear targeted by Southern analysis but which are HATS may indicate errors in the
HR process.
The hprt enzyme activity of a cohort of targeted clones was also analysed to check
for anomalous levels of activity as a consequence of point mutations which do not
completely ablate gene function.
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Figure 2-2













ANALYSIS OF CLONES: (1) Southern: Genotype
(2) HAT Selection: Phenotype
Are there any clones of the correctant structure by genotype
that are HATS, and that may thus be failed recombinants?
HPRT Enzyme Activity analysis of HAH clones to ascertain
the likelihood of small mutations failing to completely ablate
gene function
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Such an analysis may detect mutations not obvious from the study of Zheng et al.
These include point mutations, small rearrangements and deletions occurring at some
distance from the site of integration of the vector. There is some evidence that such
mutations occur during insertion events (Doetschman et al., 1987; Thompson et al.,
1989). Such errors may be difficult to detect by Southern analysis, and unless they
occurred close to the linearisation site would not have been detectable by mismatch
analysis of PCR products from around this site. Unlike the Zheng study, the clones
described in this chapter were not pre-selected as being of the predicted targeted
structure before analysis.
2.3 Targeting Vector pDWMlOlneo
The targeting vector pDWMlOlneo was constructed as a variant of pDWMlOl
(Thompson et al., 1989), provided as a gift by Dr David W. Melton of the
Department of Molecular Biology, Edinburgh. A neo gene under the control of the
PGK promoter and PGK polyadenylation sequence was excised from the vector
pSPGKneo (obtained from Hein te Riele of Amsterdam; shown in figure 7-1 [a]) as a
1.5kb Bgl II fragment. This fragment was cloned into the Sal I site of pDWMlOl by
blunt-ended ligation to create pDWMlOlneo. pDWMlOlneo is shown in figure 2-3,
together with the predicted structure of the correctant hprt allele. The vector was
linearised at the Xho I site in exon 3.
2.4 Results
In two separate electroporations, vector pDWMlOlneo was transfected into
E14TG2a ES cells as described, and clones were selected in 300|ig/ml G418 and
expanded to approximately lxlO6 cells (a confluent single well of a 24-well tissue
culture plate). They were then split into two, with half being used for Southern
analysis and the remainder tested for the ability to survive in HAT medium. The hprt
68
Figure 2-3: hprt Correction Vector pDWMlOlneo
a) Vector pDWMlOlneo, derived from vector pDWMlOl (Thompson et al., 1989).
The vector includes exons 1-3 inclusive and 650 bp upstream sequence, shown as
grey or hatched blocks respectively, which is sufficient to drive corrected hprt
gene expression (Melton et al., 1986). Intronic sequence is shown as a thick
black line; bacterial sequence as a thin black line. A PGK-neo cassette was cloned
into the vector, orientation as shown. The vector is linearised at the unique Xho I
site in exon 3. Selected restriction enzyme sites are shown: B, BamH I; E, EcoR
I; X, Xho I; s and b, Sal I and Bgl II sites lost upon blunt-ended cloning-in of the
neo construct.
b) Restriction enzyme digestion of vector pDWMlOlneo. Lanes: 1, Uncut (Sal I); 2,
EcoR I; 3, DNA molecular size markers.
c) Predicted structure o.. n _ conected hprtbm3 allele. BamH I restriction enzyme
























cDNA plasmid pHPT5 (obtained from Dr David W. Melton; Konecki et al., 1982)
was used as a source of probes for Southern analysis. Either a 170 bp Xho l/Hinc II
fragment largely comprising exon 3 or a 1.3kb fragment comprising the entire hprt
cDNA was used as a probe. Table 2-1 shows the results of these experiments. Figure
2-4 shows the results of Southern analysis of some HAT-resistant clones and some
G418r, HATS clones, using exon 3 of the hprt gene as a probe.
2.4.1 Accuracy of HAT Selection Data
From table 2-1 it may be seen that the frequencies of targeting measured by
phenotype (i.e. HAT resistance) are higher than those suggested in the Southern
analysis. This was more noticeable in the second experiment. Especially in experiment
HPRT/II, it was observed that clonal growth rates in HAT varied widely. This was
unexpected, and suggested that many clones may be mixed rather than clonal, and
that the variable rate of growth in HAT medium was related to the initial proportion
of HATS contaminating cells. To test this hypothesis, HATr clones obtained in both
experiments HPRT/I and HPRT/II were re-tested for their ability to survive in HAT
medium. The results of this experiment are shown in table 2-2. Clearly, some clones
were originally incorrectly assigned as HATr. Two tested "clones" were seen to be
capable of surviving in both HAT and 6-TG. One of these (HI/122) was a targeted
clone from the G418 selection of experiment HPRT/I and the other (HI/H5) was a
clone originally selected in HAT medium. To differentiate between the possibilities
that either these two clones might be failed recombinants which maintained a
sufficient level of hprt activity to survive, albeit poorly, in HAT as well as 6-TG, or
were mixed clones, they were split into two and selected in both selective media for
10-14 days. Southern analysis and HPRT enzyme activity analysis (see below) were
then performed on the selected cell populations, and it was concluded that these were
mixed clones. Figure 2-5 shows Southern analysis of HATr and 6-TGr subclones from
71
Figure 2-4: Southern Analysis of Clones Obtained with Vector
pDWMlOlneo
The figure shows the results of Southern analysis on E14TG2a clones incorporating
pDWMlOlneo. BamH I digest, probed with exon 3 of the murine hprt gene. The
9.5kb E14TG2a band, and the 15.5kb and 7.0kb bands diagnostic for the correctant
structure are shown.
Lanes 1-5: Targeted clones carrying a corrected hprt gene, and G418r/HATr; lanes 6-
16: Untargeted clones carrying a random integration of vector pDWMlOlneo, and
G418r/HATS. Some clones, such as those in lanes 6 and 14, show an extra band of an
unpredicted size. These clones are interpreted as ones where recircularisation of the
vector has probably occurred prior to vector integration at a random locus. The
vector copy of exon 3 (the linearisation site) is thus protected from exonucleolytic
degradation at the ends of the vector prior to recombination and will therefore give a
signal upon probing a restriction digestion with an exon 3 probe.
Table 2-1: Clones Obtained with Vector pDWMlOlneo
The table summarises the genotypic (Southern) and phenotypic (HAT selection)
results for the clones obtained with pDWMlOlneo.
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Figure 2-4 Southern Analysis of Clones Targeted and Untargeted
with Vector pDWMlOlneo
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Table 2-1. Clones Obtained with Vector pDWMlOlneo
Experiment #G418r #G418r + # Screened # Not # Targeted






HPRT/II 284 60 75(4) 73 2
21%
Notes:
1) Clones selected in 300|ig/ml G418.
2) The number of clones originally selected in G418 initially scored as positive for
the ability to survive in HAT medium.
3) Includes those clones assessed as G418r/HATr in column 3; 2 clones, HI/36 and
HI/56, appeared to be untargeted when studied by Southern analysis.
4) Includes 18 of those clones assessed as G418r/HATr; 16 clones appeared to be
untargeted when studied by Southern analysis.
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Table 2-2: Analysis of Targeted Clones
Unexpected results described in the text (section 2.4.1) where it was observed that
some clones initially assigned as HATr appeared to be untargeted when studied by
Southern analysis suggested that many clones from this experiment may in fact be
mixed. The results of additional selection experiments carried out on these "nominally
targeted" clones to test this hypothesis are summarised in the table. The second
column shows whether the clone was derived from an initial selection in HAT
medium or in G418. The next column shows the number of clones tested. Not all
clones were HATr upon re-selection. For clones from experiment HPRT/I, it was
found that clone HI/56 was in fact HATs/6-TGr (i.e. mutant phenotype), and that
clones HI/H5 (initial selection HAT) and HI/122 (initial selection G418) appeared to
be HATr/6-TGr. These latter two clones were then accordingly re-tested at the level
of the genotype as shown in figure 2-5.
Figure 2-5: Mixed HATr/HATs Clones
The figure shows the results of Southern analysis on subclones obtained from clones
HI/H5 and HI/122 by re-submitting the clones to either HAT or 6-TG selection for a
period of 10-14 days. BamH I digest, using the murine hprt cDNA as a probe. It may
be seen that subclones obtained by 6-TG selection have the 9.5kb band (present in
E14TG2a) diagnostic of the deletion spanning the promoter and exons 1 and 2.
These are therefore clones carrying a random integration of vector pDWMlOlneo
and are hprt. The subclones subjected to HAT selection for the same time lack this
band, but show the 7.0kb band diagnostic of a targeted correction and are therefore
hprt+.
Because a full-length cDNA clone was used as a probe in this experiment, other
bands are also visible. The 15.5kb correctant band and the murine hprt pseudogene
are visible as a single large intense band at the top of the blot, above the 9.5kb hprtp-
deletion band. The small band common to all lanes below the 7.0kb correctant
band is the 4.9kb band encompassing exon 4 (see figures 2-1 and 2-3).
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Table 2-2 Phenotypic Analysis of
Experiment Initial #HATr #HATron # Tested
Selection of Clones Re- for 6-TG












HPRT/II G418 26 7 ND ND
27%
Note:
(1) These two clones comprise one found to be HATr, but which grew slowly in
HAT (HI/122), and one HATS (HI/56).
Figure 2-5 Southern Analysis of HATr and 6-TGr Subpopulations of
Clones HI/H5 and HI/122.
HI/122 HI/H5
HAT 6-TG HAT 6-TG




HI/H5 and HI/122, where it is clear that each is in fact a mixture of two clones, only
one of which is targeted, and a second round of HAT selection was required to
completely purify the clone. Table 2-3 and figure 2-6 (see below) also include the
hprt enzyme activity data for both HAT and 6-TG-selected subpopulations of HI/122
and HI/H5, where it may be seen that they have significantly different levels of hprt
activity depending on which subpopulation has been selected.
2.4.2 Enzyme Activity Analysis of Clones Targeted with
pDWMlOlneo
No clones which appeared to be targeted by Southern analysis were found to be
HATS. This suggests that failed recombinants are relatively rare, but it is likely that in
some cases small mutations in a gene would not completely ablate function, but result
in a reduced level of activity. A clone with a residual level of hprt activity may still be
capable of surviving in HAT medium. To examine this possibility a cohort of the
HATr clones from both experiments were analysed for HPRT enzyme activity.
* •
In addition to the G418r/HATr clones tested, the hprt activity of E14 and E14TG2a
was also measured as positive and negative controls. To examine the possibility that
targeting and selection procedures may alter hprt activity relative to wild-type as an
artefact of culture, some E14 clones which have integrated an irrelevant construct at
random loci, and some G418r/HATS clones from experiment HPRT/I, were also
analysed.
The results of this experiment are shown in table 2-3 and figure 2-6.
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Table 2-3. HPRT Enzyme Activity of Targeted and Untargeted Cells
Notes:
1) An hprt enzyme assay was always run with E14 (hprt) and E14TG2a (hprt)
cells present as positive and negative controls, respectively. The hprt enzyme
activity was calculated by multiple linear regression for all the clones present in a
particular assay based on a zero value and three different protein concentrations
(1, 5 and lOpg), corrected for background counts with an EDTA-poisoned blank.
Calculations were carried out with the "Minitab" version 9 statistical package or
the Jandel Scientific "Sigmastat" statistical package.
2) Standard deviation for the activity coefficient calculated from the regression is
shown, and is given as an error bar in figure 2-6.
3) P value gives the significance of the recorded activity coefficient. Only ElATr
clones have a significant level of enzyme activity (P<0.05).
4) Clones HI/H2, HI/E14 and HI/H5 were initially selected in HAT medium as
controls for clones isolated by virtue of their resistance to G418 in experiment
HPRT/I. HI/H5 had appeared to be both HATr and 6-TGr (see table 2-2, line 2).
Clones HI/8, HI/9, HI/36, HI/46, and HI/150 are HATS, untargeted negative
controls. Clone HI/56 originally appeared to be targeted but was subsequently
shown not to be (table 2-2, row 1, final column). Clone HI/122 appeared to be
both HATr and 6-TGr, and was shown to be a mixed clone like HI/H5 (table 2-2
and figure 2-5). Both these clones appear in the table twice, defined by the
selection to which each pure subclone is resistant. Clones HI/122 (HATr) and
HI/149 are targeted clones obtained from experiment HPRT/I by G418 selection
(table 2-1, row 1). Clones HII/252, HII/349, HII/361 and HII/464 are HATr
clones obtained by G418 selection in experiment HPRT/II (table 2-1, row 2), and
shown to be HATr (table 2-2, row 3).
77
Table 2-3. HPRT Enzyme Activity of Targeted and Untargeted Cells





WT E14 V 1402 124 <0.001
WT E14 S 1160 73 <0.001
WT E14 </ 1328 55 <0.001
WT E14 </ 498 95 0.002
WT P66 (El4) •/ 946 135 <0.001
WT W38 (El4) ■/ 1069 120 <0.001
WT W44 (El4) •/ 1249 165 <0.001
WT W55 (El4) •/ 964 180 <0.001
WT W65 (El4) V 1311 184 <0.001
WT W76 (E14) V 1045 150 <0.001
WT W85 (El4) s 773 163 <0.001
Mutant E14TG2a X -201 169 0.24
Mutant E14TG2a X 86 73 0.25
Mutant E14TG2a X -64 52 0.25
Mutant E14TG2a X -26 95 0.79
HATr HI/H2 S 669 153 <0.001
HATr HI/H4 •/ 734 157 <0.001
HATr HI/H5 (HATr) y 233 73 0.005
G418r/HATS HI/8 X -214 153 0.17
G418r/HATS HI/9 X -131 149 0.39
G418r/HATS HI/36 X -201 153 0.20
G418r/HATS HI/46 X -169 157 0.29
G418r/HATS HI/56 X -54 73 0.47
G418r/HATS HI/122 (6-TGr) X 115 73 0.13
G418r/HATS HI/150 X -136 155 0.39
G418r/HATS HI/H5 (6-TGr) X 60 73 0.42
G418r/HATr HI/122 (HATr) s 387 73 <0.001
G418r/HATr HI/149 •/ 804 142 <0.001
G418r/HATr HI/149 •/ 700 73 <0.001
G418r/HATr HII/252 </ 326 52 <0.001
G418r/HATr HII/349 V 299 95 0.020
G418r/HATr HD/361 S 364 52 <0.001
G418r/HATr HII/464 V 1193 5 <0.001
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Figure 2-6 HPRT Enzyme Activities of Targeted ES Cell Clones
The figure shows the hprt enzyme activity for each clone tested (see table 2-3 for
values).
Multiple points in a single column indicate that more than one value has been
obtained for a particular type of clone.
Symbols:
1) Inverted solid triangles. E14 cells (4 values).
2) Upright solid triangles. E14 cells which have integrated an irrelevant vector at a
random locus (7 values). Reading from left to right, clones: P66, W38, W44,
W55, W65, W76, W85.
3) Solid squares. E14TG2a cells (4 values).
4) Open upright triangles. E14TG2a cells transfected with pDWMlOlneo but not
targeted at the hprt locus (6 values), reading from left to right: HI/36, HI/150,
HI/8, HI/9, HI/46, HI/56.
5) Open circles. Correctant E14TG2a clones targeted at the hprt locus with
pDWMlOlneo and selected for that event in HAT medium (3 values). Reading
from left to right, clones: HI/H2, HI/H4, HI/H5. The value with a filled circle in
the same column as HI/H5 is the subclone selected from HI/H5 for the ability to
survive in 6-TG. It may be seen that this clone has the mutant genotype and is
thus a separate, untargeted clone, by referring to figure 2-5.
6) Open diamonds. Correctant E14TG2a clones targeted at the hprt locus with
pDWMlOlneo and selected for that event in G418 (7 values). Reading from left
to right, clones: HI/149 (duplicate values were obtained for this clone), HI/122,
HII/252, HII/361, HII/464, HII/349. The value with a filled diamond in the same
column as HI/122 is the subclone selected from HI/122 for the ability to survive
in 6-TG. It may be seen that this clone has the mutant genotype and is thus a






























2.5.1 Failed Recombinants Appear to be Rare
In experiments HPRT/I and HPRT/II a total of 451 G418r clones were isolated and
analysed by phenotype. A little over a third of these (171; 38%) were screened by
Southern analysis using either exon 3 or the entire cDNA of the hpri gene as a probe,
and no evidence was found for failed recombinants; that is, there were no clones
which had a defined targeting event when analysed by Southern hybridisation which
were HATS. This result places an upper bound on the frequency of such events, with
a 95% confidence limit of 2% of stably-transfected cells, or 46% of targeted events,
although here (targeted clones analysed by Southern hybridisation) the sample size is
small (5 clones) and the frequency of failed recombinants may be much lower.
2.5.2 Mixed Clones Were Obtained at High Frequency
A surprising result from these experiments was that there was a sizeable proportion
of clones which were HATr yet when analysed by Southern appeared to be
untargeted. This was, if anything, the exact opposite of what was expected from the
experiment, since even if HR insertion events proceed with perfect fidelity the
number of HATr clones may only equal the number of clones shown to be targeted at
the level of the genotype, but never exceed it. This therefore suggested that some
"clones" were in fact mixtures, and that depending on the nature, or lack, of the
selection applied to a subculture of cells, different populations of cells outgrew the
others to become the majority. A small proportion of HATr cells present may not be
noticeable on Southern hybridisation but following subculture and selection in HAT
medium, may overgrow the untargeted hpri cells.
Therefore groups of clones originally assigned as HATr were re-tested for their ability
to survive in HAT medium. These results suggested that a sizeable proportion (about
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50-75%) of "clones" so produced were in fact mixtures, with a very few HATr cells
contaminating a majority of G418r/HAT cells. In the case of two clones which
appeared to be resistant to both HAT and 6-TG, it was formally shown by repeated
Southern analysis after subselection that the clones were mixed.
This problem may have arisen for several reasons. For example, it is very difficult
when plating out ES cells to ensure perfect cloning because ES cells tend to form
clumps of a very few cells when they first adhere to the substrate. At higher plating
densities, clones can grow into each other, so that what may appear to be a single
clone is in fact composed of more than one clone. The creation of mixed clones from
otherwise pure populations of cells is also possible during either feeding of plates
during selection or picking clones, because cell aggregates are released from the plate
surface into the medium by mechanical disruption, allowing the movement of cells to
other sites on the plate or their contamination of wells containing other clones, during
the picking process.
2.5.3 HPRT Activities of Targeted Clones Are Lower than those of
Wild-Type.
It may be that a mutation introduced into the locus by the recombination event affects
the function of the protein but does not completely destroy it, and therefore the
relative hprt enzyme activity of a group of the targeted (HATr) clones was analysed
biochemically and compared to that of wild-type and mutant cells. The individual
results for each clone tested are shown in table 2-3 and figure 2-6. The clones were
also grouped according to the starting cell type (wild-type E14 or mutant E14TG2a),
whether they had been subjected to a targeting procedure or not, and of those
transfected with vector pDWMlOlneo, whether they were untargeted or were
identified as targeted after initial selection in G418 or HAT medium. Between 3 and
8 values were obtained for each cell type, and the mean hprt enzyme activity for each
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is shown in table 2-4 and figure 2-7. Using the Mann-Whitney non-parametric two-
sample rank test it was shown that there is no significant difference in hprt enzyme
activity between unmodified E14 cells and E14 cells carrying a neo-containing
construct at an irrelevant locus. There was also no significant difference in hprt
enzyme activity between unmodified E14TG2a cells and E14TG2a cells transfected
with pDWMlOlneo but which have not undergone a recombination event at the hprt
locus. However, the difference in hprt enzyme activity between wild-type and mutant
cells is significant, as expected. It was therefore concluded that any observed
differences in enzyme activity could not be attributed to culture or selection artefacts.
There was also no significant difference in hprt enzyme activity between E14TG2a
cells targeted with pDWMlOlneo whether the cells were selected initially in HAT
medium or in G418. This suggested that the hprt gene is no more likely to be
mutated if the correction event is selected at the level of phenotype or screened at the
level of genotype, and was therefore taken as implying that the recombination event
generally proceeds with fidelity. However, it is obvious from figure 2-7 that there is a
striking difference in hprt activity between wild-type cells and targeted correctants,
and this difference is significant. The standard deviations of these groups appear
comparable, suggesting similar distributions around different mean enzyme activities.
Does this suggest that most of the correctants have undergone errors in
recombination, with perhaps clone HII/464 being the only faithful event out of the 9
clones analysed (see figure 2-6)? This is a possible explanation, but the Dixon
parameter for the hprt enzyme activity of this clone in comparison with the other
clones targeted with pDWMlOlneo is 0.493, providing no evidence that this clone is
a significant outlier from the group (P>0.05; Dixon, 1953). Furthermore, it is now
known that in ES cells and mice carrying an hprt allele corrected with the parent
vector (pDWMlOl) of the construct used in the present study hprt transcription
occurs at a reduced level (in most tissues, approximately 30% of normal) compared
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Table 2-4 and Figure 2-7: Mean HPRT Enzyme Activities
This Table and Figure together show the mean hprt enzyme activity for each type of
clone described in the present study. These are:
1) Wild-type E14 cells (hprt+\ HAT1).
2) E14/G418r clones are E14 (and thus HATr) clones which have been subjected to
G418 selection and cloning. They were included in the analysis to monitor for any
change in hprt activity caused by long-term culture and selection.
3) E14TG2a cells (,hprtbm'3; HATS).
4) E14TG2a/G418r/HATs clones are a cohort of clones from experiment HPRT/I
which were shown to be untargeted both by Southern analysis and HAT
selection.
5) E14TG2a/HATr clones were targeted with vector pDWMlOlneo and selected in
HAT medium as positive controls for the predicted targeted repair of the hprt
gene.
6) E14TG2a/G418r/HATr clones were targeted with vector pDWMlOlneo and
selected in G418. Analysis by Southern and/or HAT selection showed they were
targeted at the hprt locus.
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Table 2-4 Mean HPRT Enzyme Activities
N* Clone Type n Mean Activity Std. Dev. Std. Error
1) E14 4 1097 412 206
2) E14 /G418r 7 1051 184 70
3) E14TG2a 4 -51 118 59
4) E14TG2a/G418r/HATs 8 -90 123 44
5) E14TG2a/HATr 3 545 272 157

















to that of the wild-type allele (Melton, 1990). This was attributed to suppression of
transcription caused by the presence of bacterial plasmid sequences immediately
upstream of the hprt promoter. This is most likely to be the cause of the reduction in
hprt activity seen in these clones.
2.6 Conclusion
There was no incontrovertible evidence obtained in this study for a high frequency of
unfaithful HR events occurring in insertion events. Although most targeted correctant
events analysed had a variably-reduced level of hprt activity compared with wild-type
ES cells, it is unlikely that such changes were caused by the introduction of
deleterious mutations during the integration event. No clones analysed at the level of
Southern blot showed anomalous patterns and the reduction in hprt enzyme activity
was also observed to an identical extent in clones which were directly selected for
targeted correction of the hprt allele in HAT as well as those subjected to selection in
G418, (and which were thus not dependent upon the restoration of gene function for
their survival). The introduction of the neo gene may have contributed to the effect
on expression caused by the bacterial plasmid sequences, resulting in a wide
variability of expression. This objection peTiaps represents a fault in the experimental
design (which was not obvious initially) as pDWMlOl was originally thought to fully
restore hprt activity (Thompson et al., 1989). The reduction in expression observed
makes the separation of those clones which have a reduced level of transcription due
to interfering sequences from those with a point mutation difficult. Further work to
clarify this issue is required. I suggest the use of RT-PCR of the hprt mRNA from
targeted clones followed by single-stranded conformational polymorphism (SSCP)
analysis as a possible strategy. Digestion of the cDNA into 3 or 4 approximately
equal-sized fragments prior to separation and SSCP analysis could be expected to
detect 80-90% of mutations introduced into the coding sequence of the gene
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(Hayashi, 1992). Subject to these reservations however, the conclusion from this
work is that, consistent with previous results (Zheng et al., 1991), gene targeting by
insertion does appear to proceed with a level of accuracy compatible with the
accomplishment of experiments requiring a high degree of fidelity in the HR event,




DELETION BY HIT AND RUN
Introduction of a Deletion by Hit and Run
3.1 Introduction
The advantage of the Hit and Run technique is its fine control of the genetic changes
created; that is the ability to introduce a mutation into the mammalian genome with
great precision, leaving no other changes which might feasibly complicate analysis of
the phenotype produced. It is therefore likely to find most application in the creation
of subtle mutations, such as single base-pair substitutions, with the objective for
example of producing strains of mice which provide models of human congenital
diseases by carrying similar alleles in homologous genes. Precise analysis of this
process is difficult as such mutations are often difficult to detect because the analysis
must be locus and sequence-specific. To permit the relatively simple study of a hit
and run experiment through each step, it was therefore decided that the mutation
should be sufficiently large as to be observable by Southern blot at each step.
Frequencies of all the observed events would therefore be easily calculable, without
the need either to study a selectable gene such as hprt, or to analyse by sequencing
large numbers of clones.
This experiment used the vector pKiDOPNT described below to attempt the deletion
of a 2.3kb region encompassing exon 0 and the associated promoter sequence of the
murine K-ras gene. In addition to the characterisation of the hit and run process, it
was expected that a K-ras knockout would be produced, which would be a valuable
resource in the study of K -ras involvement in development and neoplasia.
3.2 Targeting Vector pKiDOPNT
Targeting vector pKiDOPNT was constructed by Dr D. James Williamson of our
group, designed to introduce a deletion into the K-ras gene of the mouse. The
predicted deletion would span approximately 2.3 kb of sequence 5' to the first
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translated exon of the K-ras gene, completely encompassing the untranslated exon 0
and the promoter region. It was constructed from the vector pPNT (Tybulewicz et
al., 1991; see figure 7-1 [b]) by incorporating a 4 kb Sal I fragment from vector
PBKT-142 (Guerrero et al., 1984) from which a 2.3 kb Xba I fragment containing
exon 0 and the surrounding sequence had been removed. The vector is shown in




Vector pKiDOPNT was electroporated into E14 ES cells as described, and 158 G418r
clones were successfully screened using probe 3 (figure 3-2) as an external probe
located within the region of homology. Probe 3 comprises the Xba I fragment of the
deletion and is therefore an external probe because it is not homologous to any vector
sequences. This slightly unconventional strategy was adopted because problems of
specificity were initially experienced with the probes designed for this experiment,
probes 4' (5' external) and 5 (internal). One clone, designated P66, gave a band-shift
to a larger size as expected for a hit event, and was accordingly screened further to
verify its structure. Use of probe 4' initially suggested that P66 was a targeted clone
of the structure indicated in figure 3-2 (see figure 3-3 [a]).
3.3.2 Back Selection of Clone P66: High Cell Density
gClone P66 was accordingly expanded to 10 cells and back-selected in ganciclovir
with the objective of producing clones carrying the 2.3 kb deletion in the K-ras gene.
The density of cells was 5xl06 cells per 100mm plate. 36 clones were obtained,
designated P66/1-P66/36 inclusive.
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Figure 3-1: Targeting Vector pKiDOPNT
a) The structure of vector pKiDOPNT. The vector carries 3.5kb non-isogenic
homology (source: hybrid of mouse strains AKR-RF/J) to the 5' upstream
sequences of murine K-ras (grey block). A short region of bacterial plasmid
derived from the construct PBKT-142 (Guerrero et al., 1984) is also present
(black block). The vector carries a 2.3kb deletion including the promoter
sequences and exon 0, encompassed by two Xba I sites (X). The vector is derived
from pPNT (see figure 7-1 [b]) and as such includes a neo and an HSNtk gene
(orientation as shown) and a bacterial plasmid (pUC 18, shown as a thick black
line). Relevant restriction sites are shown: B, BamH I, which is the linearisation
site of the vector; X, Xba I; P, Pvu II; K, Kpn I; E, EcoR I. The sizes in kb of
fragments from selected restriction digestions of the construct are shown.
b) Restriction enzyme digestion of vector pKiDOPNT. Lanes: 1, BamH I; 2, BamH I
& EcoR I; 3, EcoR I; 4, Pvu II; 5, Xba I; 6, DNA molecular size markers. N.B.:




































Figure 3-2: Targeting Structures for Vector pKiDOPNT
The figure shows, to scale, the structure of the wild-type murine K-ras locus in the
exon 0-exon 1 region, and the predicted insertion and deletion structures introduced
at the locus with vector pKiDOPNT. Relevant probes are shown: 4' and KR8XK, 5'
external; probe 5, internal; probe 3, external located internal to the homology.
Relevant restriction sites are also shown: B, BamYL I; E, EcoR I; X, Xba I; K, Kpn I;
H, Hind III.
The expected band sizes (in kb) for each of the possible structures with internal and
external probes on an EcoR I digest are shown in the table below:
Probe Wild-Type "Hit" Insertion "Hit & Run" Deletion
Internal (Probe 5) 8.7+1.5 9.6(5')+ll(3')+1.5 7.8






























Figure 3-3: Vector pKiDOPNT Integrates at the K-ras Locus
a) Use of 5' external probe 4' to check an EcoR I digest of DNA prepared from neo+
clones obtained with vector pKiDOPNT and initially screened with probe 3. The
8.7kb band due to the wild-type allele and present in all clones is indicated.
b) The same blot of 129/Ola wild-type (lane 1), and clone P66 (lane 2) DNAs
digested with restriction endonuclease EcoR I, probed with a 5' external probe
(KR8XK; left-hand blot) and internal probe 5 (right-hand blot).
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Figure 3-3
(a) 5' External Probe Screen ofG418r Clones Selected for Integration of
PKiDOPNT











These clones were analysed by Southern Blot and PCR, using the following analyses:
1) Internal Probes (P5, neo, HSWtk)
2) 5' External Probes (P4' & KR8XK)
3) neo PCR
Sample data obtained with internal probe 5 are shown in figure 3-4. The clones
appeared to fall into several broad classes (table 3-1).
3.3.3 Back Selection of Clone P66: Low Cell Density
Small numbers of clones were obtained in the selections described in sections 3.3.2,
3.3.5.2 and 4.4, and this was probably due in major part to metabolic cooperation
deleting many clones by "kiss of death" which would otherwise have survived. This
hypothesis was tested as described in section 4.5.1, and it was concluded that for
ganciclovir selection 1()5 cells/lOOmm plate is the optimum number to plate. P66 was
therefore plated out at this cell density, and the backselection was repeated. 90 clones
were screened using internal probe 5 and 5' external probe KR8XK. The result of this
selection is shown in table 3-2 with sample data from the Southern analysis shown in
figure 3-5.
3.3.4 Clone P66 has a Modified K-Ras Allele, but with an
■Unpredicted Structure
■Figure 3-3 (b) shows the results of Southern analysis of HM1 (strain 129) wild type
-and P66 K-ras-modified ES cell genomic DNA with internal probe 5 and 5' external
irobe KR8XK, performed on the same blot. Although P66 was originally thought to
le a correctly-targeted clone, the data in the figure, and the results of the back
selection at a low cell density (described in the previous section) suggest that this is
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Figure 3-4: Backselection of Clone P66 (High Cell Density)
The figure shows sample data obtained with internal probe 5 on an EcoR I digest of
some clones obtained by backselection of clone P66. The 8.7kb wild-type band is
indicated. The clone in lane 18 was originally thought to be a hit and run revertant
carrying a deletion.
Table 3-1
All the data obtained for the 36 clones obtained by backselection of clone P66 under




High-Density Backselection of K-ras Clone P66
Internal Probe External Probe neo Status Number
Class 1 WT WT - 14
Class 2 WT WT + 5
Class 3 WT+1 band WT + 9
Class 4 WT+1 band WT - 1
Not fully assigned; WT based on a subset of the probes described 2
Not fully assigned; neo+ 5
Note: "WT" indicates the band pattern expected for a clone which is wild-type at the
K-ras locus is observed; i.e. an 8.7kb band is detected with internal probe 5 and 5'
external probe 4' on an EcoR I digest.
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Figure 3-5: Backselection of Clone P66 (Low Cell Density)
The figure shows sample data obtained with internal probe 5 on an EcoR I digest of
some clones obtained by backselection of clone P66. The 8.7kb wild-type band and
large band (~18kb) due to the modified allele of clone P66 are both indicated. Lane 1
is wild-type 129/Ola strain DNA, and lane 2 is clone P66. Lanes 3-13 inclusive are
revertant clones of P66 obtained after selection in ganciclovir. Two patterns are
observed for the revertant clones; either a pattern identical to that of the wild-type
allele, or a pattern lacking the middle, 3', band, but retaining a wild-type and a large,
5', band.
Table 3-2
All the data obtained for the clones obtained by backselection of clone P66 under low




















Note: "WT" indicates the band pattern expected for a clone which is wild-type at the
K-ras locus is observed; i.e. an 8.7kb band is detected with internal probe 5 and 5'
external probe 4' on an EcoR I digest.
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not the case. As can be seen from the Southern analysis, the band pattern differs from
that expected. The smallest band, of approximately 8.7 kb, is due to the wild type
allele on one chromosome. For a correct targeting event of the kind shown in figure
3-2 two larger bands are expected with internal probe analysis. These additional
bands are 9.6kb (5' fragment) and 1 lkb (31 fragment) in size. The largest fragment
observed is approximately 18kb. Because this fragment is also observed with the
external probe, it is concluded that the K-ras gene is disrupted, with the larger
fragment at the 5' end of the modified locus. Because the large fragment was also
observed in many clones obtained upon back selection of P66, it was concluded that
this fragment does not incorporate a functional HSWtk gene. This discrepancy is not
due to a simple error in genomic mapping because were the 5' EcoR I site located
further away from the locus, making the targeted fragment larger, the wild-type
fragment would also be correspondingly large.
As shown in figure 3-1, there is an EcoR I site in vector pKiDOPNT, immediately 5'
to the HSVf/t gene, and it is this site which should limit the size of the detected 5'
£coR I fragment of the targeted locus to 9.6kb. The fragment observed is some 8kb
larger than expected, indicating that an fcoR I site is missing. On back selection even
an unfaithful excision event would usually be expected to remove this site because of
its proximity to the HSVrA: gene, and thus change the observed sizes of both the 3'
and 5' fragments by merging them into one fragment. It was therefore concluded that
either the 3' EcoR I site of the 18kb 5' fragment is not the 5' £cc>R I site of the 3'
fragment, or that the commonly occurring excision event restores a fragment of the
same size (18kb).
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3.3.5 Fast-Track Hit and Run with pKiDOPNT
3.3.5.1 Rationale
The targeting frequency of K-ras with vector pKiDOPNT is low: less than 1% of
integrations result in a homologous recombination event. Furthermore, the only event
observed was not the one anticipated in the experiment design. This may be due to a
feature of the experimental design, or of the K-ras locus in the mouse-for example
the location of the gene may attenuate expression, thus selecting for competing
events such as the one suggested for P66 by selecting for events which integrate
more than one neo gene at the insertion stage (see discussion section).
In an attempt to circumvent this, and also to investigate the efficiency of the hit and
run process, the experiment described in section 3.3.5.2 was performed. The
assumption upon which this experiment rests is that the number of clones subjected
to backselection is much increased; to approximately 4000 in this case. Thus the
chance of carrying out the backselection upon a rarely-occurring correctly targeted
clone is increased some 27-fold. The individual number of cells representing each
neo+ clone is smaller, but still numbers approximately 5xl04 cells for each clone. If it
is assumed that the majority of clones are random integrants, the corresponding
majority of cells in the selection will lack the requisite duplication of homology to
undergo a homologous recombination event and will die in ganciclovir selection.
Some such cells can be expected to form clones by undergoing a point mutation or
6 8
deletion in the USVtk gene. A mutation frequency of between 1 in 10-10 may be
expected (data on hprt, see, for example, Valencius and Smithies, 1991b) resulting in
about 20 ganciclovir clones derived from random events (mutation rate of 1 in 107
8 3
on 2x10 cells) expected in this experiment. Reversion frequencies of from 1 in 10 to
1 in 106 have been recorded for backselection of characterised "hit" clones (Valencius
& Smithies, 1991b, Hasty et al., 1991c). This suggests a range of approximately 2-
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2000 revertant clones would be obtained from such an experiment, assuming an initial
targeting frequency of 1 in 150 G418r colonies. It was therefore expected that the
Fast-Track protocol would produce relatively few clones at the end of the
experiment, but that those obtained would be enriched for ones which had reverted
back to wild type or the desired mutant from a targeted hit event over those derived
from random integration events which had managed to survive by loss of the HSVYA:
gene by mutation.
3.3.5.2 Results of the Fast-Track Hit and Run Experiment
HM1 cells were used for this targeting experiment because of their reputedly highly
g
efficient targeting and germline transmission frequencies (Magin et al., 1992). 10
ES cells were electroporated with pKiDOPNT as described, and subjected to
selection in G418 for 14 days. Approximately 4000 clones were obtained. All these
g
clones were pooled and expanded to 2x10 cells. These cells were then also subjected
to back selection as described in section 7.4.2. 58 clones were obtained, designated
HKiD01-FlKiD058 inclusive. These clones were studied by Southern analysis as
shown in figure 3-6 and summarised in table 3-3.
3.3.6 Chimaera Production
Initial results based on internal probe data (probe 5) suggested that 4 clones, P66/32,
HKiD0/10, HKiD0/52 and HKiD0/55 had undergone the desired "run" event to
produce a clone carrying the intended deletion. These clones were injected into
blastocysts and chimaeras were made. Germline transmission was not observed. After
1 year, the 5 chimaeras were killed, subjected to necropsy and the tissue samples
taken were examined histologically by a pathologist (Dr David J. Harrison,
Edinburgh). Three of the mice had tumours. The first mouse had a teratoma.
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Figure 3-6: Fast-Track Hit and Run with Vector pKiDOPNT
The figure shows sample data obtained with internal probe 5 on an EcoR I digest of
some clones obtained by a fast-track hit and run protocol as described in the text. The
8.7kb wild-type band is indicated. Clones in lanes 10 and 13 were originally thought
to be potential hit and run deletion revertants. Lane 17 includes a wild-type control.
Table 3-3
All the results obtained with the probes shown for the clones derived by the fast-track
hit and ran protocol described in the text are summarised.
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Figure 3-6
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Table 3-3
Clones Obtained by Fast-Track Hit and Run with pKiDOPNT
Internal Probe External Probe neo Status Number
Class 1 WT WT - 16
Class 2 WT WT + 2
Class 3 WT+1 band WT + 9
Class 4 WT+1 band WT - 3
Class 5 WT+>1 band WT - 1
Class 6 WT WT+18kb - 1
Class 7 WT+>1 band WT+18kb - 1
Class 8 WT+1band WT+18kb - 1
Not fully assigned; WT based on a subset of the probes described 18
Not fully assigned; neo+ 6
Note: "WT" indicates the band pattern expected for a clone which is wild-type at the
K-ras locus is observed; i.e. an 8.7kb band is detected with internal probe 5 and 5'
external probe 4' on an EcoR I digest.
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Teratomas have a high incidence in strain 129 (Stevens, 1983; Hardy et al., 1990)
and it is therefore unlikely that this tumour was a direct result of the mutation at the
K-ras locus. A second animal, (a female), had a malignant liver tumour. However, a
PCR (Cui et al., 1993; kindly performed by Dr Jane Armstrong) to decide the sex of
the tumour tissue showed it to lack a Y chromosome. This result does not formally
exclude the possibility that the liver tumour was derived from a karyotypically
abnormal cell (e.g. an XO segregant of an ES cell-derived XY cell). However,
because the mouse was a female and the levels of chimaerism observed, as estimated
by coat colour mosaicism, were uniformly low (<10%), it was most likely that the
tumour was in fact derived from host blastocyst tissue rather than the XY (male) E14
ES cell line. The third animal examined had a malignant leukaemia. Glucose
phosphate isomerase isozyme analysis was performed on part of the tissue, and
showed a slight elevation in GPI-lsa. The host strain of mouse is GPl-lsb, whereas
strain 129 is GPI-lsa. However a representation of GPI-Isa of approximately 20%
minimum is necessary to conclude that a tissue is composed to a significant extent of
ES cell-derived cells because of the relatively high background of GPI isozyme
analysis, and the slight elevation observed in the leukaemia sample was not sufficient
to confirm that the tumour was ES cell-derived. From these results it was concluded
that none of the chimaeras' disease could be unequivocally attributed to the
introduced mutation and, because of the small sample size of the chimaeras, no
further analysis was carried out on these animals.
3.4 Discussion
3.4.1 The Structure of Clone P66
Only one clone characterised at the stage of insertion of vector pKiDOPNT into the
ES cell genome appeared to have integrated the vector at the K-ras locus. This
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clone was designated P66. As considered in section 3.3.4, it appears however that
this clone does not have the structure predicted (shown in figure 3-2).
3.4.1.1 Common Competing Events Seen in Targeting Experiments
Do Not Account for the Results Obtained with Clone P66.
The following sections consider possible structures for the unpredicated K-ras
insertion clone P66, and some mechanisms which might have produced such
structures.
3.4.1.1.1 Recircularisation of the Vector
Should the linearised vector recircularise prior to integration into the genome by
homologous recombination, it may undergo either an insertion event at an unplanned
point in the locus or integrate by replacement. Here however, the insertion would
result in either the designed structure shown in figure 3-2 or a reverse, discussed as
possibility (2) in the next section. If the vector integrates by replacement, it would
produce a deletion at the designed site but this would never be detected because the
resulting clone would be neo and therefore fail to survive G418 selection.
Recircularisation of the vector prior to integration by HR in an unplanned fashion
therefore does not account for the structure of P66.
3.4.1.1.2 Branch Migration
Upon generation of a cross-over structure at the insertion site of the vector, branch
migration of the Holliday Junction along the homology can occur. This may result in
the changing of the structure obtained from that predicted by conversion of a
mutation to wild-type or vice-versa when the heteroduplex is repaired (Hasty &
Bradley, 1993). Four possibilities may be expected in the case of an insertion vector
carrying a mutation in an arm of homology. First, the predicted structure, where the
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mutation is present in one of the linear duplications of homology (in this case, the 5'
one), derived from the vector, and the other duplication is wild-type, being derived
from the endogenous locus. This structure has been ruled out above (see section
3.3.4). Second, a reverse of the predicted structure, where the mutated duplication
and the wild-type one are swapped relative to each other due to branch migration and
heteroduplex repair. The third possibility is a locus where both of the duplicated
regions of homology are wild-type. Fourth, a locus where both of the duplicated
regions of homology contain the mutation. These possible structures are shown
schematically with the predicted EcoR I fragments detected with internal and external
probes in figure 3-7.
None of the above listed events can account for the structure of P66, because none of
these possibilities would result in a structure with such a large 5' fragment.
Possibilities (2) and (3), where there would be no 2.3kb deletion at the 5' duplication
of homology, would appear completely wild-type when tested with the external
probe. Possibility (2) would only produce one larger band (approximately lOkb)
detectable by the internal probe, plus a small band of 3.6kb. Possibility (4) would not
have been identified by the initial screen, which relied on the presence of the 2.3kb
fragment in the targeted locus, and in any case would give the mutated band size
(9.6kb) for the 5' fragment with the external and internal probes which was not
observed, and a 3' fragment of only approximately lOkb when analysed with the
internal probe.
Furthermore, there is no reason to suggest that a backselection carried out on any of
these possible structures would result in an unpredicted event in preference to a
conventional homologous recombination which deletes the vector and one of the
regions of duplicated homology.
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Figure 3-7: Structures Produced Upon Branch Migration by
pKiDOPNT
The figure shows, to scale, the alternative possible structures produced at the K-ras
locus by vector pKiDOPNT, should branch migration and heteroduplex repair occur
during homologous recombination. Below each structure the predicted band sizes
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3.4.1.1.3 Concatenation of the Vector.
Vector pKiDOPNT is linearised with the restriction endonuclease BamH. I, and as
such has cohesive ends when electroporated into ES cells. Thus multiple tandem
copies of the vector could conceivably become integrated into the genome by
concatenation into a linear array by virtue of their sticky ends prior to insertion.
However, were this the case one would expect to see a minimum of 4 bands when
studying the locus by EcoR I digestion and internal probe analysis. These would be
the bands expected for the targeting event as predicted, and extra band(s)
representing additional copies of the vector in the genome. Integrated copies of the
vector arranged "head-tail" would give an extra 12kb band with the internal probe
representing one or more copies of the complete vector. This band would be
expected to become progressively more intense depending on the number of copies
of the vector integrated. A 9kb fragment would be observed for an event linking two
long arms of homology. The internal probe would fail to hybridise with certain EcoR
I fragments of concatamers joined short arm to short arm, because it has no
homology to this arm of the vector. The possible results of such an event are shown
in figure 3-8. One would expect that the backselected clones obtained from a clone
carrying multiple copies of the vector would be comparable with those obtained from
a clone with a single copy, because survival in ganciclovir demands that all of the
integrated copies of the HSVr& gene be removed in the excision event. My
observations were not consistent with these predictions, and therefore it is concluded
that integration ofmultiple copies of the vector in a tandem array into the K-ras locus
do not account for the structure of clone P66.
Concatenation of the vector followed by its integration into the genome by
replacement instead of insertion also produces a structure similar to the predicted
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Figure 3-8: Structures Produced Upon Concatenation of pKiDOPNT
The figure shows, to scale, the two alternative structures produced at the K-ras locus
by vector pKiDOPNT should concatenation occur. The arrow indicates the direction
of the short arm (3' end) of the homology. Below the structure the bands observed by
Southern analysis with 5' external probes or internal probes on EcoR I digest are
shown. Structure 1 shows the bands obtained with a vector with concatenates "head-
tail", and structure two show the more complicated possibilities observed if "head-































event, or possibility (4) considered in section 3.4.1.1.2, which as already described is
incompatible with the observations.
3.4.1.1.4 Intra-Vector Recombination
As shown in figure 7-1 (b), targeting cassette pPNT also has internal linear
homologous duplications of sequence, namely the PGK promoter and poly-A
sequences which drive the two selectable markers. Each duplication is approximately
400bp long. Recombination can thus feasibly occur between these regions, resulting
in the deletion of either the neo gene (by recombination between the PGK promoters)
or the HSVrk gene (by recombination between the PGK poly-A sequences). Whilst
this mechanism is attractive in that it results in deletion of the EcoR I site, and thus
may result in a larger fragment than expected when analysed with the external probe,
the resulting clone would be either G418sor ganciclovir1) This is not the case: Clone
P66 was isolated after G418 selection, and is therefore neo+. The results of
backselection of this clone show that it is ganciclovir7 (and is therefore also HSWtk+).
3.4.1.2 Variations on a Theme
Intra-vector recombination is the only mechanism so far suggested which would
result in the loss of a restriction site and thus increase the size of the fragments
observed with the internal and external probes used to analyse this locus.
Concatenation of the vector prior to such an event could generate several
possibilities, shown schematically in figure 3-9. The final structure generated depends
on whether a neo or HS\tk gene is deleted by recombination between either the PGK
promoter or PGK poly-A sequences respectively, and whether such a recombination
occurs in the 5' or 3' copy of the vector.
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Figure 3-9: Structures Produced By Concatenation/ECR Events
With pKiDOPNT
Schematic structures obtained by a combined concatenation and ECR event upon
pKiDOPNT, leading to a double structure which has lost one of the selectable
markers. The BamH I site (where concatenation is assumed to occur) and diagnostic
EcoR I site are shown. The structures are described further in the text, but briefly, it
is seen that there are four possibilities depending on whether intra-vector
recombination occurs in the 5' (structures 1 and 2) or 3' (structures 3 and 4) copy of
the vector, and whether the neo (structures 2 and 4) or the HSVr£ (structures 1 and
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Structures of the type shown in parts 3 and 4 of figure 3-9 are not relevant to the
present discussion. This is because the deletion including the diagnostic EcoR I site is
at the 3' end of the construct, so that the 5' EcoR I fragment of the structure
detectable by the 5' external and internal probes is of the same size and structure as
that predicted and shown in figure 3-2. Structure 2 has an HSVtk gene in the 5' arm,
which appears unlikely because many clones obtained from back selection retain the
5' large fragment, yet survive ganciclovir selection. Inactivation of the remaining
HSVrA: gene by point mutation is unlikely in such cases because there are two copies
of the gene, and thus the chance of both copies being inactivated to permit survival in
ganciclovir is correspondingly smaller.
Therefore if such an event occurred in the system presently under discussion, the
integrated vector is most likely to be that of structure 1 in figure 3-9. Figure 3-10
shows the structure for clone P66, based on vector pKiDOPNT undergoing such a
concatenation/recombination event prior to insertion. The structure is consistent with
the Southern analysis data from both the internal and external probes, in that the 5'
fragment is the correct size, 18kb, making it the largest fragment to be observed at
the locus. An EcoR I site has been lost, resulting in only two (larger than wild type)
bands observable in the targeted locus with the internal probe, and one with the
external probe and probe 3. As suggested from backselection data, the large 5'
fragment has no HSVr/: gene.
3.4.2 Low Cell Density Back Selection of Clone P66
This back selection is discussed first, because the results obtained are less
heterogeneous than those obtained from the high density back selection of clone P66
and the "Fast-Track Flit and Run" protocol described.
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Figure 3-10: Structure of Clone P66
Clone P66 is postulated to have been generated from a pair of copies of vector
pKiDOPNT which have undergone a concatenationfiECR event prior to insertion into
the K-ras locus. The figure shows the suggested structure of the modified locus,
where it may be seen, consistent with experimental data, that:
1) By 5' external probe a large, 18kb, fragment is detectable.
2) This large fragment is also detectable with the internal probe.
3) A fragment larger than wild-type (8.7kb) and consistent with a targeted
modification of the gene, is detectable by the internal probe and the external
probe located within the region of homology at the 3' end of the locus.
4) The large 5' fragment has no copy of the HS\tk gene, and therefore
recombination events leaving the fragment in place will produce clones which are
GANCr/G418r, as observed.
5) The structure has a triplication of homology, and therefore multiple reversion
possibilities exist.
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Of the clones for which a result was obtained, 55 (61%) appeared to be wild type,
and 35 (39%) retained the 18kb band at the 5' end of the P66 targeted locus. As may
be seen from consideration of figure 3-10, there are more possibilities for intra-
chromosomal recombination within the P66 locus than in the simpler structure
originally predicted. This is because the K-ras locus is thought to contain a
triplication of the regions of homology, and also contains duplications of homology
due to the sequence of pUC and neo from the targeting cassette. Some of the
possibilities are irrelevant, as they do not result in loss of the HSVYA: gene, for
example between the two neo genes. There are four groups of possible combinations
for recombination. The first possibility is a resolution to wild-type, and is a result of
recombination between the outer two lengths of homology recombining 5' to the
intended deletion. Second, a hit and run deletion, as desired, can be produced by
recombination between the outer two lengths of homology 3' to the Xba I site which
forms the 3' boundary of the deletion. The third possibility is the production of a
modified locus with a single large EcoR I fragment, observable by both internal and 5'
external probes. This is 17-18kb in size, and as such is likely to be unresolvable from
the 18kb fragment of P66 by agarose gel electrophoresis. There are two possible
variants of this structure, depending on the site of cross-over, but both produce a
clone with a similar Southern analysis pattern because there is an ZscoR I site at the
extreme 3' end of the Xba I fragment comprising the deleted region. Both of these
possible structures are generated by recombination between the middle and 3'
homology repeats, or between the duplications of the pUC plasmid sequence. These
two additional possible recombinant structures are shown in figure 3-11. The fourth
and final possible recombination event which could occur and result in a GANCr
clone is the deletion of the remaining HSVtk gene by recombination of its poly-A
sequence with that of the adjacent neo gene.
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Figure 3-11: Alternate Reversion Structures from Clone P66
There are two additional possible reversion events from the structure of clone P66
shown in figure 3-10, which may be generated by recombination between the 3' and
middle triplications of homology, or between the duplication of plasmid sequences.
These structures are shown opposite. It may be seen that both structures lack an
HS\tk gene and are therefore GANCr, and that each generates a large EcoR I
fragment detectable with both the internal and 5' external probes and indistinguishable
in size from the 5' fragment of clone P66. No other fragment, other than the wild-
type 8.7kb fragment expected from the unmodified allele on the other chromosome,
is detectable with the internal probe, i.e. the approximately lOkb 3' fragment seen in
clone P66 with the internal probe is lost.
Table 3-4: Reversion of Clone P66
The table shows the possible reversion structures obtained from a back selection
experiment upon clone P66, and the approximate frequencies expected for each
structure should the probability depend exclusively upon the length of homology























ssible Reversion Events from Backselection of Clone P66
Event Homology (kb) % Expctd. % Obsvd.
Resolution to Wild Type 2.4 21.8 61
Hit and Run Deletion 1.1 10.0 0
neo+ Structure with large £coRI Fragment 7.1 (6kb +1.1 kb) 64.5 39
Deletion ofHSWtk gene 0.4 3.6 0
123
Thus it is concluded that on backselection of P66, events of type 1 and 3 are
observed, but not events of type 2 or 4. Table 3-4 gives the approximate length of
homology available in the P66 structure over which a recombination event would
generate each type of reversion event delineated above. The penultimate column
shows the expected frequencies for each type of event if it is assumed that each has a
probability proportional to the length of homology involved in producing the required
crossover. The final column shows the results actually obtained by experiment,
described in section 3.3.3.
The data do not closely fit with the predicted events. The most obvious possible
reason is because the suggested structure of P66, although it is the only one which
has been found to be consistent with the available data, has not been formally shown
to be the true structure. Thus the results obtained from backselections on this clone
could not agree with predictions because of inaccuracies in the supposed starting
structure. However, it is almost certainly naive to predict targeting frequencies based
simply on lengths of homology, as it is well-known that many other factors play a
part, for example whether the regions of homology recombining are isogenic (Te
Riele et ai, 1992; Van Deursen & Wieringa, 1992; Deng & Capecchi, 1992). Special
features of the primary sequence may also be significant, as is implied by the
observation that targeting frequencies have been found to vary by three orders of
magnitude between different genes (Camerini-Otero & Kucherlapati, 1990).
Although 400bp is not below the limit at which intrachromosomal recombination has
been shown to occur (Waldman & Liskay, 1988), such a short length of homology is
known to be less efficient at promoting recombination (Liskay et al., 1987). Thus a
frequency sufficiently small as to be undetectable in this analysis for event (4), that is
recombination between duplicated PGK polyadenylation sequences to delete the
HSVr& gene, does not seem surprising. However, reversion to wild-type is favoured
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over event (3), despite the length of homology available for such a cross-over being
approximately only 1/3 the size. Event (3) may be selected against because it leaves a
duplication of homology still present in the genome which is also capable of
recombination, and the conditions used have strongly selected for clones in which
homologous recombination events have occurred at this locus. Therefore there may
also be selection for an event which spans the entire locus rather than just a part of it,
since the machinery accomplishing the event is present at the locus and has a viable
substrate on which to work.
Why are no hit and run deletion events observed? A measurable percentage, albeit
not high, would be expected from the structure as drawn, as well as from the
designed structure or indeed many other structures which could be produced by
integration of this vector. This is difficult to answer. As previously remarked, branch
migration of the crossover is a common event during recombination. Should this
occur in this case, with the Holliday Junction moving through the site of deletion, a
large (2.3kb) region of single-stranded DNA is produced and in some cases this
would be repaired using information from the other strand. This would reduce the
frequency of backselected clones carrying a deletion, and also has the effect of
enriching for the reversion to wild-type event (as observed).
3.4.3 High Cell Density Back Selection of Clone P66
Results obtained from this population of clones more closely resembles those
obtained from the Fast-Track protocol than the clones obtained by backselection of
Clone P66 at a low cell density. In both of these experiments the cells were selected
at a sufficiently high density that metabolic cooperation could occur. Because a
widely differing population of revertant clones was obtained by backselection of
clone P66 depending on the plating density, it was concluded that metabolic co-
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operation during the selection significantly changes the nature of the selection (and
hence the population of surviving clones).
Clones characterised as showing a wild type pattern constituted the largest single
group of clones in this population, as might be expected from the discussion of the
other backselection on this clone described in section 3.4.2 above (39%-44%).
3.4.3.1 Random Deletion
Random deletion (unfaithful excision) is a strong candidate as a mechanism for
removal of the HSVtk gene under conditions of metabolic stress caused by
backselection at a high cell density. The EcoR I site is immediately adjacent to the
HSVr/c gene and as such would be expected to be lost in the majority of such
deletions, resulting in an EcoR I fragment of any size between 2-3kb and 30kb. As
there are two neo genes present in the locus, it is quite feasible that the clone remain
neo+ after such an event. However one would not expect clones which have
undergone such deletions to appear wild type when analysed with the external probe
as a rule. This is theoretically possible, in that the deletion may span from 5' of the
site of hybridisation of the external probe to the HSVr/: gene, but this is unlikely from
a statistical point of view to be the most common event; for it to be so would require
the HSVtk gene to favour deletion in the 5' direction and deletion to frequently
initiate within the gene or plasmid sequence so that a band of unpredicted size is seen
with the internal probe. The result obtained for one clone, comprising a class 4-type
event described in section 3.3.2, is consistent with this mechanism.
3.4.3.2 Re-Integration Events
Pickup events, where a target sequence recombines with a vector and then re¬
integrates into the genome elsewhere have been recorded in the past (Adair et al.,
1989), and extrachromosomal events involving the association of homologous and
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non-homologous recombination events have recently been described (Sakagami et
al., 1994). It appears that in clones of classes 2 and 3 described in section 3.3.2 and
table 3-1, (that is wild-type by external probe but still having another band by one or
both of the internal probes 5 and neo), some vector sequence has re-integrated into
the genome at another locus, following excision of a region of sequence
incorporating the HS\tk gene. This conclusion was reached because the results
obtained with the external probe for the vast majority of these clones indicate a wild-
type structure, suggesting that a recombination event occured to regenerate the wild-
type K-ras locus. However, the internal probe indicates that vector sequence is still
present. The fragment observed is of a random size. Simple deletions are unlikely to
account for all of these clones because the diagnostic EcoR I site is immediately
adjacent to the HSVf/: gene and therefore in the majority of cases a band shift would
also be observed with the 5' external probe as well. Very large deletions
encompassing the entire region containing sequence homologous to the external
probe would usually be expected to encompass the regions of homology to probe 5,
and in these case the clones could no longer be neo+ (as is the case with clones of
class 2) and yet fail to generate a detectable signal with the internal probe.
3.4.4 Fast Track Hit and Run with pKiDOPNT
3.4.4.1 Screening of clones HKiD01-HKiD058
58 clones were obtained from this selection, as described in section 3.3.5.2. Overall
they were similar in character to those obtained from the high density backselection
of clone P66, but slightly more heterogeneous (as expected), and with certain
significant differences. 16 clones were defined as wild type, and another 18 clones
were wild type as far as defined, by external probe(s) and neo. Thus whilst some of
the 18 incompletely characterised clones were probably derived from random
integration events which were neo', it appears that the largest single group of clones
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obtained from this selection are wild type (27.5%-58.6%). A significant difference
between this group of clones from the comparable group produced by backselection
of clone P66 is that they are derived from uncharacterised precursor cells: all that is
known about the cell from which each clone obtained in this backselection is derived
is that it is neo+. Therefore it is not known for each wild type clone obtained here
whether it is truly wild-type, having integrated the vector at the target locus and then
regenerated the wild-type locus by homologous recombination, or whether a random
integrant has excised the vector sequence by a deletion mutation so that it generated
no signal when analysed with the internal probe.
Most of the remaining clones obtained are wild-type when studied using the external
probe, but have one or more extra bands observed using the internal probes (table 3-
3: classes 3-6 inclusive). They may or may not be neo+. It is possible to account for
all of these clones as random integrations of the either vector or some part thereof
which have subsequently undergone point mutation or deletion to inactivate the
HSVtk gene. However, they could also be derived from targeted cells which have
undergone deletion/re-integration events similar to those considered in section
3.4.3.2.
3.4.4.2 Fast Track Hit and Run Does Enrich for Events at the Target
Locus
No hit and run deletion events were obtained in this experiment, as was the case with
both back selections on clone P66. However, three clones produced patterns similar
to that seen for some of the clones obtained in the previous backselection carried out
on a known clone (clone P66). Clones HKiD054, HKiD056 and HKiD057 (classes 6,
7 and 8, respectively) show a large band with the 5' external probe similar to that
seen with P66 and many of its derivative clones. This shows that an insertion event
has occurred at the target locus and that the clone is derived from a cell in which
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deletion of its functional copy of the HSVtk gene has occurred. However
consideration of the internal probe results for these clones shows differences between
these clones and their conventionally-produced counterparts. First, the internal probe
results are all different, showing each to be an independent clone; thus the enrichment
for recombination events at the target locus is increased (5.2% compared to 1.7%).
The other major difference is that the internal probe pattern does not correspond with
that of the external probe: the internal probe results are consistent with a wild-type
locus (HKiD054) or show one other smaller band (HKiD()57), or more than one
other band (HKiD056).
This may indicate a problem with transfer of larger fragments to the filter on the
Southern used for the internal probe, which could be the case for HKiD054.
However, the observed hybridisation by the internal probe to other clones in this
group argues against this, rather that the event occurring in these cells differs
significantly from that proposed to have occurred in clone P66. Because they are
undetectable by 5' external probe, the subsidiary bands seen are either at the 3' end of
the locus, or are elsewhere in the genome, perhaps present as the result of pickup
events. They may represent additional integrations of the vector into the genome at
random.
The exact nature of the event(s) occurring at the K-ras locus is difficult to resolve. It
is difficult to conceive of an event which produces a pattern so strikingly similar to
that seen on clones known to have undergone recombination at the intended locus,
albeit in an unpredicted event, and yet which does not appear to react with the
internal probe. This question cannot be answered categorically because the only
information reliably pertaining to the K-ras locus is that provided by the external
probe. Data generated using the internal probe may reflect the occurrence of events
elsewhere in the genome. However, the fragment size observed with the 5' external
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probe suggests an event similar to that occurring in clone P66, but clearly with
further complications: possibly a large deletion of the region generating a large
fragment containing no homology duplications. In a similar way to the majority of
clones obtained in the high cell density backselection of clone P66, the variably-sized
bands visible in the internal probe analysis are possibly due to pickup events, but the
possibility also remains that the entire locus has rearranged and created two different
fragments visible by internal or external probe.
3.4.5 High Cell Density in Backselection
In the backselections described in sections 3.3.2 and 3.3.5.2 the higher plating density
of cells present in the selection introduces other variables into the system. Cells able
to survive such selection conditions which eliminate their neighbours are unlikely to
be behaving in a similar physiological manner to the wild-type. By virtue of their
cellular environment, e.g. the position in the cell cycle, or accumulation of a
mutation, they may be more prone to undergoing changes than normal ES cells and
thus as well as surviving selection by loss of the HSVr& gene other changes permit
escape from "kiss of death", and incidentally produce a small but diverse group of
clones whose analysis suggests uncommon events. That these clones have arisen from
a population that in some way deviates from the normal ES phenotype is also
suggested by the fact that of the relatively few chimaeras created from these clones,
the level of chimaerism observed was not large (less than 10% by coat colour
estimation) and germline transmission of the allele was not achieved. It is therefore
likely that the cells surviving the selection were either differentiated or genetically
compromised, and the selection conditions enriched for a non-pluripotent subset of
cells which have undergone unpredicted events (Sheardown & Hooper, 1992). It is
generally regarded that for optimum transfer of the modified allele through the
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germline, ES cells should be at their lowest possible passage number and that they
should not be exposed to suboptimal growth conditions (Robertson, 1987).
3.4.6 Chimaera Studies
After initial internal blot data were obtained for clone P66/32 and clones HKiDOlO,
HKiD052 and HKiD055, which were initially thought to be targeted hit and run
deletions, some chimaeras were made whilst further verification of the structures was
sought. Unfortunately these results showed that the clones were not K-ras exon 0
deletion mutants and chimaera production was terminated. However, the chimaeras
were not killed until after a year, when they were then examined. Few chimaeras
were obtained, and those which were obtained were not highly chimaeric and did not
pass on their ES cell-derived mutation to their offspring as discussed above.
Although three out of five chimaeras had neoplastic malignancies in evidence upon
pathological examination, no significance to the status of the animal's K-ras gene
could be inferred from these tumours.
3.5 Conclusion
An attempt has been made to introduce a deletion mutation removing the exon 0
region from the K-ras gene of the mouse by hit and run gene targeting in ES cells.
Although events were observed at the K-ras locus itself, these occurred at a low
frequency and no event of the type expected was obtained. This may represent an
effect of the K-ras locus itself on the recombination process, for example being
located in a poorly recombinogenic region of the genome, or flanking sequences
complicating the selection by downregulating neo expression so that there is selection
for more than one neo gene to become incorporated. An insertion event (clone P66)
was observed at the K-ras locus, but this was an unpredicted event and backselection
of this clone failed to produce a hit and run deletion. The event producing clone P66
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appeared to involve a concatenation and extra-chromosomal recombination event
prior to the integration of the vector into the K-ras locus.
Backselection at a cell density high enough for the ES cells to participate in metabolic
cooperation was found to select for a small subpopulation of clones which have
undergone multiple events in the genome, thus producing a disparate collection of
clones many of which had one or more fragments of the vector incorporated in their
genomes. A low density of cells in backselection produces a clearer picture due to the
eradication of such complications but was still not able to generate a hit and run
mutation.
A "fast track" protocol based on backselection of all neo+ clones obtained from the
initial step with the objective of enriching for those clones which have undergone the
rare event of a targeted insertion was also unable to produce the desired mutation,
but it was shown that some 5% of the clones obtained by this procedure had
experienced a recombination event at the K-ras locus, suggesting that it may provide
the basis of an improved selective procedure if undesired competing recombination




MUTATIONS BY HIT AND RUN
Introduction of Point mutations By Hit and Run
4.1 Introduction
The impetus for the development of the hit and run technique is the desire to generate
precise, small mutations in the genome which will allow the creation of animal models
which are representative of human diseases, or permit studies of aspects of gene
function in vivo not possible with a knock-out type experiment. To this end, two
targeting vectors were used in experiments which aimed to introduce small mutations
into the K-ras gene. The first, pKiTPNT, aimed to introduce a point mutation into
codon 12 of the gene, and thereby introduce an activating gly—>asp mutation of the
type observed in malignancy. Vector pK4BAPNT was designed to introduce a frame-
shift into exon 4B prior to the polylysine domain and post-translational modification
site, with the objective of effectively deleting this splicing variant as a functional
molecule. Such experiments, which are designed to introduce smaller mutations, may
additionally shed light on the behaviour of pKiDOPNT described in the previous
chapter. A much more efficient targeting efficiency might suggest, for example, that
the mutation to be introduced by a hit and run experiment affects its efficiency and
that the method is not suitable for the creation of large deletions.
4.2 Targeting Vector pKiTPNT
This vector was constructed by Dr D. James Williamson in our group. It is derived
from the pPNT targeting cassette (Tybulewicz et al., 1991), described in chapter 7
and shown in figure 7-1, and includes a 2.8kb Xba l-Kpn I fragment of homology to
the murine K-ras gene derived from the plasmid PBKT-142 (Guerrero et al. 1984).
This fragment incorporates the murine exon 1 of K-ras, and carries a G—>A mutation
at position 35 which converts the wild type glycine residue to an aspartic acid
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residue. Vector pKiTPNT is shown in figure 4-1, and the structures of the wild-type
locus and the designed insertion event are shown in figure 4-2.
4.3 Targeting Vector pK4BAPNT
4.3.1 Design of pK4BAPNT
A distinctive feature of K-ras is that unlike its close relatives H-ras and N-ras, it has
two splicing variants which differ in their C-termini. The protein is linked to the inner
cell membrane by post-translational modifications at the C-terminus (see the
Introduction, sections 1.2.2 and 1.2.4), but little is known about the functional
differences of the two different K-ras p21 proteins. Part of the present study
therefore attempts to address this question using two approaches. In chapter 5, an
RT-PCR-based study is described which looks at the relative expression of the two
alternative fourth coding exons in different tissues during development of the mouse.
Secondly, targeting experiments are currently underway to delete one or other of the
exons, so that animals and ES cells which are only capable of manufacturing one
form of the protein may be studied. Dr D. James Williamson and Dr Charles Patek
are carrying out an experiment to force the use of exon 4B by removal of exon 4A by
replacement. Vector pK4BAPNT is designed as a complementary experiment, where
the exon 4A splicing variant is the only functional one.
As described in the introduction, section 1.2.4, p21K~™'Ui undergoes three post-
translational modifications, namely farnesylation of the cysteine residue of the CAAX
motif four amino acid residues prior to the C-terminus, followed by proteolytic
removal of the terminal three amino acids and carboxymethylation of the new C-
terminal substituted cysteine. These modifications are essential for the membrane
localisation of p21'", which is essential for function (reviewed in section 1.2.4).
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Figure 4-1: Targeting Vector pKiTPNT
a) The structure of vector pKiTPNT. The vector carries 2.8kb of non-isogenic
homology (source: hybrid mouse of strains AKR-RF/J) to the region
encompassing exon 1 of murine K-ras (grey block). The vector carries an
activating gly-^asp codon 12 activating mutation generated by a G—>A transition
at position 35 of exon 1. The vector is derived from pPNT (see figure 7-1 [b])
and as such includes a neo and an USVA gene (orientation as shown) and a
bacterial plasmid (pUC 18, shown as a thick black line). Relevant restriction sites
are shown: S, Sal I, which is the linearisation site of the vector; X, Xba I; K, Kpn
I; E, EcoR I, St, Stu I. The sizes in kb of fragments from selected restriction
digestions of the construct are shown.
b) Restriction enzyme digestion of vector pKiTPNT. Lanes: 1, Stu I; 2, Sal I




Figure 4-2: Targeting Structures for Vector pKiTPNT
The figure shows, to scale, the structure of the wild-type murine K-ras locus in the
exon 0-exon 1 region, and the predicted insertion structure introduced at the locus
with vector pKiTPNT. Because the introduced mutation is so small, at the scale
shown the wild-type and hit and run mutant structures are identical. Probe 3 is
shown. Selected restriction sites are also shown: B, BamU I; E, EcoR I; S, Sal I; K,
Kpn I; N, Not I; P, Pvu II.
The expected results for Southern analysis of targeted clones obtained with this
vector, using probe 3 are shown below:
Restriction Digest Wild-Type/"Run" "Hit" Insertion
Pvu II 9.5kb 6.5kb



























The structure of the murine K-ras gene (George et al., 1985) is similar to that of the
human c-K-ras2 gene (Shimizu et al., 1983b, McGrath et al., 1983 & Capon et al.,
1983), and is shown schematically in the introduction. As may be seen from figure 1-
10, deletion of the entire exon 4B by replacement as planned for exon 4A is not an
appropriate strategy because immediately 3' to the exon 4B coding sequences are the
K-ras untranslated sequences, including the polyadenylation signal, and removal of
part or all of these sequences would also affect the behaviour of the exon 4A-
containing mRNA in addition to that of exon 4B.
Taking these two considerations together, hit and run was therefore selected as the
most appropriate strategy for this experiment. A small mutation introducing a
premature stop codon into exon 4B prior to the poly-lysine string and the CAAX
motif could be expected to functionally ablate the exon 4B variant p21™s protein by
preventing correct localisation of the molecule at the cell surface (see introduction).
The exon 4A-containing mRNA should be unaffected because no change has been
made to any of the untranslated sequences or the size of the mRNA, and therefore
the mRNA can be expected to behave identically to the wild-type with respect to
stability and polyadenylation.
4.3.2 Construction of pK4BAPNT
Vector pK4BAPNT was constructed as shown in figure 4-3. It is derived from the
pPNT targeting cassette (Tybulewicz et al., 1991), and vector pY413 (George et al.,
1985) which carries 3.6kb genomic sequence incorporating the murine K-ras exon
4B. The unique Hind III site in pPNT was removed by digestion of the construct
with Hind III, filling in of the cohesive ends by Klenow enzyme and then re-ligating
the ends. This permitted the use of the unique Hind III site in the homology as a
linearisation site prior to electroporation of the construct.
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Figure 4-3: Construction of Targeting Vector pK4BAPNT
A flowchart showing the steps involved in the construction of the targeting construct
designed to introduce a missense mutation into exon 4B of murine K-ras, pK4BA
PNT. The vector homology is derived from pY413 (George et al., 1985) and the
selectable markers and bacterial plasmid sequences from pPNT. The mutation was
introduced at a BstB I site near the start of exon 4B, and a small fragment containing
this exon was subcloned out of pY413 for the mutagenesis process because there is a
second such site in the homology region. This fragment was then replaced to restore
the homology region in vector pY413, and the complete, modified length of
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The small Hind III fragment of pY413 was removed by digestion with Hind III and
religation to generate the construct pY413AH, and the construct pK4Bg was
generated by the subcloning of the small Hind III fragment so produced into pUC19.
This smaller Hind III fragment contains K-ras exon 4B and only has one BstB I site
which is present in the exonic sequence. pK4Bg was digested at this site with BstB I,
treated with Klenow enzyme and then religated, to generate pK4BgAB which lacks
the BstB I site. Dideoxysequencing analysis showed the loss of a T residue in the site,
which resulted in a frame-shift giving a premature stop signal as shown in figure 4-4.
The small Hind III fragment was then cloned back into pY413AH at the Hind III site
to regenerate the genomic fragment contained in pY413, except that a point mutation
in exon 4B is now present at the BstB I site. Dideoxysequencing was used to check
that the orientation of the fragment was correct. The 3.6kb genomic fragment from
pY413AB was excised with the enzyme EcoR I and cloned into pPNT at the unique
EcoR I site to produce vector pK4BAPNT. Vector pK4BAPNT is shown in figure 4-
5, together with the wild-type and insertion locus structures.
4.4 Experiments with pKiTPNT
With the objective of generating an activating point mutation, vector pKiTPNT was
introduced into E14 ES cells. 150 clones successfully screened with probe 3 showed
no correctly-targeted insertion events, indicating a low targeting frequency with this
vector.
Because of this low targeting frequency, at the same time as the comparable
experiment with vector pKiDOPNT described in section 3.3.5.2 was carried out, the
vector was re-electroporated into ES cells and the approximately 1500 clones so
g
obtained were pooled, expanded to 2x10 cells and backselected in ganciclovir at a
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Figure 4-4: Point Mutation to be Introduced into K-ras Exon 4B
a) Dideoxysequence analysis of the start of murine K-ras exon 4B sequence, as
present in vector pK4BAPNT, showing the deletion of a thymidine at the BstB I
site of the wild-type gene.
b) The introduced mutation results in a frame-shift leading to a premature
termination of translation of the K-ras exon 4B splicing variant prior to the









Poly-Lysine String CAAX Motif Ter
CiAGCAAAGATGGGAAGAAGAAGAAGAAGAAGTCAAGGACAAGGTGTACAGTTATGTGA
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Figure 4-5: Vector pK4BAPNT and its Targeting Structures
The figure shows, to scale, the structure of vector pK4BAPNT, the wild-type murine
K-ras locus in the exon 4B region, and the predicted insertion structure introduced at
the locus with vector pK4BAPNT. Because the introduced mutation is so small, at
the scale shown the wild-type and hit and run mutant structures are identical. To the
right of the vector structure is shown a restriction enzyme digestion of pK4BAPNT.
Lanes: 1, Hind III (linearised); 2, EcoR I; 3, DNA molecular size marker. As with the
other vectors designed to target K-ras described in this thesis, pK4BAPNT is based
on pPNT and as such has a neo gene as a positive selectable marker and an HSVtk
gene as a negative selectable marker (orientation as shown). The asterisk indicates
the site of the point mutation. The sizes in kb obtained by EcoR I restriction enzyme
digestion of pK4BAPNT are shown.
Selected restriction sites are shown: Bg, Bgl II; E, EcoR I; H, Hind III; Bs, BstB I;




































density of 5xl()6 cells/lOOmm plate. 29 clones designated HK1-HK29 inclusive were
obtained from this experiment.
4.4.1 Screening of Clones HK1-HK29
The original objective was to screen these clones by Southern Analysis using probe 3
on separate Pvu II and BamH I digests as above, but this probe is unreliable because
of a relatively high level of non-specific hybridisation in comparison to specific
hybridisation. Alternative screening strategies were therefore devised. However, use
of the arms of the vector homology was unsuccessful because of very high
background hybridisation. Faint and non-specific hybridisation was observed to an
exon 1 genomic probe. No signal was obtained using the K-ras cDNA as a probe or
the Kpn I-Pst I fragment derived from PBKT-142 as a 5' external probe to analyse a
Kpn I digest. Oligonucleotide probing using the exon 1 PCR primer described in
section 7.4.3 end-labelled with P-33 was similarly unsuccessful due to lack of signal
at a high stringency wash (2xSSC at 56°C) or non-specific hybridisation at a low
stringency wash (6xSSC at room temperature).
It was therefore concluded that the genomic sequence of K-ras in the region of exon
1 is refractory to reliable Southern analysis because of poor probe specificity. For this
reason, a two-part strategy based on the PCR was adopted:
1) Screening for neo and the diagnostic mutation to test for the presence of vector
sequence and the mutant K-ras exon 1 sequence in the genome.
2) Clones designated neo in part 1 were then subjected to RT-PCR of K-ras RNA
followed by the diagnostic PCR to ascertain presence or absence of the desired
mutation at the K-ras locus, and confirming the generation of a functional mRNA
product carrying the mutation from the gene.
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Part 1 of the screen was carried out as described in section 7.3.6.3. Duplicate samples
of each clone's genomic DNA were run in parallel, one of which was spiked with an
equal quantity of genomic DNA from a clone known to be neo+. Thus false negatives
due to poisoning of the PCR by contaminants present in a particular DNA sample
were avoided. The diagnostic PCR designed to observe and follow the point mutation
was also run on each sample.
The second part of the screen relies on the fact that genomic DNA will not be
susceptible to the PCR because the introns make the fragment to be amplified too
large for the Taq polymerase enzyme (approximately 40kb). Thus the analysis works
at the level of transcription and a positive result indicates a clone which carries the
mutation and is correctly transcribing and splicing the gene with the desired mutation.
For this analysis, ES cells from each clone were grown and RNA prepared and
reverse transcribed as described for the analysis of splicing variant expression
described in chapter 5. The PCR amplifying the K-ras cDNA was run on the sample.
An aliquot was run on a 1.2% agarose gel and a plug of agarose from the K-ras
cDNA band was taken with a Pasteur pipette and blown into 500|al ddH20 and
incubated at 55°C for 10 minutes, lql of this dilute solution of RT-PCR product was
then used as template for the codon 12 mutation PCR described in section 7.3.6.2.
The results obtained from this screen are shown in table 4-1.
From table 4-1 it may be seen that unfortunately no correctly-targeted clones carrying




The table shows the results of the screening of clones HK1-29, obtained by a fast-
track hit and run protocol with vector pKiTPNT, by a two-part PCR strategy.
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Table 4-1
Genomic Screen Wt!Neo- Mutant/iVeo Wt/Ateo+ Mutant//Veo+
N2 Clones 4 2 12 6
(There were additionally 4 clones carrying the mutation, and 1 wild-type, which were
uncharacterised with respect to neo)
RT-PCR Tested 2 2 4 6
RT-PCR: WT 2 2 4 6
RT-PCR: Mutant 0 0 0 0
(All 4 clones carrying the mutation, but with an unknown status with respect to neo,
were also shown to be wild type at the K-ras locus by RT-PCR) ____
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4.5 Experiments with pK4BAPNT
4.5.1 Metabolic Cooperation In Ganciclovir Backselection
This vector, constructed as described in section 4.3, was electroporated into HM1 ES
cells, and submitted to the fast-track protocol as described. However, backselection
was carried out at different cell densities to monitor for distortion of the results by
metabolic cooperation, as was suspected to be the case in experiments described
previously. Cells were therefore plated out at different densities of cells per plate and
the number of colonies obtained was counted. The results of this experiment are
shown in table 4-2, and graphically in figure 4-6.
It was concluded that approximately 105 cells per 100mm plate is optimal for
selection in ganciclovir, providing a workable compromise between the number of
plates required for an experiment and the number of clones obtained, and this cell
density was accordingly used for the repeated backselection of clone P66 described in
section 3.3.3.
4.5.2 Screening of Clones obtained with Vector pK4BAPNT
188 clones were picked from the backselection described above, from the low cell-
density plates. To minimise labour in the screening process, the initial screen used
was somewhat similar to that finally used for the clones obtained with vector
pKiTPNT, namely RT-PCR of K-ras followed by enzymatic digestion of the product
with BstB I and agarose gel electrophoresis to separate the products. Loss of the
BstB I site would indicate a successful hit and run event producing a transcribed
mRNA with a mutation in exon 4B as designed. The K-ras allele on the other
chromosome provided a control for enzyme activity. Clones carrying such a mutation
could then be further screened to check for the presence of anomalous events, by
Southern analysis, dideoxysequencing or PCR as necessary, but of the 67 clones
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Table 4-2 and Figure 4-6: Variation in Cloning with Increasing Cell
Density in the Presence of Ganciclovir
HM1 ES cells were transfected with vector pK4BAPNT and subjected to G418
g
selection. Clones were pooled and the cells expanded to 2x10 cells. The table shows
the number of clones obtained by plating neo+ cells at different cell densities per plate
and subjecting the plated cells to ganciclovir selection. These data are also presented
in figure 4-6 as the number of GANCr clones obtained per original cell plated.
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Table 4-2
N2 Cells/lOOmm Plate N2 GANCr Clones
Obtained
Mean N2 of Clones/Cell
plated
ixioT 376 3.50x10 2
324







Number of GANCr Clones Obtained/Number of Cells Plated
Plating Density (Cells/lOOmm Plate)
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successfully screened by this method none was found to be carrying the desired
mutation.
4.6 Discussion
4.6.1 Targeting Efficiency of Vector pKiTPNT
The targeting efficiency of this vector is clearly low, because no correctly-targeted
insertion events were observed. This is probably due to the nature of the homology
carried by the vector. The length of homology is 2.8kb, which is relatively short by
modern standards; many workers are currently using homologies in the region of
lOkb in targeting constructs to optimise targeting efficiencies (see, for example,
Rudolph et al., 1993a, 1993b; Ernst et al., 1994; Gorry et al., 1994). A marked
increase in targeting frequency was observed when the length of homology in the
targeting vector was increased from 1.3kb to 6.8kb (Hasty et al., 1991a). However,
2.8kb has been shown to be sufficient for measurable gene targeting to occur (Adair
et al., 1989; Schulman et al., 1990; Hasty et al., 1991a; Deng & Capecchi, 1992;
Scheerer & Adair, 1994).
Targeting efficiency is also affected by small divergences in homology. It has been
shown that targeting constructs built with homology regions derived from the same
strain of mouse as the ES cell to be targeted can be much more efficient than those
made from non-isogenic DNA (Te Riele et al., 1992; Deursen & Wieringa, 1992;
Deng & Capecchi, 1992). This reflects polymorphic differences in untranslated
sequence between the two strains, which reduce the maximum length of
uninterrupted homology of the targeting construct by mismatches. Elimination of
such differences by the use of isogenic DNA increases the effective length of
homology, and hence targeting efficiency, of the vector. The murine homology in this
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case is derived from an AKR-RF/J hybrid mouse, whereas the ES cells are 129/Ola-
derived, and therefore this may be a significant factor in this experiment.
Target genes also vary widely in their recorded targeting frequencies (Camerini-
Otero & Kucherlapati, 1990), for unknown reasons. This phenomenon may be related
to characteristics of the target locus such as its chromatin organisation. There are
some indications that the targeting frequencies of ras genes are low: Other work in
our group, some of which is described in this thesis, suggests this is the case, as have
informal discussions with a group involved in similar work (T. Jacks group; personal
communication) Targeting of the N-ras locus was observed to be very inefficient (a
targeting frequency of 1/5000-7000 transfected cells; Cases & Dautry, 1992;
Umanoff et al., 1995) when targeted by PNS-replacement. Efficient targeting of
human c-K-ra^-2 was observed (29% G418r colonies) but was carried out using a
PNS replacement vector with 6.7kb of homology and a promoterless neo gene as the
positive selectable marker on a transformed human cell line and therefore the
relevance to the present results is dubious (Shirasawa et al. 1993). An attempt to
target the H-ras gene was also unsuccessful (Crombie, R., Balmain, A., Clarke, A. R.
& Hooper, M. L.; personal communication).
4.6.2 Study of Clones Obtained By Fast-Track Hit and Run With
Vector pKiTPNT
Many problems were experienced during the screening of the potentially-targeted
exon 1 clones, which is why further electroporations of the vector were not carried
out to generate additional clones and increase the probability of obtaining a hit and
run activated K-ras gene. Since the locus appeared to be extremely refractory to
successful Southern analysis, an alternative analysis examining the K-ras locus at the
level of transcription, namely RT-PCR, was chosen as the best way of circumventing
the problems experienced. As well as showing the presence or otherwise of the
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desired alteration, it also shows that the modified gene is still operational and that
functions such as splicing have not been impaired by other mutations introduced by
the hit and run method.
Unfortunately no correctly-targeted hit and run clones have been identified from the
29 obtained. The largest group (12 clones) contain neo but are negative for the
mutation both at the genomic and transcribed levels. These are most probably clones
which have incorporated a proportion of the vector sequence at a random location in
the genome, but have excluded the fragment of homology incorporating the mutation
during the integration event, i.e. have not integrated the very 5' end of the construct.
However the possibility of a targeted event which has failed to recombine correctly
and produced a gene which fails to transcribe a stable mRNA is not formally
excluded by this analysis. Random integration is also the most likely explanation for
the second largest group of clones, namely those which have incorporated both the
neo gene and the point mutation into the genome but fail to express the mutation at
the level of mRNA. Four clones were completely wild-type by the analyses carried
out. These may be either random integration events largely or completely excised by
deletion or they may be hit and run events which have reverted to wild type. A hit
and run event which has resolved to wild type appears less probable, however, given
that there is no unequivocal evidence for a targeting event in any of the other groups
of clones. Again, random integration is the most likely explanation for clones which
are mutation positive at the genomic level but are neo , with a deletion removing the
selectable markers.
4.6.3 pK4BAPNT as a Hit and Run Vector
pK4BAPNT was designed and constructed as a hit and run vector whose purpose is
to introduce a frame shift mutation leading to a premature stop codon in exon 4B of
the murine K-ras proto-oncogene.
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An assay based on PCR followed by restriction endonuclease digestion, described in
section 4.5.2, has been designed and optimised which permits the identification of the
mutant murine gene.
Although only 37% of clones picked in this experiment were successfully screened no
clones characterised by the desired event were noted, as determined by K-ras RT-
PCR followed by restriction endonuclease digestion of the products and agarose gel
electrophoresis. A total of 67 clones were screened, and it is therefore not possible to
rule out low-frequency targeting as in the other two K-ras experiments described.
The genomic clone pY413 was the only available clone at the time of vector
construction, and therefore the length of homology within the constructed vector is
probably suboptimal. The mutation is necessarily at the 5' end of the vector
homology, so that most revertant cross-overs occurring in a targeted clone with an
insertion structure of the type shown in figure 4-5 are predicted to favour the
restoration of the wild-type exon. Approximately 8% of cross-overs between
homology duplications of this structure, calculated from a comparison of relative
lengths of homology on each side of the mutation, are predicted to leave the mutation
in the genome. However, branch migration events have been shown to be capable of
drastically modifying the frequency at which the mutation is observed in each of the
homology duplications (Hasty et al., 1991c) and it was therefore anticipated that
backselection would almost certainly occur on clones which have the mutation either
in both duplications or in the 5' duplication as well as that shown in figure 4-5. For
such clones the opposite applies: nearly all reversion events can be expected to retain
the mutation.
Ignoring branch migration and heteroduplex repair-mediated conversion of the 5'
homology duplication, the above calculation predicts that 8%, or about 5 clones out
of 67, might be predicted to have retained the point mutation in K-ras exon 4B, but it
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must be borne in mind that many of the G418r clones in the backselection are likely to
be random integrations, which have undergone mutations in the HSVtk gene to
produce GANCr clones, and therefore the expected number of targeted revertants is
reduced.
4.6.4 Fast-Track Hit and Run
A potential criticism of this protocol is that the background level of mutation of the
HSVr& gene actually observed would be too high to facilitate the isolation of targeted
clones. As may be seen from figure 4-6, at a cell plating density of lxlO4 cells/plate
2 6 r
3.5x10 clones/plated cell were obtained. This corresponds to 7x10 GANC clones
from 2xl()8 G418r clones. Therefore at such a sufficiently low plating density that
bystander killing by metabolic cooperation may be ignored, a much larger number of
GANCr clones was obtained than originally expected. The results of screening some
of the clones obtained by this procedure with vectors pKiTPNT and pK4BAPNT
tend to agree with this criticism, and it may be that the level of competing illegitimate
recombination events and mutations of the HSV4/: gene make the experiment
unworkable at the present locus. However, it will be remembered that in chapter 4,
evidence was presented for a measurable level of events at the target locus by vector
pKiDOPNT, even if the desired hit and run event was not observed. This is consistent
with the idea that hit and run reversion events will be favoured over the survival of
illegitimate recombination events by mutation but that because the vector fails to
target as predicted, the desired event was not detected in this case.
It is likely that the level of background GANCr clones in this experiment impeding the
isolation of targeted clones is an artefact of the negative selectable marker, and that
the premise of the experiment is correct. HSVf/: cannot be positively selected in wild-
type cells; in the vectors described in this thesis, neo was used as a positive selectable
marker. Furthernore, there is also the possibility that mutations in the HSVtk gene
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during propogation of the construct in E. coli will result in a cohort of clones
resistant to gancicolvir. After transfection of the vector and before backselection,
there is a significant time when HS\tk is not under selection-approximately 14 days
during the growth of clones under positive selection in G418, followed by pooling
(when each clone comprises approximately 1000-5000 individual cells), and then a
further 4-5 days of expansion to a total cell number of 2x10 cells prior to plating and
backselection the following day. This corresponds to approximately 18 cell
generations (our own observations; Hasty et al., 1991c), and constitutes a problem
because of the exponential growth of cells: a cell undergoing point mutation of the
HSWtk gene during the first cell generation and growing at the same rate as other ES
cells until backselection produces over 250,000 HSVt/c "daughter" clones upon
backselection. Thus reversion events due to intra-chromosomal recombination
(selected, predominantly, at the final cell generation when a single HS\tk~ cell
generates two clones) are swamped by the background of point mutations in the
negative selectable marker occurring during positive selection and expansion. The
conclusion from this experiment is therefore that HSVWGANC selection is an
inappropriate negative selection method for the fast-track hit and run technique. The
hprt gene, used as both a positive and negative selectable marker in hprt ES cells,
would represent a significant improvement on the present system, because HAT
selection could be maintained during cloning of transfectants and cell expansion, thus
eradicating the vast majority of spontaneous mutants. Enrichment for the desired
event over the present strategy would therefore be significantly improved, and thus
the isolation of the desired mutants is predicted to become a relatively trivial
problem. Because there is effectively an additional selection for homologous
recombination events at the target locus in addition to that for stable transfection
events, the frequency of targeted recombinants should be very high and with the
suggested refinement this strategy might have general applicability.
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4.7 Conclusion
Two vectors were constructed with the objective of introducing point mutations into
the murine K-ras gene. One such vector (pKiTPNT) was shown to have a very low
targeting frequency so that it was not possible to carry out a backselection on a
targeted clone. This experiment would be improved by the use of a vector with
increased, isogenic homology to the target locus to improve the targeting efficiency
and also by the development of efficient and specific screens for such clones. PCR
between the vector and the external genomic sequence may provide a more efficient
screen at this locus than Southern analysis, and with the advent of long-distance PCR
protocols becomes a much more realistic prospect for the screening of ES cell clones
for targeting events, because it is no longer necessary to keep one arm of the
homology very short to permit PCR amplification of a diagnostic fragment (Barnes,
1994; Cheng et al., 1994).
The targeting efficiency for vector pK4BAPNT is unknown because this vector was
only used in an experiment where the backselection was carried out on pooled clones.
This vector should therefore next be used to electroporate ES cells and screen clones
at the G418r stage to check the initial targeting frequency of this construct. Although
such a site is at present unknown, a linearisation site closer to the middle of the
region of homology than the Hind III site originally chosen may prove useful in
increasing the targeting efficiency (Dickinson et al., 1993). If targeted insertions can
be obtained, backselection can be expected to produce a low but observable number
of mutation events. A higher efficiency of retention of the mutation is predicted if a
clone which has the mutation in the 5' duplication of homology can be isolated.
Should this prove not to be the case, the vector homology should be expanded on the
5' arm of the homology containing the mutation. This should improve both the
targeting frequency and the frequency of reversions under backselection to the
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mutant form. Use of the exon 4B reverse PCR primer described in section 7.4.3
combined with the "Vectorette" (ICI) single direction PCR-based genomic walking
system using a proof-reading polymerase would be an appropriate method of deriving
the required extra genomic sequences.
RT-PCR was a convenient and precise assay for point mutations introduced into the
mouse genome, showing whether or not the experiment had introduced the designed
mutation into the target gene, and that the modified gene still produced a functional
mRNA molecule.
4.7.1 Mutations Introduced by Hit and Run
Although the conclusion is a somewhat negative one, it now appears likely that the
lack of success in deriving insertion and hit and run revertant clones with vector
pKiDOPNT described in the previous chapter is not due to the specific nature of the
mutation (a large deletion) to be introduced, because similar results were obtained
with vectors designed to create either a tiny (lbp) deletion or a missense mutation. It
is therefore concluded that the vector architecture and the nature of the target locus
are the most important factors in determining the targeting efficiency in an
experiment and is furthermore predicted that there is no reason why the mutations




VARIATION OF EXON 4
SPLICING OPTIONS IN
MURINE DEVELOPMENT
Variation of K-Ras Exon 4 Splicing Options in
Murine Development
5.1 Introduction
As described in the Introduction, section 1.2.2, the K-ras proto-oncogene has two
alternative C-terminal exons, designated 4A and 4B. Although not associated with a
catalytic activity, these exons are regarded as essential to the function of the protein,
in that they encode the region of the protein at which the molecule is linked to the
inner surface of the plasma membrane. This has been shown to be necessary for
normal function of ras (Willumsen et al., 1984a, 1984b; Leevers & Marshall, 1992).
The exons differ somewhat, in that exon 4A lacks the poly-lysine string which
characterises exon 4B. Despite this, most studies, focusing on the behaviour of ras as
an oncogene or an effector of cell signalling function, have not differentiated between
the two forms of K-ras, or indeed usually between any members of the ras family,
and so subdivisions of function between isoforms remain unresolved. For example,
the v-onc form of K-ras is K-rasA (McGrath et al., 1983; Shimizu et al., 1983b), but
overexpression of K-ras has also been observed in transformed cells (George et al.,
1985). Relatively little is known of the more subtle, but presumably important,
differences in function suggested by the conservation of the ras genes. It was
therefore decided, in parallel with targeting experiments designed to separate the
function of the two K-ras isoforms, that the representation of the two different forms
of K-ras in different situations be investigated. Such a study would hopefully reveal
any subdivisions of function.
The objective of the experiment was to observe any differences in the relative
preferences of the two K-ras splicing variants in the mouse during development,
either between stages of development of the embryo or between tissue type, which
may indicate subdivision of function of one variant from another. The stratagem
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adopted was that of reverse-transcription-polymerase-chain-reaction (RT-PCR), to
measure the relative proportions of mRNA of each splicing variant, in a variety of
different tissues at different stages of development. RNA was prepared from each
tissue sample, and using oligo dT12.i8 as a primer cDNA was prepared. The cDNA
was then used as template in a K-ra.v-specific PCR and the relative amounts of
product of each splicing variant were determined. Determination of the proportions
of the mRNA species was achieved by separating the cDNA products by agarose gel
electrophoresis, Southern blotting the gel and hybridisation to a K-ras cDNA probe.
Densitometry of the autoradiographs provided a simple method of determining
relative proportions of each cDNA.
5.2 Results
5.2.1 Validation of the Analysis
It is clearly of prime importance that any differences in relative expression observed
represent real differences in the tissue under study, and not artefacts of the PCR
reaction or procedures used to analyse the products.
5.2.1.1 Primer/Template Sequence Considerations
The mRNAs of each splicing variant, as shown in the Introduction, both contain
exons 1 and 4B. There is therefore no difference in binding affinity between the
templates and primers for either of the 2 possible cDNA species which might lead to
an increase in amplification efficiency for one variant at the expense of the other.
5.2.1.2 Cycle Number
Care was taken to avoid allowing the PCR to progress significantly past the
logarithmic stage of reaction, and thus possibly introduce a limiting factor other than
the quantity of template. Figure 5-1 shows the amount of product obtained, measured
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Figure 5-1: Increase in Quantity of Specific Product With Increasing
Cycle Number for PCR of K-Ras cDNA
The figure shows the increase in product of the K-ras PCR with increasing cycle
number. This is measured as an increase in the size of the densitometric peak,
representing the product at the specified cycle number, after Southern hybridisation
as described in the text. Densitometry of the bands was used to generate a plot of
relative peak absorbance against cycle number. After printing, each peak was cut out




K-ras PCR: Variation of Product Quantity with Cycle
Cycle Number
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densitometrically, versus cycle number of the PCR. All following PCRs were done at
21 cycles, which was shown empirically to produce a measurable quantity of product
in most cases and yet just precedes the plateauing of the PCR.
5.2.1.3 Quantification of Products
In order to confirm that the relative fractions of each PCR product as measured by
densitometry, corresponding to relative abundances of mRNA in a tissue, are an
accurate reflection of the proportions of each mRNA species the experiment shown in
figure 5-2 was performed. A total of lpg of the two cloned K-ras cDNAs was mixed
in different molar ratios as template, and then subjected to the PCR. The cDNAs were
obtained by RT-PCR of mouse strain 129/Ola liver RNA using the primers described
in section 7.4.3 and cloned into pUC19 (Yanisch-Perron et al., 1985). Dideoxy
sequencing revealed no differences from the published sequence (George et al.,
1985). The RT-PCR products were separated by agarose gel electrophoresis and
Southern blotted. The PCR products were then hybridised to the K-ras cDNA
containing exons 1, 2, 3, 4A and 4B, and the filter was autoradiographed.
Autoradiographs were taken at several exposures, to avoid the introduction of errors
as a consequence of saturation of the film.
Autoradiographs were analysed by scanning laser densitometry, and the relative band
densities were compared with the relative proportions of each template initially used
in each reaction.
As is shown in figure 5-2, there was very good agreement between the relative
proportions of each template in the reaction and the relative intensities of each band,
as measured on the autoradiograph by laser densitometry. A correlation coefficient
between the proportion of each cDNA present as template and the density of the band
representing it on the autoradiograph of greater than 0.999 was recorded.
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Figure 5-2: Quantity-Specific Nature of the PCR of K-Ras cDNAs
a) Southern analysis of K-ras PCR carried out on lpg of control murine K-ras
cDNAs, mixed in the molar quantities shown above the bands.
b) Graph of the observed splice variant proportion as a percentage of the total K-ras
PCR product against the proportion expected based upon the actual ratios of
template used in the PCR. Symbols: black triangle, expected values; white




















a Observed Splice Variant Proportions







5.2.2 K-Ras Exon 4 Splicing Options in Murine Development
Balb/c mice were taken every three days of pregnancy from day 9 onwards to birth,
and sacrificed. Embryos were dissected as far as technically possible at each stage of
development. Embryos were not dissected earlier than day 9 post coitum because of
the technical difficulties of dissection and the problem of separating maternal from
embryonic tissue. Three to five samples of each tissue from different embryos were
analysed separately. In addition, ES and EC cells were analysed as an approximation
of early stage (day 3.5) development, although it should of course be borne in mind
that these are actually cell lines adapted to in vitro conditions. The ES and EC cells
were also subjected to induction of differentiation in vitro as described in chapter 7
and the differentiated populations studied.
Sample data, obtained by RT-PCR and Southern hybridisation to the K-ras cDNA, of
K-ras transcripts from ES and EC cells and isolated mouse tissues are shown in
figure 5-3.
Table 5-1 shows the results obtained for the exon 4 splice options analysis carried out
on the developing mouse embryo. These data are also presented in a graphical format
in figure 5-4, where any changes with time are perhaps more easily seen.
5.3 Discussion
5.3.1 PCR of Murine K-ras cDNA is Quantity-Specific
The major criticism of this type of analysis is that the data obtained, (i.e.
measurements of the relative proportions of each K-ras splicing variant for a given
tissue at a given stage in the development of the mouse embryo), may not accurately
reflect exon 4 expression patterns in the mouse. Discrepancies may arise because of
the introduction of artefacts or distortions at one or more of several stages: reverse
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Figure 5-3: Tissue Specific K-Ras Splicing Variant Preferences in
the Developing Mouse
The figure shows the results of Southern hybridisation of RT-PCR product of murine
K-ras transcripts to the K-ras cDNA probe containing exons 1, 2, 3, 4A and 4B.
Samples from various tissues at different stages of development are shown. The
examples of undifferentiated ES and EC cells at the top row ("E 3.5") are duplicated
at two different exposures of the autoradiograph to show that only the K-rasB
transcript was observed for undifferentiated E14, HM1 and PSA4 cells.
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Figure 5-3
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Table 5-1: Tissue Specific K-ras Splicing Variant Preferences in the
Developing Mouse
A B
The table shows the relative proportions of K-r&v transcripts K-ras and K-ras
expressed in each tissue type, as a percentage of the entire K-ras mRNA measured.
Each value is given as a mean of up to 5 samples.
Notes:
1) Stage of development is given in days; "N" denotes a neonatal sample.
2) The number of samples is shown in column n.
3) "Diff. 1" indicates differentiation stage 1; see chapter 7.
4) "Diff. 2" indicates differentiation stage 2; see chapter 7.
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Tissue Day n 4B Mean (%) 4A Mean (%)
EX4 3.5 1 100 0
E14 (Diff 2) 3.5 2 90 10
HM1 3.5 1 100 0
HM1 (Diff 1) 3.5 1 53 47
HM1 (Diff 2) 3.5 4 85 15
PSA4 [EC] - 1 100 0
PSA4 [EC] (Diff 2) - 2 79 21
Embryo 9 5 100 0
Embryo+Yolk Sac 9 2 100 0
Embryo 12 5 99 1
Gut 15 4 77 23
Gut 18 4 60 40
Small Intestine N 4 48 52
Large Intestine N 3 50 50
Stomach N 3 70 30
Liver 12 4 89 11
Liver 15 4 60 40
Liver 18 4 77 23
Liver N 3 70 30
Kidney 15 4 86 14
Kidney N 4 85 15
Heart 15 4 97 3
Heart 18 4 99 1
Heart N 4 85 15
Lungs 15 4 72 29
Lungs 18 4 75 25
Lungs N 4 66 34
Spine 15 5 87 13
Spine 18 3 97 3
Spine N 4 90 10
Brain 15 5 99 1
Brain 18 4 97 3
Brain N 4 76 24
Brain Stem 15 3 91 9
Brain Stem 18 4 98 2
Brain Stem N 4 98 2
Eye 15 4 95 5
Eye N 4 94 5
Head 12 5 96 4
Head 15 5 99 1
Head N 1 100 0
Limbs 12 2 100 0
Limbs 15 5 71 29
Blood 15 1 92 8
Yolk Sac 12 5 56 44
Yolk Sac 15 5 54 46
Yolk Sac 18 4 44 56
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Figure 5-4: Tissue Specific K-ras Splicing Variant Preferences in the
Developing Mouse
The Figure shows the relative proportions of K-ras transcripts K-rasA (red) and K-
ras (blue) expressed in each tissue type, as a percentage of the entire K-ras mRNA
measured. Each value is given as a mean of up to 5 samples.
Notes:
1) Stage of development is given in days; "N" denotes a neonatal sample.
2) Error bars represent standard error of the mean for the tissue type and
development stage.
3) "Diff. 1" indicates differentiation stage 1; see chapter 7.
4) "Diff. 2" indicates differentiation stage 2; see chapter 7.
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transcription, PCR, Southern analysis, autoradiography. It was therefore essential to
optimise the analysis before proceeding to the mouse, and this is the purpose of the
experiments described in section 5.2.1.
The control experiments described in sections 5.2.1.2 and 5.2.1.3 were carried out
using 0.1-lpg of linear K-ras cDNAs mixed either in equimolar ratios (5.2.1.2) or in
varying molar ratios (5.2.1.3). This amount was chosen for the optimisation
experiments because it was likely to be representative of the quantities of K-ras
mRNA/cDNA recovered from tissue samples.
Experiment 5.2.1.2 shewed that the amount of product continues to increase during
the PCR up to approximately 22-23 cycles, and then the plateau effect begins to be
seen as the amount of new product synthesised begins to level off. 21 cycles was
therefore selected as the optimum number for the analysis because this is high enough
to give an easily detectable quantity of product and yet remain within the exponential
region of the PCR, and thus avoid any potential problems with preferential
amplification which may occur as the reaction begins to saturate. The cDNA is single
stranded and so only one PCR primer can bind the template on the first round of the
PCR. Consequently, at the start of the analysis there is one round of arithmetic rather
than geometrical amplification of the target sequence. Therefore 21 cycles of PCR on
the tissue-derived cDNA more properly equates to 20 cycles of PCR in the control
experiment, thus placing the system effectively in the middle of the exponential range
of the PCR.
Experiment 5.2.1.3 showed that there was good agreement between the starting
ratios of the two variants at the beginning of the PCR and the ratios measured after
PCR, Southern blotting and autoradiography. Results gained from murine tissues
should therefore accurately reflect the relative amounts of each cDNA obtained after
reverse transcription.
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It should be borne in mind that this experiment is not a truly quantitative PCR in the
classical sense, because the objective is not to compare amounts of product between
samples, but rather to quantify the ratio of the two variants both present in the same
sample. For this reason it was unnecessary to include an internal standard in the PCR
reaction tube, but simply to show that measured ratios correspond well with the
ratios of starting template.
The only source of error unaccounted for in the above control experiments is the
starting material itself, i.e. RNA from tissue samples. Degradation of RNA by poor
handling can be expected to reduce yield, although the use of RNAse-free materials
and the use of liquid nitrogen to store RNA samples ameliorates this. However,
would one mRNA species be significantly more stable than the other? Such a
situation would result in poor estimates of relative expression by overestimating one
splicing variant at the expense of the other. This was thought unlikely here however
because of the relatively small size difference in the mRNA species (under 5%,
George et al., 1985) and the fact that the exon producing the size difference is
internal to the primers. Thus exonuclease-mediated degradation can be expected to
affect the quantity each variant obtained equally. Because both the mRNA species
have the same untranslated sequences and encode products of almost identical size
A B
(189 amino acids for K-ras and 188 amino acids for K-ras ) the "physiological"
stability of each mRNA species in the cell is almost certainly identical (Sachs, 1993).
5.3.2 K-Ras is Represented in All Tissues Studied
In agreement with previous work (Muller et al., 1983; Leon et al., 1987), K-ras
expression was observed in all embryonic tissues studied. The only exception to this
is blood, where it was rarely observed, but this was due to the difficulty of obtaining
adequate quantities of embryonic material.
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This analysis does not formally show that K-ras is expressed in every cell type,
because not every tissue type was examined, and most tissues comprise more .han
one cell type, but it appears likely from these observations that the K-ras gene is
ubiquitously expressed at the tissue level in the mouse.
5.3.3 K-Ras Exon 4B is Always Expressed in Cells, Whereas Exon
4A is Not
As can be seen from the results in table 5-1 and figures 5-3 and 5-4, the expression of
K-ras mRNA isoforms varies between tissue types. The mRNA of K-ras is present
in all tissues studied. Furthermore, this form is almost always the most abundant,
whatever the tissue. The only exceptions to this rule, neonatal small intestine and day
18 yolk sac, are where the values for exon 4A and exon 4B are sufficiently close that
they are within the errors of the experiment and therefore no significance can be
concluded from this.
K-rasA is usually expressed in lower amounts, and in some cases such as neural tissue
and muscle tissue is observed in very low quantities indeed (<10%). Further analysis
is required to show whether such cell types in fact produce only the exon 4B
transcript and the exon 4A transcript observed merely represents contamination from
other cell types present in the sample.
5.3.4 Within a Tissue, K-Ras Splicing Variant Expression Does Not
Usually Vary Significantly During Development
As is seen from the graphical presentation of the data, within any tissue type there is
usually no obvious trend with respect to the relative proportions of each K-ras
mRNA species over time. The Mann-Whitney non-parametric test was used to test
the significance or otherwise of differences between proportions of K-ras in similar
tissue samples at different stages of development.
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There are few exceptions to the finding that there are no significant differences in K-
ras exon 4 splicing variant expression over time within the same tissue type. In the
A
heart, a slight elevation in K-ras (from extremely low levels to 15% of the total) was
observed between day 18 embryos and newborn animals. In the liver between days 12
and 15 of development, an elevation in K-ras (from approximately 10% to 40% of
the total) was observed. However, in both these cases the importance of these
findings is cast into doubt by the lack of a significant difference between either of
these stages of development and any of the others measured for the same tissue. They
are therefore likely to be stochastic artefacts of the analysis.
In the case of the gut, there may be a slight increase in K-rasA during development.
There was no significant difference between large and small intestine of the neonate,
and so these values were pooled to form a group of 7 observations designated
A B
"neonatal gut". Significant increases in K-ras compared to K-ras were observed
between day 15 gut and neonatal gut and between day 18 gut and neonatal gut.
Although it is obviously important to avoid over-interpretation of the data, this
observation may reflect a small but significant change in K-ras expression patterns in
the gut during the later stage of development, when the gut is undergoing active
differentiation processes (see next section; Kaufman, 1992).
At day 9, no K.-rasA expression was observed in whole embryos, but within certain
individual tissues (e.g. yolk sac and liver) at day 12, expression of this variant was
g
observed. Thus it may be that for approximately the first half of development, K-ras
is the only significant K-ras isoform expressed. However, a finer-level analysis of
early-stage embryos is required to show this, as it may be that small amounts of K-
rasA present in particular cell types at this stage of development were not detectable
g
in the analysis due to an excess of competing K-ras , present in all tissues.
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In the majority of tissues studied significant modulation of K-ras expression patterns
during development was not observed. These tissues included the embryonic brain,
brain stem, spine, eye, heart, lungs, kidney, liver and yolk sac. As already seen
however, there are frequently significant differences between tissue types. This result
is consistent with the hypothesis that a cell type's pattern of K-ras expression
depends on the cell type and that proliferation of the tissue during growth does not
usually alter this; rather it is more likely that expression of K-ras is an early event in
development. The fact that K-ras is expressed, albeit as K-ras only, in ES cells, (see
also Pal et ai, 1993) is consistent with this hypothesis. It is therefore suggested that
the K-ras splicing pattern for a particular cell type is probably determined at or
before the time of differentiation into that cell type.
5.3.5 K-ras Splicing Variant Exon 4A is Associated with
Differentiation
The most significant findings from this work are those pertaining to the study of ES
cells and their differentiation. Three cell lines were studied-the ES cell lines E14 and
HM1, and the EC cell line PSA4. PSA4 is an EC cell line which shows a wide
spectrum of cell types upon in vitro differentiation (Table 1, and references therein,
of the Appendix, Silver et al., 1983). In addition to analysis of the parent cells, the
cells were subjected to the induction of differentiation in vitro as described in chapter
7 and the differentiated derivatives were also studied.
The major difference between the use of cell lines and tissues derived from a mouse is
that prior to any in vitro differentiation treatment the cells are a pure population, with
little or no contamination of the population by other minority cell types as is present
in tissues derived from the mouse. Therefore it was concluded that in ES and EC
cells, the exon 4B splicing variant is the only K-ras transcript expressed. However,
upon differentiation in vitro, K-rasA expression rapidly (within days of the removal of
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LIF) becomes upregulated to comprise an appreciable proportion of the total K-ras
mRNA as the cells lose their pluripotent phenotype and become committed to various
pathways of differentiation. Although not formally shown, it is likely that the
relatively wide variation in 4A:4B ratios recorded for individual populations of
differentiated ES and EC cells is a reflection of the extent of differentiation and the
proportions of particular lineages which developed from the pluripotent cells in the
different experiments. It is interesting to note that no evidence for the presence of the
K-rasA transcript was observed at day 9 of embryogenesis. Although this remains to
be confirmed by a finer-level analysis, it may suggest, in combination with the results
obtained from the in vitro differentation of pluripotent cells, that induction of K-rasA
transcription is a relatively late event in embryogenesis (between days 9 and 12).
As described above, some evidence for a role of K-rasA in gut development and
differentiation was also observed in this study.
Is the upregulation of K-rasA expression an initiating event in the formation of
different tissues from undifferentiated precursors, or merely an associated
observation? The fact that studies of ras on cell lines (Hagag et al., 1986;
Szerberenyi et al., 1990) suggest an important role for ras in differentiation may
argue for the former proposition: the presence of multiple splicing variants with
subtly different functions provides another level of control over ras-mediated
activation/differentiation of the cell. The different splicing variants may interact with
different upstream and downstream molecules to activate similar, but not necessarily
the same, genes in response to ras activation. This is also consistent with the other
major observation of this work, that splicing variant usage does not usually change
over time within a tissue type. It is suggested that once a cell is committed to a
certain lineage, K-ras splicing patterns tend to remain constant as one of the
functions of the molecule is to maintain the appropriate differentiated phenotype of
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the cell by activating the right genes in the right proportions. This may be upset in
neoplasms by mutation of ras, and indeed may be affected by the type of neoplasm
(tissue type) in question.
Further analysis of individual cell types derived from differentiated ES and EC cell
precursors, together with a finer-level analysis of the early-stage embryo, will be
important in verifying the association of K-ras expression patterns with pathways of
differentiation. Comparison of the ability of ES cells carrying homozygous mutations
B A
forcing the exclusive expression of either K-ras or K-ras to differentiate along
particular lineages as compared to their wild-type controls, and an analysis of the
same mutations in the context of the mouse embryo will formally show the
significance of varying K-ras expression patterns in particular developmental
processes. Since it is already apparent that quantitative differences in K-ras exon 4
variant expression are seen between different tissues, it is suggested that there may
also be phenotypic differences observed in mice heterozygous for mutations deleting
B A
either K-ras or K-ras as the appropriate quantitative balance between the two
isoforms of K-ras is perturbed.
B A
Should mice carrying mutations deleting either K-ras or K-ras prove to be viable,
an analysis of the profile of K-ras mutations in tumours in these animals and of the
spectrum of tumours which may be induced may also prove informative in the study





This study has examined some aspects of the hit and am gene targeting technique as a
method for the introduction of small mutations into the mammalian genome, and some
aspects of the function and expression of the K-ras proto-oncogene in vivo. An
important issue when attempting a hit and run experiment is the accuracy with which
the homologous recombination event between a chromosome and the introduced
plasmid is accomplished. A low level of fidelity in this process might engender the
introduction of undesired mutations together with the intended modification. This
question was investigated in the context of the hprt gene (chapter 2). It was
hypothesised that an error introduced into the target locus during a hit and run
experiment would most likely be introduced during the initial insertion ("hit") step of
the procedure, since unexpected mutations have previously been observed in gene
targeting experiments (Thomas & Capecchi, 1986; Doetschman et al., 1988;
Thompson et al., 1989; Brinster et al., 1989), but a high level of accuracy has been
observed in intra-chromosomal recombination events upon which the second, "run",
step of the procedure depends (Stachelek & Liskay, 1988). Therefore a strategy based
upon the correction of the hprtb m3 allele by an insertion vector was adopted to study
this problem. In addition to the required correcting sequences, a neo gene was included
in the targeting construct to permit the recovery of all "targeted" clones, whether they
were faithful or unfaithful recombinants. A comparison of Southern analysis and
phenotypic analysis (assessed by the ability of recombinant clones to survive in HAT
medium) was used to study the clones for evidence of errors occurring during HR and
resulting in a HATS phenotype. The hprt enzyme activity of targeted clones was also
analysed. A wider standard deviation of hprt enzyme activities for targeted clones as
compared with wild-type controls was expected if small errors in recombination
resulted in clones with an attenuated level of hprt activity which were still HATr.
Although the results were somewhat clouded by a reduced level of hprt enzyme
activity in the targeted clones, probably due to the presence of interfering bacterial
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plasmid sequences in vector pDMWIOlneo (Melton, 1990), it has been possible to
make certain conclusions regarding the accuracy of HR events. No evidence was
obtained for the presence of deletions at the site of integration, as has been previously
reported (Doetschman et ai, 1988; Thompson et al., 1989). In the present study, there
was no reason why clones would not be identified in which deletions had occurred at
the 3' end of the integration site (as well as the 5' end as previously reported), resulting
in ablation of hprt function, because clone isolation was independent of gene function.
None of the clones shown to be targeted by Southern analysis were found to be HATS.
It was also observed that the mean level of hprt enzyme activity of a targeted clone
was independent of the method of selection of the clone, which is inconsistent with a
high rate of error in the HR process. It was therefore possible to set a upper limit on
the inaccuracy of gene targeting, despite the relatively small sample size, which is
compatible with the successful execution of hit and run gene targeting experiments.
Experiments were also carried out which had the objective of introducing small,
defined mutations into the murine K-ras gene, by hit and run (chapters 3 and 4). These
mutations were a large deletion covering the promoter/exon 0 region, a missense
mutation creating an activating mutation, and a deletion of a single base-pair leading to
a ffameshift and premature termination of translation of (specifically) K-ras . A low
targeting efficiency was observed. In the case of the vector designed to create a
deletion, only one clone which had undergone a recombination event at the target locus
was obtained, and this was subsequently shown to have been generated by an
unpredicted event. The event leading to the structure suggested is thought to have
involved the combined concatenation of two vector molecules and an intra-vector
recombination event to produce a more complicated targeting plasmid structure prior
to insertion. Upon integration of the rearranged construct into the target locus by
homologous recombination, a complex insertion structure resulted, containing a
triplication of homology and two copies of the positive selectable marker, but not the
negative selectable marker. This created multiple possibilities for intra-chromosomal
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recombination events upon backselection, some of which were observed, and some of
which (including, unfortunately, the desired deletion) were not.
Similarly, no targeted clones, suggesting a very low targeting frequency were observed
for the construct designed to introduce an activating mutation at codon 12 of the K-ras
gene. Further problems were experienced with this experiment, in that it proved
difficult to screen the clones obtained by Southern blot. Therefore, a "fast-track"
protocol was designed both to accelerate the production of and increase the probability
of obtaining the desired revertant mutation in a hit and run experiment. This protocol
was adopted with this vector and the other vectors designed to introduce mutations in
the K-ras gene. The fast-track protocol showed very little improvement over the
conventional approach with the selectable markers in use (neo and HSV4&) due to an
unacceptably high level of background mutation at the HS\T& gene. It is suggested
however, that this may be avoided by the use of an hprt minigene as both a positive
and negative selectable marker, which would eliminate the majority of background
clones obtained in this type of experiment. The problems experienced in the screening
of clones obtained with vector pKiTPNT were solved by the use of RT-PCR to
generate a substrate which could be subjected to diagnostic restriction enzyme
digestion, to directly analyse the mRNA of the target gene. This strategy was also used
to provide a rapid screen for clones obtained with the vector designed to introduce a
premature termination codon into the K-ras gene. No such clones were obtained,
probably because of the problem of HSWtk mutation described above, although
refinements to this experiment have also been suggested. The screen at the mRNA
level based upon RT-PCR represents a generalised approach to the screening of
targeted mutations which is unaffected by limitations of Southern analysis, such as
sensitivity and the size of changes introduced into the target locus which may be
studied.
The expression of the two alternative K-ras exon 4 splicing variants in the developing
mouse has also been studied (chapter 5), by means of an RT-PCR strategy which
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amplifies both of the K-ras cDNA molecules in proportion to their original relative
amounts. This allowed a direct comparison of the ratios of the two mRNA species
from different tissues at different stages of development of the mouse to be made.
From the results obtained in this study, it is apparent that there is a significant, defined
subdivision of function of the two splicing variants of K-ras in vivo. In agreement with
previous work (Muller et al., 1983; Leon et al., 1987; Pal et ai, 1993) K-ras
expression was observed at all stages of development and in all tissues studied, but
A B
these studies have not sought to differentiate between K-ras and K-ras . Here,
B A
however, it was shown that whilst K-ras is ubiquitously expressed, K-ras has a more
limited pattern of expression, and where present is usually the minor component of the
A B
K-ras mRNA in a tissue. There was little evidence for changes in K-ras and K-ras
during the growth of differentated organs, suggesting that the K-ras expression pattern
for a particular cell- or tissue-type is an event determined early in development. An
association of K-ras splicing variant expression patterns with the differentiation of cell
types was demonstrated, based upon the observation that ES or EC cells, of different
lines, normally expressed exclusively K-ras but upon in vitro differentiation a





7.1 Manipulation of DNA
7.1.1 Large-Scale Preparation of Plasmid DNA
7
Two 20(0.1 aliquots of competent Escherichia coli cells (>2x10 CFU/pg pUC19),
strain DH5a (Life technologies) were removed from -70°C storage and thawed on
ice. l|U.l (about ljig) of DNA solution was added to one of the tubes of E. coli cells
and the tubes incubated on ice for 30 minutes. The cells were heat-shocked at 42°C
for 40 seconds and placed on ice. 80pl of S.O.C. medium was added to the tube and
the cells were incubated at 37°C for one hour in a shaking incubator (225 rpm). The
transformation was plated out onto an L-amp plate (disposable 100mm bacterial
culture dish containing L-broth supplemented with 50jJ.g/ml ampicillin and 1.2%
bactoagar) and incubated overnight at 37°C.
S.O.C. Medium L-Broth
Bactotryptone 20g/l Bactotryptone lOg/T
Yeast Extract 5g/l Yeast Extract 5g/l
NaCl, MgCl2, MgS04 lOmM each NaCl 0.17mM
KC1 2.5mM in ddH20, autoclaved
Glucose 20mM Supplemented with 50|lg/ml ampicillin
in ddH20, filter sterilised where stated
Supplemented with 1.2% w/v Bactoagar for
plates
The next day a colony was picked from the plate transformed with plasmid DNA (the
other plate should give no colonies) and was placed in 10ml L-broth supplemented
with ampicillin and the cells grown for about 8 hours in a shaking incubator at 37°C.
This culture was added to a 500ml flask of L-broth with ampicillin and incubated
overnight in a shaking incubator at 37°C, 225 rpm.
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The following morning the cells were harvested by centrifugation at 4000xg for 10
minutes at 4°C. The supernatant was discarded and the cells lysed by resuspending in
10ml Solution 1 with 5mg/ml lysozyme and incubating at room temperature for 5
minutes.
Solution 1: Glucose 50mM
Tris.HCl pH 8.0 25mM
EDTA lOmM
20ml of fresh Solution 2 was then added, mixed by inversion and the lysate was
incubated on ice for 10 minutes.
Solution 2: NaOH 0.2M
SDS l%w/v
15ml Solution 3 was added, the lysate mixed by inversion and incubated on ice for 10
minutes.
Solution 3: Potassium Acetate 3M
Glacial Acetic Acid 11.5% v/v
The precipitated proteins were removed by centrifugation at 48000xg for 20 minutes
at 4°C and the DNA was precipitated from the supernatant by addition of 0.6
volumes of propan-2-ol, mixing by inversion and incubating at room temperature for
15 minutes. The DNA precipitate was recovered by centrifugation at 17000xg for 30
minutes at room temperature. The supernatant was discarded, and the pellet washed
with 70% ethanol and then dried under vacuum. The DNA was resuspended in 4ml
TE buffer.
TE Buffer: Tris.HCl pH 8.0 lOmM
EDTA ImM
4g of caesium chloride and 0.4ml lOmg/ml ethidium bromide were then added and
the DNA solution placed in a polythene tube. The tube was centrifuged in an
evacuated ultracentrifuge overnight (Beckman, rotor V65ti) at 2xl05xg, room
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temperature. The DNA band was visualised with long-wave U.V. radiation, and
recovered with a syringe and wide-bore needle. 6-10 extractions (two more
extractions than was sufficient to completely remove the red colour from the
solution) with CsCl-saturated propan-2-ol were then carried out to remove the
ethidium bromide from the plasmid. The plasmid DNA was precipitated by combining
0.45ml DNA solution with 0.5ml H20 and 0.54ml propan-2-ol and centrifugation at
13000rpm for 2 minutes in a microfuge. The supernatant was discarded and the pellet
air-dried and finally resuspended in 0.5ml TE.
7.1.2 Small Scale Preparation of Plasmid DNA
This method is a modification of the procedures described by Birnboim & Doly
(1979) and Ish-Horowicz & Burke (1981), described in Sambrook et at. (1989).
Solutionsl, 2 and 3 were as described in section 7.1.1. A single bacterial colony from
a lOOpl transformation was transferred to 1ml L-broth supplemented with 5()|lg/ml
ampicillin and incubated with shaking overnight at 37°C. The cells were harvested by
centrifugation in a microfuge for 30 seconds at 4°C and the supernatant discarded.
The pellet was then resuspended in 1 OOpl cold solution 1 (omitting lysozyme), mixing
by vortexing. 200|ll fresh solution 2 was added and mixed by inversion. 150pl
solution 3 was then added, the lysate again vortexed and incubated on ice for 5
minutes. The tube was centrifuged for 5 minutes in a microfuge, and the supernatant
transferred to a fresh tube. An equal volume of 50% phenol: 50% chloroform was
added, mixing by vortexing, and then microfuging for a further 2 minutes at 4°C. The
aqueous layer was removed and the DNA precipitated by addition of 2 volumes of
ethanol. After 2 minutes, the tube was microfuged for 5 minutes at 4°C and the
supernatant discarded. The pellet was air-dried and redissolved in 50|ul TE pH8.0
containing 20pg/ml DNAse-free pancreatic RNAse. Inserts of clones were then
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checked by restriction digestion and agarose gel electrophoresis, and dideoxy
sequencing, prior to transformation and large-scale preparation.
7.1.3 Preparation of DNA Fragments using Powdered Glass
The Geneclean Kit from Bio 101, La Jolla, USA was used for the preparation of
DNA fragments for ligations, probes, etc. Briefly, The desired amount of DNA was
digested with the appropriate restriction endonuclease, and separated on a 0.8%
agarose-TBE gel. The band was visualised quickly with U.V. light and excised from
the gel with a scalpel. 0.5 volumes of Bio 101's modifier solution for TBE gels and
4.5 volumes of 6M Nal solution were added and the gel dissolved at 55°C. lOpi, or a
larger amount if appropriate, ofGlassmilk1M were added and the sample incubated on
ice for 5-15 minutes. The glass was then recovered by centrifugation for 10 seconds
in a microfuge and washed 3 times with Bio 101's NaCl/Ethanol/H20 wash. The
DNA fragment was then eluted from the glass into TE at 55°C for 5 minutes.
7.1.4 DNA Ligation
Following fragment isolation, appropriate amounts of fragments calculated according
to Sambrook et al., 1989, from Dugaiczyk et al. 1975 (typically a total of about
150ng DNA) were mixed with 0.4 Weiss units T4 DNA ligase and ligation buffer and
incubated at room temperature for 4 hours.
Ligation Buffer: Tris.HCl pH 7.8 50mM




Hexamminecobalt (III) chloride ImM
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7.1.5 Klenow Reaction
DNA fragments were sometimes rendered blunt-ended by the use of Klenow
fragment (Sambrook et ai, 1989). After digestion, the solution was made to 25pM
for each of the dNTPs and 1 unit klenow enzyme added. The mixture was incubated
at 30°C for 15 minutes and then the enzyme was deactivated by heating to 75°C for
10 minutes. The DNA was then dialysed against water for 3-5 minutes prior to
further manipulations.
7.1.6 Dephosphorylation of Vectors
To increase the efficiency of ligation reactions by preventing re-circularization of the
vector, 1 unit Calf Intestinal Phosphatase (Boehringer Mannheim) was added to the
linearised vector with CIP Buffer and the mixture incubated at 37°C for 30 minutes.
The vector was then gel purified prior to ligation.
CIP Buffer: Tris.HCl pH 9.0 50mM
(Final conc.) MgCl2 ImM
ZnCl2 O.lmM
Spermidine ImM
7.1.7 DNA Sequence Analysis
7.1.7.1 DNA Template Preparation
DNA was sequenced directly from plasmid (Hattori & Sakaki, 1986), templates being
prepared as follows: 1-2 pmoles (usually about 2-4pg) plasmid DNA were diluted to
18pl with ddH20 and denatured by the addition of 2pl 2M NaOH and incubation for
5 minutes at room temperature. 8pi 5M ammonium acetate (pH 7.5, filter sterilised)
was added and the DNA precipitated by the addition of lOOpl ethanol and incubating
the tube at -70°C for 5 minutes. The denatured plasmid was recovered by
centrifugation at 1300()rpm for 15 minutes in a microfuge at 4°C and the supernatant
discarded. The pellet was washed with 500(0.1 75% ethanol, microfuged for 2 minutes
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at 4°C and dried under vacuum. The prepared template was finally resuspended in 7|i
1 ddH20 and sequenced.
7.1.7.2 Dideoxy Sequencing
Chain-termination sequencing (Sanger et al, 1977) was carried out using the
(R)
Sequenase Version 2.0 system from United States Biochemical, Cleveland, USA,
according to the manufacture's instructions. Briefly, template prepared as described
in section 7.1.7.1 was mixed with l|il (about 0.5pmol) sequencing primer and 2ql 5x
reaction buffer and the mixture incubated at 65°C for 2 minutes before being
permitted to cool to below 30°C over a period of 30 minutes to anneal the primer to
the template.
Reaction Buffer (5x): Tris.HCl pH 7.5 0.2M
MgCl2 0.1M
NaCl 0.25M
The template/primermix was then placed on ice and lql 0.1M DTT, 2(0.1 labelling mix
diluted 1:5 in ddH20, 0.5ql [a-35S ] dATP (lOqCi/ql, Amersham) and 2ql Sequenase
enzyme (diluted 1:8 in enzyme dilution buffer) were added, mixed and the reaction
incubated at room temperature for 2-5 minutes.
Labelling Mix: dGTP, dCTP, dTTP 7.5qM each
Enzyme Dilution Buffer: Tris.HCl pH 7.5 lOmM
DTT 5mM
BSA 0.5mg/ml
Reactions were then teminated by placing 3.5fil reaction into each of four tubes
warmed to 37°C, containing one of the four (A, C, G or T) termination mixes. The
tubes were incubated a further 3-5 minutes at 37°C and then reaction was halted by
the addition of 4|j.l Stop Solution.
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Sequencing reactions were denatured at 90°C for 2 minutes and immediately run on a
6% polyacrylamide, 8M urea 0.4mm sequencing gel prewarmed to 50°C. (Either lx
TBE or a 0.5-5x TBE gradient gel). Upon completion of elecrophoresis, the gel was
fixed for 20 minutes in 10% methanol, 10% acetic acid, blotted onto Whatman 3MM
paper, dried and exposed to autoradiography film overnight.
Termination Mixes: dATP, dCTP, dGTP, dTTP 80p.M each
One of ddATP, ddCTP, ddGTP, ddTTP 80|lM
NaCl 50mM
Stop Solution: Formamide 95% v/v
EDTA 20mM
Bromophenol Blue 0.5g/l
Xylene Cyanol FF 0.5g/l
7.1.8 Targeting Constructs
Targeting vectors are described in their respective chapters. The PGKneo component
of vector pDWMlOlneo was derived from pSPGKneo (a gift of Hein te Riele,
Amsterdam). This construct is shown in figure 7-1 (a).
The constructs designed for targeting of the K-ras gene were based upon pPNT
(Tybulewicz et al., 1991), a pUC-based cassette (Yanisch-Perron et al., 1985)
containing the neo gene as a positive selectable marker (Southern & Berg, 1982) and
the HSVri: gene (Colbere-Garapin et al., 1979) as a negative selectable marker. Both
genes are under the control of the phosphogycerate kinase (PGK) promoter and
polyadenylation sequences (Adra et al., 1987). Vector pPNT is shown in figure 7-1
(b).
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Figure 7-1: Targeting and Selection Constructs
a) pSPGKneo. This construct was used as the donor of the 1.5kb Bgl II neo
fragment cloned into vector pDWMlOl to generate pDWMlOlneo (see chapter
2). Selected restriction sites are shown: B, Bgl II; H, BamH I; P, Pst I; E, EcoR I.
The numbered blocks represent, respectively: 1, Phosphoglycerate Kinase (PGK)
promoter; 2, neo gene coding sequence with the orientation and translated region
shown by an arrow; 3, PGK polyadenylation sequence. The bacterial plasmid
sequence pSP72 is shown as a black line.
b) pPNT. This construct forms the basis of vectors pKiDOPNT, pKiTPNT and
pK4BAPNT (see chapters 3 and 4). Selected restriction sites are shown: H,
BamH I; P, Pst I; Pv, Pvu II; E, EcoR I; K, Kpn I; Hn, Hind III; X, Xba I. The
numbered blocks represent, respectively: 1, PGK promoter; 2, neo gene coding
sequence with the orientation and translated region shown by an arrow; 3, PGK
polyadenylation sequence; 4, Herpes Simplex Virus thymidine kinase (HSVr&)
gene coding sequence with the orientation and translated region shown by an













7.2 Culture of ES Cells and EC Cells
7.2.1 Cell Lines
The following cell lines were used where mentioned in the appropriate chapters:
Cell Line ES / EC Cell Line Mouse Strain Reference
E14 ES 129/Ola Handyside et a/.,1989
E14TG2a ES 129/Ola Hooper et al, 1987
HM1 ES 129/Ola Magin et a/.,1992
PSA4 EC 129/Sv Martin & Evans, 1975
7.2.2 Routine Culture of ES and EC cells
7.2.2.1 Media
ES cells were cultured in Complete Medium (CM5:5) supplemented with LIF
(Leukaemia-inhibiting Factor) (Williams et al., 1988, Smith et al., 1988, Moreau et
al., 1988) prepared by transfection of Cos-7 cells (Chen and Okyama, 1987) and
O.lmM (3-mercaptoethanol or with CM5:5 supplemented with 60% CM5:5
conditioned by Buffalo Rat Liver (BRL) (Smith and Hooper, 1987) cells, and (3-
mercaptoethanol. Rarely, a feeder layer was used.
Complete Medium (CM5:5)
Glasgow's Modified Eagle's Medium (GMEM) (Life technologies)* lx
Foetal Calf Serum & Neonatal Calf Serum 5% v/v each
Non-essential amino acids (Life Technologies):
Glycine, L-alanine, L-aspartic acid, L-asparagine and L-glutamic acid 0. ImM each
L-proline and L-serine 0.2mM each
Sodium Pyruvate l.OmM
* lx GMEM includes L-Glutamine at 2.0mM and 2.5g/l Sodium Bicarbonate, but
these were added separately to the prepared medium
For preparation of BRL-conditioned medium, a confluent monolayer of BRL cells in
a 175cm2 flask was incubated with 60ml CM5:5 for 7 days and then the medium was
aspirated off and filtered through a sterile 0.8pm filter before storage at -20°C.
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To prepare feeder cells, a just-subconfluent layer of primary fibroblasts was cultured
for 2 hours in the presence of l()|ig/ml mitomycin-C in medium and then washed 3
times in PBS. The cells were removed from the flask by trypsinisation and seeded out
at lxlO6 cells/ 25cm2 flask.
For differentiation experiments, media CM(3 (CMS:5 supplemented with (3-
mercaptoethanol but not LIF) and EFN|3 (Medium as above containing (3-
mercaptoethanol but lacking non-essential amino acids, sodium pyruvate and LIF)
were used as described.
7.2.2.2 Serum
Two types of serum were used, foetal calf serum (FCS) and neonatal calf serum
(NCS). Batches were purchased from various manufacturers and tested before use by
being used to prepare standard medium, with LIF. ES cells were passaged by
standard trypsinisation and stopping the trypsin with the medium containing the
tested sera; this medium was then used to feed the culture of ES cells (10 cells in a
6cm culture dish) for 7 days, re-feeding after 3 days. The cells were stained with
1.5g/l Leishman's stain in methanol, and serum batches were deemed satisfactory if
cloning efficiencies of 20-30%, predominantly of undifferentiated cells, were seen.
7.2.2.3 Culture Conditions
ES Cells were routinely cultured by growing in CM 5:5 supplemented with LIF and (3
-mercaptoethanol on tissue culture treated plastic (Falcon, Nunc or Costar) coated
with swine skin gelatin (Sigma). A solution of 10g/l gelatin in ddFI20 was prepared
and autoclaved twice. This was then diluted 1:10 in ddH20 and tissue culture
plasticware was coated by covering the surface with the lg/1 gelatin solution and
leaving the plate or flask at room temperature for a minimum of 15 minutes. Cultures
were kept at a temperature of 37°C, in a humidified atmosphere of 5% C02, 95% air.
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Medium was changed as appropriate, usually every day or every other day, and cells
were passaged, usually about 1:6-1:10, just before confluence was reached.
7.2.2.4 Passaging ES Cells
To subculture ES cells, the cells were fed with fresh medium about 2 hours prior to
passaging. After this time, the medium was aspirated and the cells were washed twice
with sterile phosphate buffered saline (PBS, obtained as a tablet concentrate from
Flow Laboratories or lOx concentrate from Life Technologies).
Phosphate-Buffered Saline: NaCl 8g/l
(Calcium- and Magnesium-free) KC1 0.2g/l
Na2HP04 1.44g/l
KH2P04 0.24g/l
The PBS was aspirated and 1ml TVP for a 25cm2 flask was added and the cells
incubated at 37°C for 3-5 minutes.
TVP: Trypsin (Flow Laboratories) 0.25g/l
Chick Serum (Flow Laboratories) 10g/l
EDTA (Na2 salt) ImM
in Ca/Mg-free PBS, filter-sterilised
The cells were then disaggregated by a sharp tap to the flask and a minimum of an
equal volume of medium was added. The cells were then diluted as appropriate with
medium and replated on fresh plasticware coated with 0.1% gelatin. The ES cells
were refed after 2 hours.
7.2.2.5 Freezing Cells
ES and EC cells when not required were stored in the vapour over liquid nitrogen.
Cells were trypsinised as described in section 7.2.2.4, washed once by neutralising the
TVP with 10-20ml CM5:5 and centrifuging the cell suspension for 5 minutes at
lOOOrpm, and then resuspended in freezing medium. The cells were then cooled at an
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approximate rate of l°C/minute to -70°C overnight, and moved to storage over liquid
nitrogen the next day.
Freezing Medium: CM5:5 80% v/v
FCS 10% v/v
DMSO 10% v/v
(rendered slightly acid with sterile 1M HC1 and filter-sterilised)
To bring frozen cells back to culture, a freezing vial was removed from liquid
nitrogen and thawed in a 37°C water bath as quickly as possible. The cells were
washed in 10-20ml CM 5:5 before replating.
7.2.3 Transformation of ES Cells by Electroporation
ES cells were transformed by electroporation, using a BioRad Gene Pulser. 10s cells
(approximately one confluent 175 cm2 flask) were trypsinised as above and harvested
by centrifugation in a 20ml sterile universal for 5 minutes at lOOOrpm. The cells were
resuspended in 0.6ml PBS containing 150flg linearised plasmid DNA (verified by
agarose gel electrophoresis). The cell/DNA suspension was placed in a 1ml
electroporation cuvette (BioRad, path length 0.4cm) and an electric pulse (3|iF,
800V, time constant 0.1s) was applied. The ES cells were immediately transferred to
100ml CM5:5 and plated out in 90mm tissue culture dishes. The following day, the
medium was aspirated and selective medium added.
7.2.4 Selection of Transformed ES Cell Clones
ES cells plated out at a density of 107 cells/90mm plate (unless stated otherwise)
were subjected to selection for 10-14 days, until clones were visible to the naked eye
(l-2mm in diameter) and were then picked into individual wells of a 24-well plate and
disaggregated to permit expansion.
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On achieving confluence, wells were divided into two parts. Half the cells were
frozen, and the other half were used to prepare genomic DNA for screening of the
clones.
Selective Media
CM5:5 supplemented with LIF and (3-mercaptoethanol, supplemented with:






(2) 6-TG 2-amino-6-mercaptopurine (Sigma) lOpg/ml
(3) G418 Geneticin Sulphate (Life Technologies) 300|ig/ml
(4) Ganciclovir Dihydroxy-propoxy-Guanine 2p.M
7.2.5 In-Vitro Differentiation of ES and EC Cells
2.5xl06 cells were seeded out onto a 60mm tissue culture dish and cultured in EFN(3
for 3 days. Clumps of cells were then dislodged from the dish by directing a jet of 5ml
medium across the bottom of the dish 3 times, and harvesting the cells by allowing
them to sediment out under gravity. The cells clumps were then transferred with a
wide-bore pipette to a 100mm dish previously coated with agarose: Solutions of 1%
agarose (Miles) and 2% agarose in PBS were autoclaved. A 100mm culture dish was
coated with a layer of 2% agarose, removing the excess, and when the layer had set
at room temperature, a 1% agarose layer was applied onto this. 10ml EFN(3 was
added and the agarose layers equilibrated overnight with medium at 37°C, 5% CO2 in
air. The cells were then cultured on agarose for about 6 days with EFN(3, changing
the medium every other day, until aggregates of cells with defined cavities were
observed. This was defined as "differentiation stage 1". Aggregates were then
harvested by sedimentation under gravity, and seeded out onto 4 non-gelatinised
60mm culture dishes, and cultured as a suspension in medium CM(3, changing the
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medium as often as required, for 4-5 weeks. The end of this period was defined as
"differentiation stage 2". Samples of cells were taken at the end of both stages for the
K-ras PCR analysis described in section 7.4.3.
7.3 Analysis of ES Cell Clones
7.3.1 Preparation of ES Cell Genomic DNA
ES cells were harvested by brief centrifugation in a microfuge, and then 0.5ml of lysis
buffer, supplemented with 600pg proteinase K (Sigma), was added. The cells were
incubated overnight at 37°C with shaking. The lysate was extracted twice with an
equal volume of phenol to remove the proteins, and then with an equal volume of
chloroform. The aqueous phase was taken and an equal volume of propan-2-ol was
added to precipitate the DNA. The tube was centrifuged for 2 minutes at 13000rpm
in a microfuge and the propan-2-ol/water mix discarded. The DNA pellet was then
briefly vacuum-dried and resuspended in 100-500(11 (depending on yield) TE buffer.






7.3.2 Restriction Digestion and Agarose Gel Electrophoresis of
Genomic DNA
Approximately 10pg (30pl) ES cell clone DNA was digested overnight at 37°C with
a 3-fold excess of restriction enzyme in the manufacturer's recommended buffer
supplemented with ImM spermidine. 10% by volume loading dye was then added
and the digested DNA fragments were separated by agarose gel electrophoresis in a
0.8% w/v gel in lx TBE buffer at 40-100mA. The DNA was visualised by staining
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for 20 minutes in 0.5jig/ml ethidium bromide and then destained for 20 minutes in
dsH20.
Loading Dye (lOx): Bromophenol Blue 4g/l
Ficoll 400 300g/l
TBE Buffer: Tris-Borate 90mM
EDTA 2mM
Made to pH 8.0
Scaled-down versions of the above procedure were used for routine preparation of
DNA fragments for probes, ligations, to estimate DNA concentration, etc.
7.3.3 Southern Analysis of ES Cell Clones
7.3.3.1 Southern Transfer of Digested DNA
Transfer of DNA to hybridisation filters was carried out essentially as described by
Southern (1975), with modifications recommended by the membrane manufacturers
(Amersham). Briefly, the DNA was partially depurinated by treating the gel with
0.25M HC1 until the tracking dye had changed colour, and then rinsed in ddH20 for
30 minutes. This process is reported to enhance the transfer of larger fragments
(Sambrook et al., 1989). A capillary blot was then set up: A tray was filled with
0.4M NaOH, and a platform suspended above it. A wick made of Whatman 3MM
paper was laid over this and the gel placed on top. A piece of Amersham Hybond N+
nylon membrane was soaked in 0.4M NaOH and then placed on the gel. Another
piece ofWhatman 3MM paper, also soaked in 0.4M NaOH was placed over this and
then a layer of about 2 inches of paper towels. A weight of approximately 1kg was
placed on top. The area surrounding the gel was covered with Saran-Wrap to prevent
short-circuiting of the solution resulting in a poor DNA transfer. Gels were blotted
overnight.
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7.3.3.2 Hybridisation of Southern Blotted DNA
Hybridisations were carried out in a Hybaid hybridisation oven with rotisserie in glass
tubes at 65°C. A membrane was wetted in 2xSSC and then rolled up in a fine mesh
and placed in the tube. The 2xSSC was then replaced with 25ml
Prehybridisation/Hybridisation Solution.







250pg/ml sonicated salmon sperm DNA (denatured by boiling for 5 minutes) was
added immediately before addition of the solution to the hybridisation tube. The
nylon filter was prehybridised at 65°C for a minimum of 2 hours prior to adding the
probe. Filters were hybridised overnight and then washed the next morning, rinsing
out the hybridisation bottle with 2xSSC followed by 4 washes for 15 minutes in
O.lxSSC, 1%SDS at 65°C. The bottle was rinsed again with 2xSSC and the filter
wrapped in Saran-Wrap and placed in an autoradiograph cassette with 2 intensifying
screens and a piece of autoradiography film (Kodak or Agfa). The cassette was
placed at -70°C to expose.
Filters were stripped to be re-probed according to Amersham's directions, briefly, a
30-minute wash at 45°C in 0.4M NaOH followed by a 15-minute wash at 45°C in
O.lxSSC, 0.1% w/v SDS, 0.2M Tris.HCl pH 7.5.
7.3.3.3 Preparation of DNA Probes
DNA probes were prepared by random priming of DNA fragments prepared by
restriction endonuclease digestion of the appropriate plasmid, agarose gel
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electrophoresis of the digested fragments and use of the Geneclean kit (Bio 101) to
purify the desired fragment. 25ng of linear DNA was denatured by boiling for 5
minutes. In the case of the Amersham Megaprime kit, the DNA was then snap-cooled
on ice for 5 minutes, but this is not necessary when using the Amersham Rediprime
kit. Both kits were used according to the manufacturer's instructions. Briefly, after
denaturing the DNA the deoxynucleotides, reaction buffer and 2 units of klenow
enzyme were added, either as solutions in the case of the Megaprime kit, or simply
resuspended in the solution of denatured probe in the case of the Rediprime kit. 50|i.
Ci a-32P labelled dCTP (Amersham) was added and the mixture incubated at 37°C
for 10 minutes (Rediprime) or 30 minutes (Megaprime). Rediprime kit reactions were
then halted by the addition of 1/10 volume of 0.2M EDTA. Probes were separated
from free nucleotides using a Pharmacia Nick Column (Sepharose G50) and then
denatured by boiling for 5 minutes and snap freezing on ice for 5 minutes. The
freshly-labelled probe was then added to the prehybridised filters.
7.3.6 Screening of ES Cell Clones by the Polymerase Chain Reaction
PCR reactions were carried out using Taq DNA polymerase and associated reagents
from Life Technologies, deoxynucleotides from Pharmacia and oligonucleotide
primers from Oswell on a Hybaid Omnigene heating block.
7.3.6.1 Technical Considerations Pertaining to PCR Conditions
PCR primers where appropriate are cited from the work of their original designers.
Other primers were designed by assigning the regions of the gene to be amplified, and
selecting a sequence of about 20 base pairs. If possible, a C:G pair would be chosen
for the extended end of the primer. Using the rule of thumb that the addition of a A:T
base pair would increase melting temperature by 2°C and the addition of a C:G base
pair would increase melting temperature by 4°C (Thein & Wallace, 1986), the
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melting temperatures of the two primers was kept close, and in the region of 55°C-
65°C. Suggested primer sequences were checked using the GCG v7.0 DNA sequence
analysis software "squiggles" to ensure the primer would not be excessively prone to
intra-molecular hybridisation which could interfere with the annealing step of the
PCR reaction.
Reaction programs were devised to minimise the denaturing time, as Taq DNA
polymerase has a reduced half-life at high temperatures. Initially annealing
temperatures were set at 5°C below the calculated melting temperature of the
template/primer hybrid, and refined empirically from this starting point. Extension
times were set bearing in mind that the maximum rate of synthesis of Taq DNA
polymerase is approximately 1000 base pairs per minute.
7.3.6.2 Codon 12 Activating Mutation Diagnostic PCR
This PCR introduced a diagnostic Hph I restriction endonuclease site in the product
if the murine K-ras proto-oncogene template contained an activating glycine—>
aspartic acid mutation in codon 12 (Kumar & Dunn, 1989). The primers are shown
below:
Forward Strand: 5'> ACT TGT GGT GGT TGG AGG TG < 3'
Reverse Strand: 5'> TCC ACA AAG TGA TTC TGA AT < 3'
A 50|dl reaction was set up, consisting of SOpmoles each primer, Life Technologies
Polymerase Reaction Buffer (20mM Tris.HCl pH 8.4, 50mM KC1 final
concentration), 1.5mM MgCl2, lOOpM each for dATP, dCTP, dGTP and dTTP, 5|ll
genomic DNA prepared as above as template and 2 units of Taq DNA polymerase.
50pl of paraffin oil was layered over the top of the reaction mixture, and the reaction
was run according to the program on the following page.
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1 Cycle 72°C 10 minutes
The PCR product was then digested with 2 units of Hph I (New England Biolabs) at
37°C overnight and the digested products separated by electrophoresis in lxTBE,
20% polyacrylamide to detect the presence or absence of the Hph I site. The PCR
product is a 75-mer of part of K-ras exon 1 which may be cloven into a pair of
fragments 46bp and 29bp in size by Hph I if there is a G—>A substitution in the first
position of codon 12.
7.3.6.3 Neomycin Resistance Gene PCR
To detect the presence of the neo gene in an ES cell's genome, this PCR was used.
The primers are shown below:
Forward Strand: 5' > GCG ATG CCT GCT TGC CGA <3'
Reverse Strand: 5'> GAA GGC GAT AGA AGG CGA < 3'
A 50|il reaction was set up, consisting of 45pmoles of each primer, Life Technologies
Polymerase Reaction Buffer (20mM Tris.HCl pH 8.4, 50mM KC1 final
concentration), 1.5mM MgCl2, 20jiM each for dATP, dCTP, dGTP and dTTP, 5|il
genomic DNA prepared as above as template and 2 units of Taq DNA polymerase.
50|Ul of paraffin oil was layered over the top of the reaction mixture, and the reaction
was run according to the following program:
1 Cycle 93°C 3 minutes




1 Cycle 72°C 10 minutes
An aliquot of the reaction product was then run on a 2% agarose gel; presence of a
215bp band indicated presence of the neo gene.
7.3.6.4 K-Ras Exon 4B PCR
This PCR was designed to provide an easy diagnostic test for the point mutation
which was designed to place a premature nonsense codon in exon 4B of the murine
K-ras gene. The exon is amplified and digested with the restriction endonuclease
BstBI. Loss of the restriction site indicates that the mutation is present.
The reverse strand primer was that described in section 7.4.3, and the forward strand
primer is shown below:
Forward Strand: >5' GGA ATT CCT ATA TTT CAG GGT GTT GAC GAT <3'
This primer contains an EcoR I restriction endonuclease site at the 5' end should it
ever be desired to clone the PCR product. A 100(il reaction was set up consisting of
50pmoles of each primer, Life Technologies Polymerase Reaction Buffer (20mM
Tris.HCl pH 8.4, 50mM KC1 final concentration), 1.5mM MgCl2, 20|lM each for
dATP, dCTP, dGTP and dTTP, lOpl genomic DNA prepared as above as template
and 2 units of Taq DNA polymerase. lOOp.1 of paraffin oil was layered over the top of
the reaction mixture, and the reaction was run according to the following program:
1 Cycle 94°C 3 minutes
30 Cycles 94°C 30 seconds
55°C 30 seconds
72°C 30 seconds
1 Cycle 72°C 10 minutes
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The PCR product was extracted with chloroform to remove any paraffin oil and
digested at 65°C with the restriction enzyme BstB I (New England Biolabs) in the
manufacturer's recommended buffer overnight. The digested products were run on a
2% agarose gel to check for loss of the BstB I site; the full-length PCR product is
117bp in size, and is cloven into a pair of fragments 50bp and 67bp in size if the BstB
I site diagnostic of the wild-type allele is present.
7.4 Reverse Transcription PCR of K-Ras mRNA
7.4.1 Sample Preparation
Mice were killed and dissected in PBS. Tissue samples were placed in cryo-
preservation tubes, snap-frozen in liquid nitrogen and stored in the vapour over liquid
nitrogen until required.
7.4.2 Preparation of RNA using TRIzol Reagent
When working with RNA all plasticware was either guaranteed RNAse-free by the
manufacturer, or immersed overnight in ethanol containing 0.1% v/v diethyl
pyrocarbonate prior to autoclaving. 0.1% v/v DEPC was added to ddH20 prior to
autoclaving, and this was used for the making of all solutions.
TRIzol1M Reagent (Life Technologies) was used for the preparation of RNA
according to the manufacturer's instructions. TRIzol is a mono-phasic solution of
phenol and guanidine isothiocyanate, and based on the method of Chomczynski and
Sacchi (1987). Briefly, a small sample of tissue was mixed with 1ml TRIzol,
homogenised and incubated at room temperature for 5 minutes. 0.2ml chloroform
was added, the mixture inverted several times and then incubated at room
temperature for 2-3 minutes. The tube was centrifuged at 13000rpm in a microfuge
for 15 minutes at 4°C and the aqueous phase recovered. 0.5ml propan-2-ol was
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added to precipitate the RNA which was recovered by microfuging at 13000rpm for
10 minutes at 4°C. The supernatant was discarded and the RNA pellet washed with
lml 75% ethanol, then microfuged at 6500rpm for 5 minutes at 4°C. The ethanol was
discarded and the RNA pellet was briefly dried under vacuum, prior to being
resuspended in 20|il RNAse-free ddH20. The pellet was pipetted a few times and
then incubated at 50°C for 10 minutes to aid solvation.
RNA was quantified spectrophotometrically by taking readings at 260nm and 280nm.
An O.D.260 of 1 corresponds to 40jJ.g/ml RNA. The ratio of O.D.250/O.D.2g0 was
calculated and deemed satisfactory if it was in the range 1.8-2.0. A ratio significantly
lower than 1.8 suggests contamination of the RNA with phenol or protein; higher
than 2.1 that the RNA is degraded and unsuitable for reverse transcription reactions.
For samples used in the experiments described in chapter 5, RNA quantities are
necessarily very small because of the amount of source material available, and
therefore representative samples from a set of preparations were measured as it was
impossible to test every sample to be used.
7.4.3 Reverse Transcription
Approximately l-5|ig RNA was made up to 11 pi with RNAse-free ddH20 and liil
(0.5|ig) oligo (dT)12_i8 primer (Life Technologies) was added. The mixture was
incubated at 70°C for 10 minutes and then chilled on ice. The reaction was then made
to 20pl with Reaction Mix, microfuged briefly and incubated at room temperature for
10 minutes, then 37°C for 60 minutes, and finally terminated at 90°C for 10 minutes.






The reaction was chilled on ice for 10 minutes, 1-4 units RNAse H were added and
the reaction incubated at 37°C for 20 minutes.
7.4.4 K-Ras PCR of Murine cDNA
lOjLLl cDNA was used as template in the PCR reaction. The primers are shown below:
Forward: 5'> GGA ATT CCG CCT GCT GAA AAT GAC TGA GT < 3'
Reverse: 5' > CGG GAT CCC GTG TAC ACC TTG TCC TTG ACT T < 3'
These primers incorporate an CcoR I (Forward) and a BamH I (Reverse) restriction
endonuclease site to permit easy cloning of the products when required. A 50|il
reaction was set up, consisting of 5pmoles each primer, Life Technologies
Polymerase Reaction Buffer (20mM Tris.HCl pH 8.4, 50mM KC1 final
concentration), 1.5mM MgCl2, 100p.M each of dATP, dCTP, dGTP and dTTP and 2
units of Taq DNA polymerase. 50(0.1 of paraffin oil was layered over the top of the
reaction mixture, and the reaction was run according to the program overleaf.
1 Cycle 94°C 3 minutes
21 Cycles 94°C 1 minute
The PCR generates two products 687bp and 565bp in size, representing K-rasA and
K-rosB respectively. This PCR was also used, at 32 cycles, for the preparation of
murine cDNAs to be cloned as probes, or to provide template cDNAs from clones to





1 Cycle 72°C 10 minutes
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7.5 Hprt Enzyme Analysis
7.5.1 Protein Extract Preparation
A confluent 75cm2 or 162cm2 flask of ES cells was harvested as described, and the
cells washed twice in 10ml CM5:5, twice in 10ml PBS and then stored as a pellet at
-70°C until required. The pellet was resuspended in 0.5ml Extraction Buffer and
subjected to 3 freeze/thaw cycles, with agitation, in a propan-2-ol/dry ice and 37°C
water bath, respectively. The lysate was then cleared by centrifugation for 15 minutes
at 30,000xg and the supernatant protein extract was retained and stored at -70°C
until required.




The Bio-Rad protein assay, (Bradford 1976), was used according to the
manufacturer's instructions. Briefly, volumes of ES cell extract (l-20|al) or known
quantities of BSA as a standard protein (0-1.4mg/ml) were diluted to 0.1ml with
extraction buffer, and 5ml 1:5 diluted and filtered dye reagent was added and the
solution mixed by inversion. After a minimum of 5 minutes at room temperature, the
OD595 was read versus the protein blank. Multiple linear regression was used to
calculate protein concentrations.
7.5.3 HPRT Enzyme Activity Assay (Gillin et al., 1972)
50jil reactions were set up in eppendorf tubes, consisting of 25|al 2xReaction Mix, 1-
10|ig protein extract, and ddH20 to a total volume of 50|il. Identical controls for
each tube also containing 30mM EDTA were run in parallel. Reactions were
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staggered at 20 second intervals, being started by the addition of either water
(blanks) or protein extract (samples) to the pre-incubated at 37°C reaction tube.
2xRM: 10()[il 1M Tris.HCl pH 7.4
200(0.1 ImM Hypoxanthine
5()0|il 2mM Phosphoribosyl Pyrophosphate (freshly prepared)
100|il 0.1M MgCl2
50(11 50|lCi/ml 8-14C Hypoxanthine (Amersham)
50(1.1 ddH20
Reactions were incubated for 40 minutes and then stopped by the addition of 1ml ice-
cold TB (samples) or 1ml TB-E (EDTA controls).
The sample was then filtered through a Whatman DE82 ion exchange disc with a
Millipore vacuum manifold. The tube was rinsed out with 1ml TB-E and this also
washed through the filter disc. The filter was washed twice with 5ml TB-E and then
dried overnight. The following day, the filters were counted in a scintillation counter.
7.6 Chimaera Production
7.6.1 Mouse Strains
The ES cells used (El4 and HM1) are both derived from the 129/Ola strain of
mouse, which carries the mutant alleles cch and p and as such give rise to a light
yellow mouse with pink eyes. They have the GPI-lsa isotype . Host blastocysts were
F2 crosses of CBAxC57BL/6, and thus give dark mice (25% black and 75% grey),
CBA being agouti and C57BL/6 black (a/a). They are homozygous for the GPI-lsb











isotype. Chimaerism in the coat could thus be estimated from the degree of light coat
colour on a dark mouse, and in other tissues from the relative proportion of GPI-lsa.
7.6.2 Collection of Embryos
Pregnant mice were killed 3.5 days post-coitum by cervical dislocation. The uterine
horns were dissected out, and the blastocysts flushed out by the insertion of a 25
gauge needle into the horn and injecting 1ml CM5:5 medium. The blastocysts were
collected in a 60mm tissue culture dish, from which they were picked out using a
binocular microscope and mouth-controlled pasteur pipette into a drop of medium.
This was kept under liquid paraffin at 37°C, 5% C02 in air until the embryos were
injected.
7.6.3 Injection of Blastocysts
About 1ml CM5:5 was placed at the bottom of a 90mm plastic petri dish and covered
with liquid paraffin. The blastocysts and a single-cell suspension of ES cells, prepared
by routine trypsinisation and resuspension in CM 5:5, were blown into this using a
mouth-controlled pasteur pipette. Injections were carried out using a Leitz Labovert
FS micromanipulator with a binocular microscope. About 12 ES cells, picked for
good morphology, were injected into each blastocyst, using a hand-made, rounded-
end glass pipette to hold the blastocyst and a narrower glass needle, pulled on a
Camden Instruments computer controlled electrode puller (model 773), and given a
"pen-nib" shaped point by hand, to pick up the ES cells themselves and inject them
through the zona pellucida and trophoblast layer of the blastocyst into the blastocoel.
The injected embryos were returned to the incubator, where they re-expanded, until
transfer to the foster-mother.
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7.6.4 Return of Blastocysts to Mothers
Pseudo-pregnant mice were anaesthetized by the intra-peritoneal injection of
O.lml/lOg body weight Hypnorm/Hypnovel mix (50|ig/ml fentanyl citrate, 1.7mg/ml
fluanisone,1.7mg/ml midazolam hydrochloride). Under a binocular microscope, the
appropriate area of the back was sterilised with 70% ethanol, and the end of the
uterine horn was carefully exposed, being located by its proximity to the slightly
darker ovary and the associated fat pad. A small hole was introduced into the uterus
wall with a 25 gauge needle, and then the blastocysts (8-12/each uterine horn) were
blown into the lumen through this incision using a mouth-controlled pasteur pipette.
The major incision was then sutured using a stitch for the peritoneum and 2 or 3
stitches, as required, for the skin. The mouse was then provided with a separate cage,
and kept warm over night.
7.7 Glucose Phosphate Isomerase Isozyme Analysis
The ubiquitous GPI-1 enzyme has two isoforms which can be distinguished
electrophoretically. The Gpi-lsa isoform is present in strain 129 (from which the ES
cell lines used are derived), and the Gpi-lsb isoform in CBA and C57BL/6 (F2
hybrids of which were used as host blastocysts). As described in Ansell and Micklem
(1986), this may be exploited to identify contribution of ES cell-derived tissue in a
chimaeric tissue of interest. 20mg tissue was homogenised with 50)lx1 sample buffer
and samples stored at -20°C until required.




50ml Supre Haem buffer (Helena Laboratories, #5802) was placed in each electrode
reservoir of the gel tanks and wet Whatman 3MM paper wicks placed over the
supports to contact the buffer. Cellulose acetate sheets were pre-soaked in the supre
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haem buffer for 20 minutes, 8p,l sample was loaded at the anode of the sheet with an
applicator loop and the sample electrophoresed for 90 minutes at 4°C, constant
voltage 350V. The sheet was stained by pouring on 1.2% agarose in water containing




0.4ml Tris.HCl pH 8.0
1.0ml Assay Stock
15(0-1 Glucose-6-phosphate dehydrogenase
0.5ml * 1 Omg/ml Methyl thiazolyl tetrazolium
0.5ml *2.5mg/ml Phenazine methosulphate
* Added just before use
0.3mg/ml NADP
6.5mg/ml Fructose-6-Phosphate
in 1M Tris.HCl pH 8.0, stored at -20°C


































Ethylene Diamine Tetra-Acetic Acid












kb 1000 Base Pairs
K-ras Kirsten ras proto-oncogene
LIF Leukaemia Inhibitory Factor
mRNA Messenger Ribose Nucleic Acid
NaCl Sodium Chloride
NCS Newborn Calf Serum
PBS Phosphate Buffered Saline
PCR Polymerase Chain Reaction
PNS Positive-Negative Selection
RNA Ribose Nucleic Acid
RT-PCR Reverse Transcription-Polymerase Chain Reaction
SDS Sodium Dodecyl Sulphate
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